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 The cellular pathways that govern survival in the face of diverse stresses rely on gene 
expression changes as one mechanism to respond to or protect against internal and external 
threats.  Because eukaryotic DNA is packaged into chromatin, these gene expression changes 
depend on the targeting of regulatory proteins to specifi c regions of the genome to alter 
chromatin structure, promoting or repressing transcription.  One protein domain involved 
in targeting chromatin regulators is the plant homeodomain, or PHD fi nger, a module that 
preferentially interacts with either methylated or unmethylated lysines on histones, and has 
important functions in human health.  Despite recent advances in identifying the histone ligands 
for some PHD fi ngers as well as the functions of the proteins that contain them, for many 
other PHD fi ngers, including some of the 17 PHD fi ngers of the budding yeast Saccharomyces 
cerevisiae, these questions remain unanswered.
In the research presented in this thesis, I sought to gain insight into the ligands and 
functions for three yeast PHD fi nger proteins, the Yng1 subunit of the NuA3 acetyltransferase 
complex, Jhd2, and Ecm5, the latter two both being homologous to the mammalian JARID 
family of histone demethylases.  In Chapter 2, I demonstrate that the PHD fi ngers of these 
proteins interact with histone H3 enriched for different sites of methylation depending on the 
PHD and present results of an in vitro assay used to test whether any yeast PHD fi ngers possess 
ubiquitin E3 ligase activity, a function ascribed to the PHD-related RING domain.  In Chapter 3, 
I discuss experiments performed to identify the protein interaction partners of Jhd2 and Ecm5, 
culminating in the discovery that Ecm5 interacts with the PHD fi nger protein Snt2 as well as 
the Rpd3 deacetylase, forming a complex I have named Rpd3(T).  I also discuss experiments 
showing that the ecm5 knockout strain does not have obvious defects in many yeast pathways.  
In Chapter 4, I present evidence that Rpd3(T) complex members are involved in the 
cellular oxidative stress and metabolism pathways, and discuss chromatin immunoprecipitation 
experiments followed by high-throughput sequencing which were performed to map Ecm5 and 
Snt2 localization before and after hydrogen peroxide-mediated oxidative stress.  I then discuss 
how the Ecm5 and Snt2 localization patterns relate to gene expression changes in wild-type cells 
after oxidative stress and in snt2 knockout cells.  I compare Ecm5 and Snt2 localization patterns 
in rich media before and after oxidative stress to patterns in less rich media before and after 
nutrient stress induced by the TOR pathway inhibitor rapamycin.  Finally, I discuss potential 
mechanisms through which Ecm5 and Snt2, either as a pair or as a part of the Rpd3(T) complex, 
may help to coordinate the cellular responses to oxidative and nutrient stresses, and the greater 
implications of this work. 
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CHAPTER 1: GENERAL INTRODUCTION
Eukaryotic genomes are packaged into chromatin
Eukaryotic cells face the challenge of fi tting extensive genomes into relatively modest-
sized nuclei.  They must do this in a manner that is space-effi cient but still fl exible enough to 
allow DNA-templated processes, such as transcription and replication, to occur.  This feat is 
accomplished by the packaging of the genome into a structure known as chromatin.  The cell 
biologist Walter Flemming fi rst used the term “chromatin” in late 1800’s, to describe a string-
like material within cells that readily absorbed basophilic aniline stain (Flemming, 1882).  
Approximately 45 years later, another biologist named Emil Heitz noticed that certain regions 
of chromatin remained darkly stained and condensed throughout the cell cycle, while other 
regions decondensed when not undergoing mitosis.  He named the former “heterochromatin” 
and the latter “euchromatin” (Figure 1.1A) (Heitz, 1928).  These two early studies helped launch 
the fi eld of chromatin biology, which in recent decades, has become immensely important to 
understanding genome regulation.
Working around the same time as Flemming, biochemist Albrecht Kossel discovered an 
acid-soluble substance associated with the nulcei of goose erythrocytes, and named it “histon” 
(Kossel, 1884).  Until the 1940’s, many scientists believed the histone proteins, which showed 
some degree of diversity depending on the source organism, were the source of hereditary 
information, rather than the DNA, which was thought to be too uniform between species to 
encode information (Schultz, 1941).  One partial proponent of this view was Alfred Mirsky, a 
protein biochemist working at The Rockefeller University (then The Rockefeller Institute), who 
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Figure 1.1 Chromatin structure
 A. Electron micrograph of a lymphocyte nucleus, with heterochromatin (Hc) and euchromatin 
(Ec) labeled.  The nucleolus (Nu) is also labeled. B. Schematic of chromatin as “beads on a 
string,” showing that heterochromatin has a more compact structure than euchromatin. C. Front 
view structure of the nucleosome core particle.  DNA is labeled in light blue, while histones H3, 
H4, H2A, and H2B are colored blue, green, yellow, and red, respectively.
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pioneered many of the early biochemical studies of histone proteins (Daly and Mirsky, 1955; 
Mirsky and Pollister, 1946).  However, in 1944, Oswald Avery, Colin MacLeod, and Maclyn 
McCarty, also working at The Rockefeller Institute, reported that the “transforming principle” 
responsible for converting a non-virulent strain of bacteria into a virulent strain was DNA, 
initiating many future studies that proved that DNA is the basis for heredity in bacteria and 
eukaryotes (Avery et al., 1944).  As DNA became increasingly accepted as the carrier of genetic 
information, the proposed function of the histone proteins switched from information carrier 
to DNA “packager,” although there was also early speculation that histones might inhibit gene 
transcription (Stedman and Stedman, 1951).  However, the details of DNA-histone interactions 
remained unclear.
In the 1970’s several studies helped to uncover the overall primary structure of 
chromatin.  First, multiple studies found that digesting chromatin with endonucleases resulted in 
a series of fragments, differing in size by approximately 200 bp, that produced a regular ladder 
when separated on a gel, suggesting that chromatin consisted of a repeating unit and that DNA 
and protein were associated within this unit (Billing and Bonner, 1972; Hewish and Burgoyne, 
1973; Mirsky, 1971).  Electron microscopy studies from C.L.F. Woodcock as well as Ada and 
Donald Olins showed that chromatin from multiple organisms formed a thin fi ber broken up by 
thicker particles, a structure that Roger Kornberg described as “beads on a string” (Figure 1.1B) 
(Kornberg, 1974; Olins and Olins, 1974; Woodcock et al., 1976).  Around the same time, Roger 
Kornberg published a model of chromatin structure based largely on biochemical and biophysical 
studies, describing a repeating unit of chromatin, consisting of an octamer of two copies each of 
the four core histone proteins, H2A, H2B, H3, and H4 (Kornberg, 1974; Kornberg and Thomas, 
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1974).  A subsequent study named this repeating unit of chromatin the “nucleosome” which both 
referenced the nuclear origin of these particles and the original term for these structures used 
by the Olinses, “nu bodies” (Oudet et al., 1975).  Whether physiologically relevant variation 
occurred within nucleosomes, and if so, how this variation was achieved, remained unclear at the 
time.
In 1997, Karolin Luger and Timothy Richmond published the crystal structure of 
the nucleosome at 2.8Å resolution, showing that the nucleosome core particle consists of an 
octamer of histone proteins which are wrapped with 146 basepairs of DNA in 1.65 left-handed 
superhelical turns (Figure 1.1C) (Luger et al., 1997).  A linker histone, called H1, associates with 
the DNA between two nucleosomes and assists in compaction of the chromatin into a tight fi ber 
(Happel and Doenecke, 2009).  The core histone proteins that make up the nucleosome octamer 
are extremely conserved throughout eukaryotes, indicating the importance of the chromatin 
structure in nuclear function.  Importantly, this high level of conservation allows studies of 
chromatin function in model organisms to be highly informative.
Mechanisms of chromatin regulation
Initially thought of as just a method to package DNA, chromatin is now understood to 
actively regulate most, if not all, DNA processes.  This is achieved through mechanisms that 
alter nucleosome structure, resulting in either increased accessibility of nucleosome-bound 
DNA or increased association between regulatory factors and the histones proteins themselves.  
At least four different mechanisms are known to regulate chromatin structure.  First, ATP-
dependent chromatin remodelers can alter the histone-DNA contacts of a nucleosome, rendering 
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it more accessible.  Numerous outcomes have been reported for remodeling, including the 
complete eviction of the histones from the nucleosome, the repositioning or sliding of the 
nucleosome along the DNA fi ber, replacement of certain histones within the nucleosome, or 
a reconfi guration of the nucleosome to a more accessible structure (Flaus and Owen-Hughes, 
2011).  The downstream consequence of these activities is to render DNA more or less accessible 
to regulatory factors such as the transcription machinery.
A second means of chromatin regulation involves the replacement of individual 
histones with “histone variants,” which can substitute for the canonical H2A, H2B, H3, and 
H4 (Talbert and Henikoff, 2010).  While some variants only contain slight differences in amino 
acid composition compared to their canonical counterparts, others are quite distinct.  In higher 
eukaryotes, where many cells are post-mitotic, variants provide an important way to alter 
chromatin structure without having to go through S phase, the point in the cell cycle when the 
canonical histones are synthesized and packaged with DNA (Frank et al., 2003).  However, even 
rapidly dividing eukaryotes such as the budding yeast, Saccharomyces cerevisiae, the model 
used in this thesis research, utilize variant histones to help regulate certain key processes.  For 
example, the yeast histone variant H2A.Z, which can substitute for histone H2A, is incorporated 
into the two nucleosomes fl anking transcription start sites, and is involved in initiation of 
transcription (Raisner and Madhani, 2006).  In addition, the yeast H3 variant, CenH3, marks 
centromeres and is important for genome integrity (Choy et al., 2012).
Another way that chromatin can be regulated is through the proteolytic cleavage of the 
histone tail from the core of the protein.  Site-specifi c histone cleavage was fi rst reported by 
Thomas Eickbush, Dennis Watson, and Evangelos Moudrianakis in the late 1970’s, who had 
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found a shorter isoform of histone H2A in histones extracted from calf thymus (Eickbush et al., 
1976).  Shortly after, David Allis and colleagues reported a clipped isoform of histone H3 in the 
transcriptionally inactive micronuclei of the ciliated protozoan Tetrahymena thermophila (Allis 
et al., 1980).  While studies into histone proteolysis continued into the early 1990’s, as more 
discoveries emerged about the fourth mechanism of chromatin regulation, post-translational 
modifi cation of the histone proteins, attention shifted away from histone “clipping.”  Recently, 
the histone H3 tail was found to be cleaved during mouse ES cell differentiation (Duncan 
et al., 2008), suggesting that histone proteolysis might play important roles in development.  
Furthermore, in budding yeast, H3 cleavage during sporulation and stationary phase growth was 
also recently reported (Santos-Rosa et al., 2009).  These new fi ndings may prompt a resurgence 
of interest in this mechanism.
Histones are the substrates for a wide range of post-translational modifi cations
One of the more widely studied mechanisms of chromatin regulation is histone post-
translational modifi cation, the covalent attachment of chemical moieties to the N termini and 
amino acid side chains of the histone polypeptides.  The fi rst scientist to describe the post-
translational modifi cation of histones was Kenneth Murray, who showed that histones from cells 
treated with radioactive methionine contained radioactive -N-methyl-lysine (Murray, 1964).  
Shortly thereafter, Vincent Allfrey, a histone biochemist and protégé of Alfred Mirsky (and 
another Rockefeller chromatin biologist), reported that histones could be acetylated as well as 
methylated (Allfrey et al., 1964).  Seeking to explain the observation that histones sometimes 
inhibited RNA synthesis and sometimes did not, Vincent Allfrey hypothesized that “relatively 
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minor modifi cations of histone structure, taking place on the intact protein molecule, offer a 
means of switching-on or –off RNA synthesis at different loci along the chromosome.” As proof 
of the existence of these “relatively minor modifi cations,” he showed that when isolated nuclei 
were incubated with radioactive sodium acetate or methionine, histones became radioactively 
acetylated or methylated, respectively.  
Since these initial discoveries, a wide variety of other histone post-translational 
modifi cations have been described, including phosphorylation, ubiquitylation, sumoylation, 
crotonylation, propionylation, butyrylation, formylation, citrullination, O-GlcNAcylation, and 
ADP ribosylation (Banerjee and Chakravarti, 2011; Bannister and Kouzarides, 2011; Jiang et 
al., 2007; Messner and Hottiger, 2011; Sakabe et al., 2010; Tan et al., 2011; Zhang et al., 2009). 
The diverse array of modifi cation types combined with the many histone residues that can act as 
substrates for these marks, results in a mind-boggling number of diverse combinations.  Noting 
this combinatorial complexity, Brian Strahl and David Allis hypothesized that “multiple histone 
modifi cations, acting in a combinatorial or sequential fashion on one or multiple histone tails, 
specify unique downstream functions,” an idea they named the “histone code hypothesis” (Strahl 
and Allis, 2000).  Indeed, there are many well documented associations between particular 
modifi cations and cellular outcomes, such as those between phosphorylation of histone H3 at 
serine 10 (H3S10) and mitosis, and between H3K4 methylation and transcription (Ng et al., 
2003; Santos-Rosa et al., 2002; Sims et al., 2003).  
While these examples provide striking proof of the coding potential for histone 
modifi cations, a key challenge in the chromatin fi eld remains to be the identifi cation of functions 
for each individual histone modifi cation and for combinations of co-occurring marks.  In that 
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regard, the budding yeast system has proved particularly useful.  Because haploid yeast contain 
only two copies of each core histone and are amenable to gene deletion and mutation, studies in 
this organism have led to many key insights in chromatin biology (Hereford et al., 1979; Smith 
and Andresson, 1983).  Furthermore, the ease with which non-histone genes can be deleted 
from yeast, allowing the search for synthetic phenotypes using combinations of mutations, has 
made the yeast system a powerful tool for unraveling chromatin pathways.  One early pioneer 
of the use of yeast for chromatin studies is Michael Grunstein.  Early histone mutant studies 
from the Grunstein laboratory helped established a much stronger causal link between histone 
deacetylation and yeast heterochromatin formation (Johnson et al., 1990; Kayne et al., 1988).  
For my own graduate studies, I was attracted to the genetic power of the yeast system, and all 
of the in vivo experiments that I will describe in this thesis were performed using budding yeast.  
However, where possible, I will note connections between this work and mammalian biology.
Histone post-translational modifi cations regulate chromatin structure in cis and trans
Histone modifi cations regulate chromatin structure in two ways.  First, post-translational 
modifi cations can directly alter the strength of histone-DNA or histone-histone contacts, 
loosening the chromatin fi ber and promoting access to the underlying DNA.  This mechanism 
of nucleosome regulation in cis, is generally associated with histone modifi cations that alter the 
charge of the histone proteins, such as histone acetylation (Robinson et al., 2008; Shogren-Knaak 
et al., 2006).  Another histone modifi cation that regulates chromatin through a cis mechanism is 
histone ubiquitylation.  This mark has recently been shown by Tom Muir’s laboratory to impair 
compaction of the chromatin fi ber, in a mechanism distinct from that of histone acetylation (Fierz 
et al., 2011).
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In addition to affecting nucleosomal structure directly, histone post-translational 
modifi cations can also regulate chromatin in trans, by creating docking sites for other 
regulatory proteins.  Trans-acting proteins recruited to chromatin through interactions with 
histone modifi cations can then promote changes in local chromatin structure, enhancing or 
repressing the expression of nearby genes. For instance, in metazoans and the fi ssion yeast 
Schizosaccharomyces pombe, H3K9 methylation creates a binding site for the HP1 protein, 
which promotes chromatin compaction, resulting in the silencing of genes associated with 
this mark. (Bannister et al., 2001; Lachner et al., 2001; Nakayama et al., 2001).  In addition 
to regulating chromatin in cis, histone acetylation can also promote recruitment of regulatory 
factors in trans: in yeast, this mark creates binding sites for the Gcn5 protein, which is known to 
catalyze histone acetylation, thus creating a positive feedback loop (Owen et al., 2000).
Readers, writers, and erasers regulate histone post-translational modifi cations
When discussing chromatin regulation, it is useful to categorize the protein players 
into writers, erasers and readers (Figure 1.2).  Writers are the enzymes that catalyze particular 
histone modifi cations.  Similarly, erasers are the enzymes that remove those marks. The last 
category of histone regulator, readers, are proteins that are recruited to or stabilized on chromatin 
by interactions with specifi c histone modifi cations.  Generally, specifi c modules within reader 
proteins mediate histone interactions.  Many families of reader modules have now been 
described.  For instance, bromodomains are known to interact with acetylated histones, while 
chromodomains show specifi city towards histone methylation (Jacobs et al., 2001; Min et al., 
2003; Owen et al., 2000).  To further add to the complexity of chromatin regulation, often a 
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Figure 1.2 Writers, erasers, and readers
 Histone regulation is achieved by proteins that catalyze histone modifi cations (writers), proteins 
that enzymatically remove histone modifi cations (erasers), and proteins that specifi cally 
recognize either unmodifi ed or modifi ed histone amino acids (readers).
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single protein or protein complex can fall into more than one of these roles (Ruthenburg et al., 
2007).  For instance, the yeast Rpd3(S) histone deacetylase complex, which I will discuss more 
below, functions primarily as an eraser, removing acetyl groups from histones, but the Rco1 
and Eaf3 subunits of this complex contain a PHD fi nger and chromodomain, respectively, two 
reader modules that promote association with H3K36 methylation (Joshi and Struhl, 2005; Li et 
al., 2007).  It should be noted that while these concepts have generally been applied to histone 
modifi cations, many examples of post-translational modifi cation of non-histone proteins have 
been documented.  One of the better-studied examples of a non-histone substrate for post-
translation modifi cation is p53, which was demonstrated to be acetylated by Wei Gu and Robert 
Roeder, working at The Rockefeller University (Dai and Gu, 2010; Gu and Roeder, 1997; Huang 
and Berger, 2008; Spange et al., 2009).  Therefore, many of the readers, writers, and erasers 
known to regulate histones are likely to have non-histone substrates as well.
Histone acetylation is a modifi cation associated with transcriptional activity in yeast
Because histone acetylation and lysine methylation are two modifi cations most relevant 
to this work, I will introduce more about these marks.  Histone acetylation has been found at 
many, though not all, of the lysines in histones, and more recently, in non-histone proteins as 
well (Basu et al., 2009; Choudhary et al., 2009).  The writers for this mark are proteins known 
as histone acetyltransferases (HATs), or more recently, as lysine acetyltransferases (KATs), in 
recognition of these enzymes’ abilities to acetylate nonhistone substrates as well as histones.  
The fi rst transcription-associated HAT was discovered by James Brownell and David Allis in 
1995, who fractionated an acetylating activity from the transcriptionally active macronuclei of 
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Tetrahymena, and used an in-gel acetylation assay to show that this activity came from a 55 kDa 
polypeptide which was later identifi ed as the homolog of the yeast Gcn5 protein (Brownell and 
Allis, 1995; Brownell et al., 1996).  Around the same time, Susanne Kleff and Rolf Sternglanz 
identifi ed another yeast HAT activity and linked this activity to a gene which they named HAT1 
(Kleff et al., 1995), and work from Daniel Gottschling’s laboratory also identifi ed the yeast 
histone acetyltransferase Hat1 (Parthun et al., 1996).  Following on these initial discoveries, the 
human Gcn5 homolog; the mammalian transcriptional coactivators p300, CBP, PCAF, ACTR, 
and SRC-1; as well as the TAF(II)250 subunit of the TFIID transcription initiation factor were 
all shown to have HAT activity, suggesting histone acetylation and active transcription might be 
linked (Bannister and Kouzarides, 1996; Candau et al., 1996; Chen et al., 1997; Mizzen et al., 
1996; Ogryzko et al., 1996; Spencer et al., 1997; Yang et al., 1996).  
Budding yeast contain at least 10 HATs, Gcn5, Hat1, Elp3, Hpa2, Esa1, Sas3, Sas2, Taf1, 
Nut1, and Rtt109 (Han et al., 2007; Kimura et al., 2005).  In vivo, many of these HATs function 
in multi-protein complexes, and at least 12 different yeast HAT complexes have been described 
(Han et al., 2007; Lee and Workman, 2007).  For instance, the NuA3 complex, which will be 
discussed more in Chapter Two of this thesis, consists of the Sas3 catalytic subunit as well as 
Taf30 (Taf14/Anc1/Tfg3), Yng1, Nto1, and Eaf6, and is capable of acetylating multiple lysines 
on histone H3 (John et al., 2000; Taverna et al., 2006).  In some cases, the noncatalytic subunits 
of these complexes stimulate HAT activity (Han et al., 2007), while in others they help target 
these complexes to specifi c regions of the genome (Bian et al., 2011; Joshi and Struhl, 2005).  
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Functions of histone acetylation
Since its discovery, histone acetylation has been largely linked with active transcription.  
Vincent Allfrey, himself, showed that chemically acetylated histones stimulate transcription 
in an in vitro assay (Allfrey et al., 1964).  Consistent with this result, numerous studies have 
shown that in vivo, chromatin with abundant H4 acetylation is transcriptionally active, and 
transcriptionally active chromatin preparations are enriched for H4 acetylation (Allegra et 
al., 1987; Hebbes et al., 1988; Johnson et al., 1987; Lin et al., 1989; Ridsdale and Davie, 
1987).  While these studies convincingly showed correlations between histone acetylation and 
transcriptional activity, whether increased acetylation is a cause or a consequence of transcription 
remained a question for the fi eld (Turner, 1991).  
However, later studies have established causal links between increased histone 
acetylation and increased transcription.  For instance, while deleting the H4 N-terminal tail 
or mutating the acetylatable H4 lysines were generally found to impair gene activation, these 
mutations have been shown to activate the normally repressed yeast GAL1 promoter (Durrin 
et al., 1991; Fisher-Adams and Grunstein, 1995).  In addition, yeast strains with catalytic point 
mutations in the Gcn5 HAT fail to acetylate gene promoters and to activate genes in response to 
de-repressing stimuli (Kuo et al., 1998; Lee et al., 2000).  Furthermore, more recent experiments 
have found that the presence of HAT complexes and histone acetylation both stimulate 
transcription in vitro (Guermah et al., 2006; Ikeda et al., 1999; Kundu et al., 2000; Tse et al., 
1998).
Acetylation has functions beyond just stimulating transcription.  For instance, this mark 
helps prevent the spread of silent heterochromatin.  In yeast, the telomeres, rDNA, and silent 
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mating type loci are actively deacetylated and silenced by the SIR (silent information regulator) 
proteins, most notably, the Sir2 histone deacetylase (Bryk et al., 1997; Gottschling et al., 1990; 
Imai et al., 2000; Rine and Herskowitz, 1987; Smith and Boeke, 1997).  The confi nement of 
silencing factors to these regions is enacted, in part, by acetylation of H4 on lysine 16 (H4K16) 
by the Sas2 (something about silencing) and Esa1 HATs (Kimura et al., 2002; Suka et al., 
2002).  Because the Sir3 silencing protein requires deacetylated H4K16 to spread Sir2 mediated-
silencing along the chromatin fi ber, Sas2-catalyzed H4K16 acetylation presents a barrier to Sir 
spreading (Liou et al., 2005).
Histone deposition and chromatin assembly have also been linked to histone acetylation.  
During S phase, histone H4 is rapidly acetylated on K5 and K12 in many eukaryotes (Chicoine 
et al., 1986; Sobel et al., 1995).  This modifi cation promotes associations between newly 
synthesized histones and chaperone proteins, which help to deposit the new histones into 
chromatin (Smith and Stillman, 1991).  In yeast, acetylation of H4K5/12 is carried out by 
the HAT1 complex (Ai and Parthun, 2004; Poveda et al., 2004).  However, unlike in other 
eukaryotes, in yeast, H4 K5, K8, and K12 acetylation all function redundantly to promote histone 
deposition (Ma et al., 1998).  Once deposited into chromatin, these acetyl marks are rapidly 
removed, allowing other patterns of histone modifi cations, specifi c to the genomic region, to be 
set up (Annunziato and Seale, 1983; Jackson et al., 1976; Ruiz-Carrillo et al., 1975).
Rpd3 is a histone deacetylase with broad functions
Acetylation is not a permanent mark, but rather is actively removed from histones by 
eraser proteins called histone deacetylases or HDACs (also known as KDACs).  Jack Taunton, 
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Christian Hassig, and Stuart Schreiber are credited with identifying the fi rst HDAC.  Taunton 
and colleagues used the irreversible HDAC inhibitor trapoxin to purify a protein from human 
thymus cells which turned out to be homologous to the known yeast repressor Rpd3 (Taunton et 
al., 1996).  Shortly after, the Grunstein laboratory purifi ed two complexes with HDAC activity 
from yeast, and identifi ed the proteins Hda1 and Rpd3 as the subunits responsible for activity 
(Rundlett et al., 1996).  These initial studies paved the way for the identifi cation of many more 
HDAC proteins and complexes, including the discovery of at least seven more yeast HDACs, 
Hos1, Hos2, Hos3, Sir2, Hst1, Hst3, and Hst4 (Kurdistani and Grunstein, 2003).
Long before its HDAC function was known, the RPD3 gene was identifi ed by Marc 
Vidal and Richard Gaber in a screen for mutants that derepress the Trk2 potassium transporter in 
the absence of its activating protein, Trk1, and therefore had a reduced potassium dependency, 
compared with trk1 single mutants (Vidal and Gaber, 1991).  This study also found that Rpd3 
was required for both full repression and full activation of certain genes, suggesting that Rpd3 
might be a transcriptional regulator.  Consistent with this idea, Rpd3 has been linked with gene 
repression (Kadosh and Struhl, 1997, 1998; McKenzie et al., 1993; Stillman et al., 1994), a 
function which makes sense in light of the links between histone acetylation and transcription 
described above.  In addition to a repressive function, some studies have found a requirement 
for Rpd3 activity in gene activation (Bowdish and Mitchell, 1993; Sharma et al., 2007; Xin et 
al., 2007).  Because these studies did not demonstrate Rpd3 localization to the genes that require 
it for activation, some scientists have dismissed these fi ndings as indirect effects of RPD3 
deletion (Humphrey et al., 2004).   However, more recent studies have demonstrated that Rpd3 
directly binds to the promoters of some of the genes that require it for activation (De Nadal et 
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al., 2004; Ruiz-Roig et al., 2010; Sertil et al., 2007; Sharma et al., 2007).  Intriguingly, Rpd3 has 
also been shown to be required for activation of the FLO11 gene locus, through a mechanism 
involving repression of FLO11-repressive noncoding RNAs originating in the FLO11 promoter 
(Bumgarner et al., 2009).  It remains unclear whether other examples of Rpd3-mediated gene 
activation are also cases where Rpd3 functions to repress noncoding RNAs that repress gene 
activity.  Taken together, these studies suggest that while Rpd3 primarily functions to repress 
target genes, in certain contexts, this protein can function as a transcriptional activator.
In addition to gene regulation, Rpd3 also functions to antagonize silencing.  In this 
regard, Rpd3 functions in an opposite fashion to the Sir2 HDAC mentioned above, which is 
required for silencing in yeast.  Cells lacking Rpd3 have greater levels of silencing at telomeres, 
silent mating type loci, and rDNA (De Rubertis et al., 1996; Rundlett et al., 1996; Smith 
et al., 1999; Vannier et al., 1996).  In addition, rpd3 cells have increased levels of Sir2 in 
heterochromatic regions and neighboring euchromatic regions (Zhou et al., 2009).  Given that 
histone deacetylation is generally associated with gene repression, the increased silencing seen 
in rpd3 mutants may seem a bit puzzling.  To reconcile these fi ndings, some have suggested 
a model in which Rpd3 and Sir2 compete for binding sites at boundary regions (Smith et al., 
1999; Sun and Hampsey, 1999; Zhou et al., 2009).  According to this model, deletion of RPD3 
frees up more binding sites for Sir2, which then enhances silencing.  Intriguingly, a recent study 
has found low levels of H4K12 acetylation, one of the preferred targets of Rpd3 deacetylation, 
at telomeric regions (Zhou et al., 2011).  It is possible that the presence of this mark promotes 
heterochromatin formation, and that the higher levels of H4K12 acetylation found in rpd3 
knockout cells result in increased levels of silencing. While the exact mechanism by which Rpd3 
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antagonizes silencing is still unclear, this function for Rpd3 may explain the observation that 
rpd3 cells have increased lifespans, since loss of rDNA silencing is known to promote aging in 
yeast (Kim et al., 1999).
Rpd3 is a member of two known yeast complexes: Rpd3(S) and Rpd3(L).  Rpd3(L) is 
the larger of the two known Rpd3 complexes, with 12 reported subunits (Carrozza et al., 2005b; 
Keogh et al., 2005).  This complex localizes to the promoters of numerous genes and regulates 
transcription (Carrozza et al., 2005a).  Rpd3(L)-mediated gene regulation has been shown to be 
important in diverse cellular processes.  For instance, Rpd3 represses genes involved in meiosis, 
and rpd3 mutants have sporulation defects (Dora et al., 1999; Hepworth et al., 1998; Lamb 
and Mitchell, 2001).  Rpd3 also represses cell cycle genes (Bernstein et al., 2000; Takahata et 
al., 2009) and the HO endonuclease gene, which is important for yeast mating type switching 
(Vannier et al., 2001).  In addition, and of particular interest to the research discussed in this 
thesis, Rpd3 has been shown to regulate both cellular stress and nutrient metabolism genes, a 
function that will be discussed in greater depth later in this introduction.
The Rpd3(S) complex consists of the subunits Sin3, Ume1, and Rpd3, which are shared 
with Rpd3(L), as well as the unique subunits Eaf3 and Rco1 (Carrozza et al., 2005b; Keogh 
et al., 2005).  As mentioned earlier, the chromodomain and PHD fi nger of Eaf3 and Rco1, 
respectively, both interact with H3K36me2/3.  Together, these interactions recruit Rpd3(S) 
to gene bodies to deacetylate histones within coding sequences and help reset chromatin that 
has been activated by transcribing RNA polymerase II (Krogan et al., 2003; Li et al., 2007; 
Li et al., 2003; Xiao et al., 2003).   This genic deacetylation is most important at genes whose 
coding sequences serendipitously harbor regions that look like gene promoters.  At these genes, 
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Rpd3(S)-mediated deacetylation helps suppress transcriptional initiation from these “cryptic” 
internal promoters, promoting transcriptional fi delity (Carrozza et al., 2005b; Joshi and Struhl, 
2005; Keogh et al., 2005).  In addition, a recent study has found Rpd3(S) at gene promoter 
regions, where it suppresses noncoding antisense transcription (Churchman and Weissman, 
2011). The research described in this thesis pertains to the discovery of a third Rpd3 complex 
and my attempts to compare the function of that complex with known Rpd3(L) and Rpd3(S) 
functions.
Histone methylation also marks transcriptionally active chromatin in yeast
In contrast to acetylation, methylation does not alter the charge of the lysine side chain.  
Therefore, this modifi cation is not thought to regulate chromatin structure in cis.  Rather, the 
effects of lysine methylation are mediated primarily through the reader proteins that interact 
with this mark.  There are three distinct states of lysine methylation.  One, two, or even three 
methyl groups can be attached to the epsilon amino group of the lysine side chain, resulting in 
monomethylation (me1), dimethylation (me2), or trimethylation (me3), respectively.  While the 
distinct roles of these three types of methylations at different lysines have not all been elucidated, 
there is evidence that different states of methylation are associated with different functions.  For 
instance, in mammalian cells, H3K4me1 and H3K4me3 have different patterns of localization, 
with the former enriched in enhancer regions, and the latter enriched in gene promoters 
(Heintzman et al., 2007).  In yeast, Oliver Rando and colleagues have shown that H3K4 
methylation exists in a gradient throughout genes, with H3K4me3 levels peaking at the 5’ ends, 
H3K4me2 levels high in the middle, and H3K4me1 levels high at the 3’ ends (Liu et al., 2005). 
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Methylation of different histone residues is associated with different outcomes.  At least 
5 different sites of lysine methylation exist in mammalian H3 (K4, K9, K27, K36, and K79), 
along with one well characterized site of methylation on histone H4 (K20) (reviewed in Goll and 
Bestor, 2002; Lachner et al., 2003).  H3K9, H3K27, and H4K20 methylation are all correlated 
with heterochromatin formation (Cao et al., 2002; Lachner et al., 2001; Muller et al., 2002; 
Nakayama et al., 2001; Schotta et al., 2004).  In contrast, methylation of H3K4, K36, and K79, 
are all associated with transcriptionally active regions (reviewed in Martin and Zhang, 2005).  
Of those six well-studied methylation sites, only H3K4, K36, and K79 are known to be 
methylated in budding yeast.  Levels of H3K4 methylation peak in the promoters and 5’ ends 
of genes (Pokholok et al., 2005).  In contrast, H3K36 methylation is enriched in the middle and 
3’ ends of active genes, largely as a consequence of the association between the enzyme that 
writes this mark, Set2, and elongating RNA polymerase II (Krogan et al., 2003; Pokholok et al., 
2005; Xiao et al., 2003).  H3K79 methylation is also enriched in coding regions and is important 
for silencing (Ng et al., 2002; Pokholok et al., 2005; van Leeuwen et al., 2002).  In addition to 
these sites, recent studies have identifi ed H2BK37, H4K5, H4K8, H4K12, and H4K31 as sites 
of methylation in yeast, as well as H2AK99, H2BK43, H3K23, and H4K59 in mammals (Garcia 
et al., 2007; Gardner et al., 2011; Green et al., 2012; Hyland et al., 2011; Zhang et al., 2003).  
Future research will be key to discovering what roles these additional modifi cations play.
Histone methylation is catalyzed by a group of enzymes called histone methyltransferases 
(HMTs, also called lysine methyltransferases, or KMTs).  These enzymes use the metabolite 
S-adenosyl-L-methionine (SAM) as a methyl donor.  The fi rst HMT was characterized by Steven 
Rea, Thomas Jenuwein, and colleagues who were studying Suv39h1, the mammalian homolog 
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of the Drosophila Su(var)3-9 suppressor of position effect variegation (Rea et al., 2000).  The 
region of this protein responsible for methyltransferase activity was shared between SU(VAR)3-9 
proteins, the Polycomb-group E(Z) protein, and the trithorax-group TRX protein, so this motif 
was named the “SET” domain.  Shortly after this discovery, Scott Briggs and colleagues reported 
that in yeast, the Set1 protein functions as an H3K4 methyltransferase (Briggs et al., 2001), and 
the yeast Set2 and Dot1 proteins were found to methylate H3K36 and K79, respectively (Ng et 
al., 2002; Strahl et al., 2002; van Leeuwen et al., 2002).
While for many years, histone methylation was thought to be an irreversible modifi cation, 
the discovery of a class of enzymes that erase this mark, called histone demethylases (HDMs, 
also called lysine demethylases, or KDMs) challenged this idea.  Yang Shi and colleagues 
identifi ed the fi rst HDM, the mammalian LSD1 protein, based on its similarity to a class of 
enzymes called amino oxidases, which were known to be capable of oxidizing methylated 
proteins (Shi et al., 2004).   LSD1 was shown to demethylate H3K4me1 and me2.  However, this 
enzyme could not utilize H3K4me3 as a substrate, leaving open the question of whether histone 
trimethylation could be enzymatically erased.  Subsequent work from Yi Zhang’s laboratory 
identifi ed a second class of HDMs, the Jumonji C, or JmjC, proteins, which were capable of 
erasing histone trimethylation (Tsukada et al., 2006).   Further studies led to the identifi cation of 
fi ve JmjC proteins in budding yeast, Rph1, Gis1, Jhd1, Jhd2, and Ecm5, of which all but Ecm5 
have been found to have activity (Kim and Buratowski, 2007; Klose et al., 2007a; Liang et al., 
2007; Seward et al., 2007; Tu et al., 2007).
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The PHD fi nger acts as a methyl-reader module
Numerous protein domains act as readers for histone lysine methylation, including 
chromodomains, Tudor domains, and MBT domains (Taverna et al., 2007).  However, at the start 
of my graduate research, I took an interest in one type of reader module in particular, called the 
PHD, or plant homeodomain, fi nger.  Initially identifi ed in two plant homeodomain proteins that 
gave this module its name, the PHD fi nger is a protein domain that, depending on the specifi c 
example, differentially recognizes either methylated or unmodifi ed lysine residues on histone 
tails.  The PHD domain typically consists of a Cys4-His-Cys3 structure that coordinates two Zn2+ 
ions and contains two anti-parallel  sheets (Figure 1.3).  There are 14 PHD fi nger-containing 
proteins, and a total of 18 PHD domains in yeast (Table 1.1), while humans have approximately 
150 PHD fi nger proteins (Bienz, 2006). 
Because of structural similarities between the PHD domain and the RING fi nger, a 
domain associated with ubiquitin E3 ligase activity, the PHD fi nger was initially thought to also 
be capable of ubiquitylation.  However, all early examples of PHD fi ngers with E3 ligase activity 
were later shown to be misclassifi ed RING domains, leading most researchers to abandon 
the hypothesis that PHD fi ngers could function as ubiquitin ligases (Aravind et al., 2003) , an 
idea that I will revisit in the second chapter of this thesis.  As the popularity of this hypothesis 
fl agged, focus switched to the idea that PHD fi ngers might mediate chromatin interactions.  
Consistent with a chromatin function for these domains, many PHD fi nger-containing proteins 
are known to be nuclear and to contain other domains associated with chromatin regulation 
(Bienz, 2006).  In addition, early studies showed that PHD fi ngers can interact with nucleosomes 
(Eberharter et al., 2001; Ragvin et al., 2004; Xiao et al., 2001).  Soon after, the PHD fi ngers 
22
Figure 1.3 The PHD fi nger is a reader module that recognizes lysine methylation states 
A. The PHD fi nger fold is characterized by 4 cysteines, 1 histidine, and 3 more cysteines 
that coordinate 2 Zn2+ ions in a structure containing two anti-parallel -sheets. B and C. The 
structures of the H3K4me3-binding PHD fi nger from the human BPTF protein (B)  and the 
H3K4me0-binding PHD from human BHC80 (C) are shown with the PHD domain in silver, 
the H3K4 peptide in green, and the Zn2+ ions in cyan. Side chains of the residues critical for 
K4me0 or me3 interaction are in purple.
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Table 1.1 The 14 PHD fi nger-containing proteins in S. cerevisiaea
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of human BPTF (bromodomain and PHD fi nger transcription factor) and ING2 (inhibitor of 
growth-2) were shown to interact preferentially with histone H3K4me2/3, functionally linking 
PHD fi ngers to readout of histone methylation (Li et al., 2006; Pena et al., 2006; Shi et al., 2006; 
Wysocka et al., 2006).
Spurred by the excitement of those early discoveries, the chromatin fi eld has seen 
a dramatic expansion of research into PHD fi ngers in recent years, leading to discoveries 
of histone ligands for a number of additional PHDs.  These newer studies have reported 
many more examples of H3K4me-interacting PHD fi ngers.  In addition, PHD fi ngers that 
preferentially associate with other methylated lysines, unmethylated lysines, acetylated lysines, 
and even methylated arginines on histones have also been found (reviewed in Li and Li, 2012).  
Furthermore, while PHD fi ngers have traditionally been thought of as mediators of histone 
interactions, the PHDs of the mammalian MLL1 and PYGO1 proteins have been shown to 
interact with non-histone proteins, expanding the potential roles of these domains (Fiedler et al., 
2008; Miller et al., 2010; Wang et al., 2010).
The importance of PHD fi ngers in chromatin regulation is underscored by the number 
of human diseases that result from either direct mutation or altered regulation of this domain 
(Baker et al., 2008).  For instance, mutations in the human RAG2 PHD fi nger, which normally 
interacts with H3K4me3 to recruit RAG2 to segments of the genome poised to undergo V(D)
J recombination, are associated with the immunodefi ciency disorders T-B-SCID and Omenn 
Syndrome (Matthews et al., 2007; Ramon-Maiques et al., 2007; Schwarz et al., 1996; Sobacchi 
et al., 2006).  In addition, mutations in the fi rst PHD of the AIRE (autoimmune regulator) 
protein, which is known to interact with unmethylated H3K4, are associated with another 
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immune disorder called autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy 
(APECED) (Bjorses et al., 2000; Org et al., 2008; Saugier-Veber et al., 2001).  PHD mutations 
have also been associated with the neurological disorders Sotos Syndrome, Weaver Syndrome, 
ATR-X Syndrome, Rubenstein–Taybi Syndrome, and Borjeson–Forssman–Lehmann Syndrome 
(Argentaro et al., 2007; Douglas et al., 2003; Kalkhoven et al., 2003; Lower et al., 2002).  Lastly, 
PHD translocations and point mutations are associated various types of cancer (Ayton and 
Cleary, 2001; Campos et al., 2004; Chen et al., 2003; Chen et al., 2001; Lochner et al., 1996; 
Reader et al., 2007; van Zutven et al., 2006; Wang et al., 2009).  The links between mutations 
in the PHD module and so many different types of human disease give added importance to the 
goal of understanding the biology of these domains.
While many published studies have provided detailed examples of the mechanisms 
by which PHD fi ngers interact with chromatin and effect changes in chromatin regulation, 
there are still a large number of PHD fi nger proteins for which this understanding is lacking.  
Even in budding yeast, which has had the advantage of many years of genetic dissection, the 
exact ligands for many PHDs and the functions of the proteins that contain them are still not 
fully understood.  In the research described in this thesis, I set out to better characterize the 
in vivo functions of two yeast PHD fi nger proteins, Jhd2 and Ecm5, and the contributions of 
their PHD fi ngers to those functions.  When I started this work, very little had been published 
about these proteins, except that they contained other potential chromatin interacting domains 
(such as JmjC and ARID domains), and were known to be nuclear (Figure 1.4) (Bienz, 2006).  
In addition, Ecm5, or extracellular mutant 5, had been discovered in a screen from Howard 
Bussey’s laboratory for mutants with impaired cell walls (Lussier et al., 1997).  Based on this 
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knowledge, I hypothesized that both proteins were likely to have interesting and novel chromatin 
functions, and in the case of Ecm5, this might involve regulating genes involved in the cell 
wall.  Shortly after starting this project, Jhd2 was shown to have H3K4 demethylase activity and 
was given its name, JmjC domain-containing histone demethylase 2, leading me to become all 
the more interested in what the function of Jhd2-catalyzed demethylation might be. (Liang et 
al., 2007; Seward et al., 2007; Tu et al., 2007) .  At the same time, Ecm5, which also contains a 
JmjC domain, was shown not to have demethylase activity, leaving the function of this protein 
unknown.
Ecm5 and Jhd2 are homologous to the Drosophila melanogaster Lid protein, as well 
as to a mammalian family of proteins called the JARID proteins (Figure 1.4).  This family 
consists of the RBP2, PLU-1, SMCX, and SMCY proteins (also called JARID1A/KDM5A, 
JARID1B/KDM5B, JARID1C/KDM5C, and JARID1D/KDM5D, respectively), and proper 
functioning of these proteins is important to human health.  Mutations in SMCX are correlated 
with X-linked mental retardation and autism spectrum disorder (Adegbola et al., 2008; Ounap et 
al., 2012; Santos-Reboucas et al., 2011; Tzschach et al., 2006).  PLU-1 is upregulated in breast 
cancer (Barrett et al., 2002; Lu et al., 1999).  Furthermore, RBP2, a protein that interacts with 
retinoblastoma tumor suppressor protein is upregulated in gastric cancer, and translocations 
involving this protein, are found in some cases of acute myeloid leukemia (Fattaey et al., 1993; 
Reader et al., 2007; van Zutven et al., 2006; Wang et al., 2009; Zeng et al., 2010).  
Like Jhd2, the mammalian JARID proteins are H3K4 demethylases (Christensen et 
al., 2007; Iwase et al., 2007; Klose et al., 2007b; Lee et al., 2007; Seward et al., 2007; Yamane 
et al., 2007).  Intriguingly, Jhd2 and Ecm5 are each homologous to different sets of domains 
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Figure 1.4 Jhd2 and Ecm5 are homologous to the Drososphila Lid and mammalian JARID 
proteins
Domain structures of Jhd2, Ecm5, and a typical JARID/Lid protein are shown. Domains are 
abbreviated as follows - JmjN: Jumonji N, JmjC: Jumonji C, PHD: Plant Homeodomain, ARID: 
AT-Rich Interaction Domain, C5HC2: Zinc Finger Domain with Cys5HisCys 2-type structure. 
The asterisk in the Ecm5 JmjC domain denotes that this domain lacks demethylase activity.
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within the JARID proteins, suggesting that yeast might have evolved two separate proteins that 
perform the JARID function together, while in mammals, this functionality is contained within 
one polypeptide.  A detailed analysis of the functions of Jhd2 and Ecm5 will both aid in our 
understanding of general chromatin regulatory mechanisms and provide specifi c insights into 
how the mammalian JARID proteins function and contribute to human disease.
Chromatin regulation as a part of the yeast stress response and metabolism pathways
Many cellular pathways ultimately culminate in gene expression changes, and therefore 
rely on chromatin factors to enable transcription.  This is certainly true of many of the yeast 
stress and metabolism pathways, which are related to this research (Figure 1.5).  Regulation of 
yeast metabolism is governed by multiple major cellular pathways. (See Zaman et al., 2008, 
for an extensive review of yeast nutrient response regulation.)  These pathways can be broadly 
divided into those that respond to carbon sources and those that respond to nitrogen sources.  
For instance, high glucose levels activate the yeast protein kinase A pathway through the Ras1 
and Ras2 GTPases, which stimulate the production of cyclic AMP (cAMP) (Dechant and Peter, 
2008).  High levels of cAMP relieve repression of PKA, resulting in the phosphorylation of 
targets that promote glucose utilization and cellular growth.  PKA signaling also activates genes 
involved in ribosome biogenesis and glycolysis and represses stress response genes.  In a parallel 
pathway, the yeast Sch9 kinase, which is a homolog of the mammalian Akt/Protein Kinase B 
and S6 kinases, also promotes growth in response to glucose.  Sch9 is also involved in nitrogen 
sensing, through the TOR pathway that will be discussed below (Jorgensen et al., 2004; Urban et 
al., 2007).  
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Figure 1.5 The complicated world of cell metabolism and oxidative stress regulation 
converges on the nucleus
Many of the yeast pathways involved in cellular metabolism and oxidative stress response are 
shown, with key pathway names are in blue boxes . Oxidative stressors (hydrogen peroxide: 
H2O2; superoxide: O2
.-; oxidized proteins: SOH) are in yellow.  Nutrient stimuli (glucose: GLU; 
amino acids: AAs) are in dark green. Membrane receptors for some pathways are in pink. A 
cysteine-containing protein is shown in red. The main kinases or effectors of the pathways are 
in orange, except for Yap1, which is in purple. Transcription factors downstream of the various 
























































When glucose is limiting, the Yak1, Snf1(AMPK), and RGT pathways work to inhibit 
biomass production and promote utilization of alternate carbon sources.  The absence of 
glucose promotes the nuclear localization of both the Yak1 and Snf1 kinases.  Nuclear Yak1 
phosphorylates downstream targets, including the Pop2 subunit of the Ccr4-Not complex which 
functions in both RNA degradation and transcriptional regulation (Moriya et al., 2001).  Nuclear 
Snf1, the yeast homolog of the mammalian AMP-activated protein kinase (AMPK), promotes 
the repression of glucose catabolism genes through the Mig1 protein (Hedbacker and Carlson, 
2008).  Snf1 also promotes the activation of genes involved in nonfermentable carbon source 
metabolism, fatty acid oxidation, and stress response through a variety of transcription factors, 
including Adr1, Cat8, Sip4, and Hsf1.  In the absence of glucose, the RGT network promotes 
repression of different hexose transporter genes by the Rgt1 and Ssn6-Tup1 repressors (Johnston 
and Kim, 2005).  In low to moderate levels of glucose, this network also ensures selective 
expression of the hexose transporters with the appropriate affi nities for the amount of glucose 
present.
Two key pathways are associated with nitrogen sensing in yeast.  First, low amino 
acid levels activate the GCN (general control non-derepressable) pathway.  The effector of 
this pathway is the Gcn2 kinase, which is activated by interaction with the uncharged tRNAs 
that accumulate when amino acid concentrations are low.  Activated Gcn2 phosphorylates the 
translation initiation factor eIF2, inhibiting translation of most genes, while at the same time, 
promoting translation of the transcription factor Gcn4.  Once translated, Gcn4 activates genes 
involved in amino acid biosynthesis.  The TOR pathway responds to nitrogen levels through 
two protein kinase complexes: TORC1 and TORC2.  In contrast to the GCN pathway, TOR 
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complexes are active when amino acids are abundant.  While both TOR complexes regulate 
growth, TORC1 does so by promoting protein synthesis, production of translation machinery, 
and cellular uptake of nitrogen and carbon sources, while TORC2 is regulates cell polarity and 
endocytosis (De Virgilio and Loewith, 2006).  In addition, TORC1, but not TORC2, is sensitive 
to inhibition by the antifungal and chemotherapeutic agent rapamycin.  Treatment of yeast cells 
with rapamycin, promotes many of the same cellular changes as starvation, making this drug a 
useful tool in studying nutrient stress (Loewith et al., 2002).  The exact mechanisms by which 
amino acid levels stimulate TORC activation are still unclear, although many of the downstream 
targets of TORC1, including the Sch9 kinase, are known.  In response to TOR signaling, Sch9 
inhibits repressors like Stb3, Dot6, and Tod6, promoting expression of ribosome biosynthesis and 
ribosomal protein genes .
In addition to pathways that sense nutrient levels, yeast have multiple pathways that 
sense and respond to cellular stressors like oxidative stress, which is another focus of this work.  
Oxidative stress is primarily caused by reactive oxygen species (ROS), highly reactive oxygen-
containing molecules including oxygen ions and peroxides (Freinbichler et al., 2011).  At low 
levels, ROS do not necessarily present a challenge to yeast cells because dedicated families 
of enzymes can detoxify them.  In fact, yeast actively generate small amounts of ROS as a 
biproduct of oxidative phosphorylation through the mitochondrial electron transport chain (ETC), 
which couples NADH production in the TCA cycle to ATP generation (Kowaltowski et al., 2009; 
Lambert and Brand, 2009).  Usually, electrons fl owing through the ETC eventually interact with 
molecular oxygen, to generate water.  On occasion, this transfer can be incomplete, resulting in 
the ROS superoxide (O2
●-).  Superoxide, itself, is quite toxic, but superoxide dismutase (SOD) 
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enzymes in the mitochondria and cytoplasm can convert superoxide to hydrogen peroxide (H2O2) 
(Fridovich, 1995).  H2O2 is also a byproduct of fatty acid oxidation in peroxisomes.  While this 
ROS is less toxic than superoxide, it can still cause damage by oxidizing macromolecules in the 
cell directly, or by being partially reduced to the hydroxyl radical (●OH), an extremely powerful 
oxidant.  Proteins are particularly sensitive to oxidation, which can convert the sulfhydryl group 
of cysteine and methionine side chains into sulfenic, sulfi nic, or sulfonic acid (D’Autreaux and 
Toledano, 2007).  Cellular catalase and peroxidase enzymes perform an important function 
by converting H2O2 to water (Herrero et al., 2008).  In addition, some small molecules in the 
cell, such as reduced glutathione (GSH), ascorbate or vitamin E can act as antioxidants, further 
protecting cells from ROS-induced damage (Evans and Halliwell, 2001).
While these enzymes and antioxidants work well at detoxifying small amounts of ROS, 
larger doses of oxidants require the use of cellular stress response pathways for detoxifi cation.  
Damaged proteins can be repaired by thioredoxin, glutaredoxin, and the methionine sulphoxide 
reductase proteins (Herrero et al., 2008).  The Yap1 transcription factor also helps cells cope 
with ROS (Rodrigues-Pousada et al., 2010).  Yap1 is known to be localized to the cytoplasm in 
unstressed cells.  Upon exposure to ROS, the peroxidase protein Gpx3 acts as redox sensor and 
ultimately causes a intramolecular double bond to form between two cysteines in Yap1, resulting 
in a conformational change that causes Yap1 to accumulate in the nucleus and activate stress 
genes.
In addition to these pathways, yeast respond to oxidative stress through two mitogen 
activated protein kinase (MAPK) pathways.  The high-osmolarity glycerol (HOG) pathway is 
primarily associated with osmotic stress response.  In response to this stress, the HOG pathway 
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becomes activated, leading to phosphorylation of the Hog1 MAPK (de Nadal and Posas, 2010).  
Active Hog1 relocalizes to the nucleus and both associates with genes directly and promotes a 
transcriptional response through the Smp1, Hot1, and Msn2/4 transcriptional activators and the 
Sko1 repressor (Alepuz et al., 2001).  Oxidative stress also activates the HOG pathway (Bilsland 
et al., 2004; Haghnazari and Heyer, 2004; Singh, 2000).  Furthermore, a recent study found that 
hypoxia activates this pathway as well (Hickman et al., 2011).  While osmotic stress results in 
rapid phosphorylation of Hog1 within minutes (Maeda et al., 1995), both oxidative stress and 
hypoxia promote a more gradual phosphorylation of Hog1, with the former peaking 1 hour after 
the onset of stress and the latter peaking 4-5 hours afterward (Bilsland et al., 2004; Hickman et 
al., 2011).  These results suggest that timing of the HOG response may help dictate which genes 
are regulated.  Acute hypoxia is known to transiently induce oxidative stress in yeast, most likely 
through increased ROS production caused by impaired fl ux through the mitochondrial ETC 
(Dirmeier et al., 2002).  Thus, these two Hog1 responses might be linked.
The Cell Wall Integrity (CWI) MAPK pathway, has also been reported to respond to 
oxidative stress (Alic et al., 2003; Vilella et al., 2005).  This pathway is activated by numerous 
inducers of cell wall stress, including acid exposure, heat shock, and hypo-osmolarity, chemicals 
that bind to or degrade the cell wall, and caffeine treatment (Levin, 2005).  Once activated, 
the CWI pathway activates the Slt2 MAPK, which regulates cell wall remodeling, vesicular 
traffi cking to the cell wall, and the expression of cell wall biosynthesis genes through the Swi4/6 
transcription factors.  Oxidative stress is thought to activate this pathway either through direct 
oxidation of lipids in the plasma membrane, where sensors of cell wall stress are located, or 
through the activation of Ask10, which may activate Slt2 via activation of an upstream kinase 
(Levin, 2005). 
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There are numerous lines of evidence that the yeast nutrient sensing and oxidative stress 
response pathways are linked.  As mentioned above, respirative ATP metabolism is known to 
produce ROS.  Both caloric restriction and the presence of yeast antioxidant genes have been 
shown to extend replicative lifespan (Barker et al., 1999; Lin et al., 2002).  Furthermore, both 
starvation and oxidative stress trigger yeast to produce trehalose (Benaroudj et al., 2001; Lillie 
and Pringle, 1980).  This disaccharide is thought to help yeast cope with these stresses, both by 
preserving the integrity of the plasma membrane and by acting as a protein chaperone (Crowe 
et al., 1984; Singer and Lindquist, 1998).  Furthermore, inhibition of the TOR pathway, which 
mimics starvation, leads to the activation of the known stress transcription factors Msn2/4 as 
well as activation of genes involved in the oxidative stress response (Bandhakavi et al., 2008; 
Beck and Hall, 1999).  Conversely, oxidative stress leads to the inhibition of protein synthesis 
and is known to activate the Snf1 kinase (Hong and Carlson, 2007; Shenton and Grant, 2003).  In 
addition, diverse forms of stress as well as starvation activate the same set of genes, called “the 
environmental stress response” (Gasch et al., 2000).
Many chromatin regulators are known to be involved in the yeast metabolic and stress 
pathways.  For instance, numerous studies have linked diverse chromatin regulators, including 
the NuA4, Gcn5, and Rtt109 HATs; the Swi/Snf and Ino80 remodelers; and the Asf1 and Spt6 
chaperones, to regulation of the PHO5 gene, which is known to be induced by low phosphate 
levels, resulting in the loss of positioned nucleosomes at the PHO5 promoter (Rando and 
Winston, 2012).  Gcn5 is also needed for the activation of the Snf1 target gene, ADY2 (Abate et 
al., 2012).  Yeast growth and stress genes are known to be differentially regulated by the TFIID 
and SAGA complexes, respectively, both of which have HAT activity (Huisinga and Pugh, 
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2004).  SAGA, SWI/SNF, and RSC (another chromatin remodeler), are all needed to activate 
genes in response to osmotic stress (Mas et al., 2009; Pokholok et al., 2006), while Rtt109, 
Asf1, and Ino80 are needed to repress genes that have become activated in response to this 
stress (Klopf et al., 2009).  Moreover, a genome-wide ChIP study reported that the associations 
of a myriad of chromatin regulators with the stress gene promoters change after heat shock, 
consistent with roles for many of these proteins in regulating transcription in response to stress 
(Venters et al., 2011).  
Notably for the research presented in this thesis, multiple studies have linked the 
Rpd3 HDAC with regulation of stress and metabolic genes.  Rpd3 and Sin3 are needed for 
the repression of rRNA and ribosomal protein genes after rapamycin treatment (Rohde and 
Cardenas, 2003; Tsang et al., 2003).  A separate study found that Rpd3(L) is recruited to 
promoters of ribosomal biogenesis and ribosomal protein genes, which it represses in response 
to inactivation of the Sch9 TOR pathway effector (Huber et al., 2011).  Rpd3 is also required for 
gene activation after rapamycin treatment, although it is unclear whether this is due to a direct 
activating role of Rpd3 or due to indirect effects (Humphrey et al., 2004).  Rpd3 is also needed 
for gene activation and repression following heat shock (Kremer and Gross, 2009; Ruiz-Roig et 
al., 2010), and for gene activation after osmotic shock (De Nadal et al., 2004).  
While these studies link chromatin function to gene expression following nitrogen stress, 
heat shock, and osmotic stress, less is known about the chromatin proteins needed to regulate 
gene expression following oxidative stress.  Furthermore, the fi eld still does not know all of the 
proteins involved in gene regulation upon these stresses.  A recent study mapped the localization 
of 200 transcription-related proteins and found that 93% of yeast genes were occupied by at 
least 10 regulators, suggesting that diverse combinations of regulators at different sets of genes 
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may underlie the complex regulation downstream of many of these pathways (Venters et al.,  
2011).  Even in yeast, in which most of these pathways have been studied extensively, there are 
still many proteins, like the PHD fi nger proteins I described above, that are suspected or known 
to interact with chromatin, but whose functions remain unclear.  Sorting out these how these 
stress and metabolism pathways are regulated has relevance to numerous human disease states, 
including cancer, diabetes, and aging (Alic and Partridge, 2011; Dazert and Hall, 2011; Lin and 
Beal, 2006; Roberts and Sindhu, 2009).
Chromatin as a sensor of metabolic state
In addition to regulating metabolism genes, chromatin and metabolism are intimately 
linked by the use of cellular metabolites as precursors for histone modifi cations (Table 1.2) 
(Teperino et al., 2010; Wallace and Fan, 2010; Wellen and Thompson, 2010).  The best-studied 
example of a metabolite that connects chromatin and cellular energy state is acetyl-CoA, a key 
molecule in the tricarboxylic acid (TCA) cycle which also serves as the acetyl source for histone 
acetylation.  Recent studies have shown that yeast go through metabolic cycles, oscillating 
between using glycolysis and oxidative respiration as the main source of energy (Slavov et 
al., 2011; Tu et al., 2005).  Just as levels of oxygen consumed fl uctuate through these cycles, 
acetyl CoA levels also show periodicity (Cai et al., 2011).  The levels of histone acetylation also 
fl uctuate in these cycles, suggesting that histone proteins may also be a cellular metabolic sink.  
The link between acetylation levels and energy status makes some sense: since acetylation levels 
and tran scriptional activity are correlated, the enrichment of histone acetyl levels when acetyl-
CoA is abundant ensures that cells will be transcribing at maximal rates when they have enough 
energy stored to make biomass.
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Table 1.2 Cellular metabolites used by histone writer and eraser enzymes
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Acetyl-CoA is not the only chromatin enzyme cofactor that is also involved in 
metabolism.  The Sirtuin family of HDACs require NAD+ for activity, linking histone 
deacetylation to the cellular NAD+/NADH ratio, a readout of the redox state of the cell (Imai 
et al., 2000). The precursor for histone methylation, S-adenosyl methionine (SAM), is a key 
metabolite involved in the generation of the amino acids cysteine and methionine (Teperino et 
al., 2010).  In addition, histone demethylation depends on -ketoglutarate, an intermediate in 
the TCA cycle. Lastly, histone O-GlcNAcylation requires the molecule UDP-GlcNAc as a donor 
(Hanover, 2010).  This sugar is created by the hexosamine biosynthesis pathway and is used to 
make cellular glycosaminoglycans, proteoglycans, and glycolipids.
 Intriguingly, some metabolic enzymes have been detected in the nucleus, suggesting 
that metabolic regulation of chromatin is occurring locally.  For instance, the metabolic 
enzyme S-adenosylhomocysteine hydrolase (SAHH), which cleaves S-adenosylhomocysteine, 
a byproduct of cellular methylation reactions, can be found in the nuclei of frog embryos 
(Radomski et al., 1999).  Furthermore, the enzyme S-adenosyl methionine transferase, which is 
known to generate SAM from methionine, is partially localized to the nuclei of rat cells (Reytor 
et al., 2009).  In yeast, the enzymes Arg5/6, which are involved in arginine biosynthesis, also 
can be found in the nucleus and regulate gene expression (Hall et al., 2004).   In addition, the 
enzymes that generate acetyl-CoA in yeast, Acs1 and Acs2, have been found in the nucleus 
as well (Huh et al., 2003; Takahashi et al., 2006).  The reason for the nuclear localization of 
these metabolism enzymes is not clear.  In some cases, they might be creating locally high 
concentrations of cofactors needed for histone modifi cation.  Alternatively, they might have 
entirely novel nuclear functions, potentially acting as transcription factors.
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PHD fi nger proteins, stress, and metabolism
The research described in this thesis initiated with my wanting to understand how PHD 
fi nger-containing proteins contribute to chromatin regulation.  Specifi cally, this thesis describes 
my work to explore the functions and associations of the yeast PHD fi nger proteins Jhd2 and 
Ecm5.  In the next chapter, I will describe experiments I performed to characterize the chromatin 
associations of the Jhd2 and Ecm5 PHD domains.  I will also summarize experiments to test the 
hypothesis that a yeast PHD domain might function as a ubiquitin ligase.  In the third chapter of 
this work, I will describe experiments aimed at determining the functions of Jhd2 and Ecm5, and 
the exciting discovery that Ecm5 forms a complex with Snt2 and the Rpd3 HDAC.  In the fourth 
chapter I will present evidence that this new Rpd3 complex functions in the yeast oxidative stress 
and metabolic response pathways.  Finally, in the fi fth chapter, I will some discuss potential 
mechanisms by which this new Rpd3 complex regulates these pathways, future experiments to 
test these mechanisms, and the greater implications of this work. 
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CHAPTER 2: BIOCHEMICAL EXPERIMENTS TO CHARACTERIZE THE YNG1, 
JHD2, AND ECM5 PHD FINGERS
Chapter Introduction
The PHD fi nger is one member of a diverse set of domains that interact with specifi c 
histone modifi cation states.  Originally named for the plant homeodomain proteins fi rst shown 
to contain this domain, the PHD fi nger has a characteristic Cys4-His-Cys3 signature which 
coordinates two Zn2+ ions (Bienz, 2006).  As discussed in the previous chapter, this domain is 
capable of recognizing specifi c lysine methylation states on histone proteins.  In recent years, a 
number of elegant studies have characterized the structures and histone associations of a diverse 
array of PHD domains.  A recent review from Li and Li (2012) elegantly summarizes these 
studies.  However, in spite of these advances, there is still much to be discovered.  Although 
many PHD domains have been characterized structurally and biochemically, there are abundant 
examples of PHDs for which a ligand has not been found, making it diffi cult to ascertain how 
these domains contribute to the functions of the proteins that contain them.  Having studied yeast 
genetics and chromatin biology as an undergraduate, I immediately sought to take advantage 
of the potential of the budding yeast, S. cerevisiae, to address some of these questions.  There 
are 14 PHD-fi nger-containing proteins in yeast. (See Table 1.1, in the introductory chapter, 
for more information about these proteins.)  Many of these yeast PHD-containing proteins are 
known subunits of chromatin regulatory complexes, and all but three are known to localize to 
the nucleus (Bienz, 2006).  Thus, it is likely that most, if not all, yeast PHD fi nger proteins play 
important roles in chromatin regulation.  
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Because of my interest in these domains, I began to work with Sean Taverna, a former 
postdoctoral fellow in the Allis laboratory, to assist him in the characterization of the interactions 
of the NuA3 Yng1 PHD fi nger with chromatin.  The fi rst part of this chapter will focus on 
pull-downs I performed with Sean’s help, to confi rm an association between the Yng1 PHD 
fi nger and H3K4me3.  Upon completion of the Yng1 project with Sean, I became interested 
in two additional PHD-containing proteins, Ecm5 and Jhd2.  Unlike Yng1, whose interaction 
with the NuA3 histone acetyltransferase complex had been known before Sean and I started 
our experiments, the functions of Jhd2 and Ecm5 were largely unknown.  I therefore set out to 
determine whether the PHD fi ngers of Jhd2 and Ecm5 could interact with histones.  This work is 
the focus of the second part of this chapter.
The third section of this chapter describes in vitro experiments I performed to explore 
whether yeast PHD fi ngers might function as ubiquitin E3 ligases.  PHD fi ngers are structurally 
similar to RING domains, which are known to have ubiquitin ligase activity (Jackson et al., 
2000).  As part of my work studying PHD fi ngers, I noticed that the Ecm5 PHD was extremely 
similar to that of the S. pombe protein Msc1, a protein whose three PHD fi ngers were all reported 
to have ubiquitin ligase activity (Dul and Walworth, 2007).  I therefore wondered whether the 
Ecm5 PHD fi nger, or for that matter any other yeast PHD fi nger, might function as a ubiquitin E3 
ligase.  With the help of Ronen Sadeh, a postdoctoral fellow in the Allis laboratory, I set out to 
test whether yeast PHD domains translated in vitro possessed ubiquitin E3 ligase activity.
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The Yng1 PHD Finger Preferentially Interacts with H3K4me3
The NuA3 histone acetyltransferase (HAT) complex is one of at least eight complexes in 
yeast responsible for setting and maintaining the high levels of histone acetylation characteristic 
of yeast chromatin (Carrozza et al., 2003).  The isolated NuA3 complex is about 500 kDa, and 
has been shown to contain the proteins Taf30 (Taf14/Anc1/Tfg3), Yng1, and the HAT/MOZ 
domain-containing Sas3 protein, responsible for HAT activity (Eberharter et al., 1998; Howe et 
al., 2002; John et al., 2000).  Because of his own interest in this complex, Sean Taverna purifi ed 
the NuA3 complex, and identifi ed the proteins Nto1 and Eaf6 as additional subunits of this 
complex (data not shown).  Both Yng1 and Nto1 contain PHD fi ngers, suggesting the possibility 
that these domains might be involved in NuA3-chromatin interactions.  In addition, the entire 
Yng1 protein had previously been shown to interact with H3K4me3, suggesting that this subunit 
in particular might play a role in mediating the interaction between NuA3 and chromatin (Martin 
et al., 2006).  However, whether this interaction was mediated through the Yng1 PHD fi nger was 
unclear.
Thus, during my rotation in the Allis laboratory, Sean and I set out to determine whether 
the Yng1 PHD domain interacts with H3K4me3.  To that end, Sean purifi ed recombinant, 
N-terminally GST-tagged Yng1 PHD domain (residues 141-219 of full-length Yng1).  I then 
purifi ed endogenous yeast histones by acid extraction from cryogenically-prepared yeast lysates, 
to use in combination with the tagged Yng1 PHD for in vitro binding assays.  We chose to use 
endogenous yeast histones rather than purifi ed recombinant histones because we expected the 
former to have the full complement of histone modifi cations occurring in yeast, and thus, to 
potentially contain the “right” combination of modifi cations (if there is any) to interact with 
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the Yng1 PHD.  As a negative control, we used a recombinant GST-Yng1 PHD point mutant, 
in which the tryptophan corresponding to position 180 in full-length Yng1 had been mutated to 
glutamate (GST-Yng1-W180E); based on comparisons to other PHD fi ngers, this mutation was 
predicted to abolish binding to methylated lysines (Martin et al., 2006).
When combined with the yeast histones, the GST-Yng1 PHD fusion preferentially 
pulled-down histone H3, and not appreciable amounts of the other core histones (Figure 2.1).  
In contrast, no enrichment of H3 was seen in pull-downs with the tagged Yng1-W180E PHD.  
Furthermore, the H3 pulled-down by the tagged Yng1 PHD was enriched for H3K4me3, and to 
a lesser extent, H3K4me2, suggesting that the Yng1 PHD domain might interact preferentially 
with this mark.  Further fl uorescence anisotropy experiments by Sean Taverna confi rmed an 
association of the Yng1 PHD domain with H3K4me2/3, and found that the Yng1 PHD domain 
interacts preferentially with an N-terminal H3 peptide containing trimethylated lysine 4.  The  
dissociation constant (Kd) for this interaction was 9.1 M, compared to Kds of 21.4, 50.7, 
and >400 M for interactions with H3K4me2, H3K4me1, and unmodifi ed H3K4 peptides, 
respectively (Taverna et al., 2006).  Furthermore, using chromatin immunoprecipitation (ChIP), 
Sean was able to show that Yng1 localizes to genomic locations containing high levels of 
H3K4me3, and that when the Yng1 PHD fi nger was mutated, there was decreased H3K14 
acetylation and transcription at target genes.  All together, the in vitro binding assay performed 
by me, and the anisotropy and ChIP experiments performed by Sean all show that the Yng1 PHD 
fi nger can interact with H3K4me3, an interaction that helps target or stabilize an association of 
the NuA3 HAT complex with active chromatin regions of the yeast genome, where it can then 
acetylate H3 in these regions.
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 Figure 2.1 Recombinant, GST-tagged Yng1-PHD fi nger interacts with histone H3 enriched 
for K4me3
GST-tagged Yng1-PHD or Yng1-PHD-W180E fusions were incubated with acid-extracted yeast 
histones and pulled-down using glutathione sepharose. Western blotting with histone-specifi c 
antibodies was used to look for histones and modifi cations that preferentially associate with the 
Yng1 PHD fi nger.  Inputs (In) are 8% of pull-downs (PD).
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The Jhd2 and Ecm5 PHD Fingers Interact with Histone H3
Having helped to uncover an association between the Yng1 PHD domain and H3K4me3, 
I turned my attention to two other PHD fi nger-containing proteins, Ecm5 and Jhd2, the functions 
of which were completely unknown at the time.  Because both proteins contained multiple 
domains (ARID, JmjN, JmjC) linked to chromatin function, in addition to their PHD fi ngers, 
I reasoned that they might have interesting and novel chromatin regulatory functions.  I was 
intrigued that both proteins contained Jumonji C (JmjC) domains, which had just been shown 
to have histone lysine demethylase activity in other proteins, leading me to wonder whether 
Jhd2 and Ecm5 might be yeast histone demethylases.  In fact, shortly after I started this project, 
Jhd2, which until that point was being referred to by its open reading frame name (YJR119C), 
was shown to have H3K4 demethylase activity through its JmjN and JmjC domains, and was 
therefore named JmjC domain-containing histone demethylase 2, or Jhd2 (Liang et al., 2007; 
Seward et al., 2007; Tu et al., 2007).  However, it remained unclear whether the PHD domain 
of Jhd2 interacted with histones, and whether this interaction was dependent on specifi c 
histone modifi cations.  Furthermore, the contribution of the Jhd2 PHD to the protein’s histone 
demethylase function was also unknown.  
In contrast to the JmjN and C domains of Jhd2, the Ecm5 JmjC domain was found not 
to have histone demethylase activity (Tu et al., 2007), and closer examination of this domain 
revealed that it lacks residues thought to be necessary for enzymatic activity, making it unlikely 
that Ecm5 functions as a demethylase.  Therefore, I chose to focus on what functions this protein 
might possess besides histone demethylation.  Ecm5 (or extra cellular mutant 5) was originally 
discovered in a screen for mutants with cell wall defects (Lussier et al., 1997).   Because Ecm5 
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contains multiple chromatin-related domains and because Ecm5 is known to be nuclear, I 
originally hypothesized that Ecm5 might have some role in regulating genes involved in cell wall 
maintenance.  In addition, Ecm5 and Jhd2 are roughly homologous to the mammalian JARID 
family of demethylases, RBBP2, PLU-1, SMCX, and SMCY (also called JARID1A/KDM5A, 
JARID1B/KDM5B, JARID1C/KDM5C, and JARID1D/KDM5D, respectively.  As discussed 
in the previous chapter, improper regulation of these proteins is linked with various human 
diseases.  Therefore, insights into the functions of Ecm5 and Jhd2 might have implications for 
the functions of the human JARID proteins, as well as for their roles in human disease.
In order to better understand Jhd2 and Ecm5, I fi rst wanted to determine whether the 
PHD fi ngers of these proteins can interact with histones.  I compared the Jhd2 and Ecm5 PHD 
fi nger sequences to those of the yeast Yng1 and human ING2 and BPTF PHD fi ngers, all of 
which are known H3K4me3-binders whose structures have been solved.  Alignments of these 
PHDs show that while the Ecm5 PHD has a slightly longer second loop region than most other 
PHDs, it is similar to the H3K4me3-binding PHD domains (Figure 2.2).  Three of the four key 
residues found to interact with H3K4me3, are conserved in the Ecm5 PHD (residues colored 
blue and red in Figure 2.2), as are two of the three residues known to be important for binding 
unmodifi ed H3R2 (residues colored green and red).  Thus, it seemed possible that the Ecm5 PHD 
fi nger might also recognize H3K4me3 or another methylation site (Figure 2.2).  In contrast, the 
Jhd2 PHD was more divergent at these residues, suggesting this PHD either does not interact 
with histone methylation, or that it does so in an entirely different manner from other known 
H3K4me3-binding PHD fi ngers.
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 Figure 2.2 Alignments of the BPTF, ING2, Yng1, Ecm5, and Jhd2 PHD fi ngers
Shown are alignments of amino acids Y2743-S2791, Y214-G260, Y157-E204, Y1240-P1289, 
and A237-V284 of the full-length BPTF (Homo sapiens, NCBI accession # NP_872579.2), 
ING2 (Homo sapiens, # NP_001555.1), Yng1 (S. cerevisiae, # NP_014707.1), Ecm5 (S. 
cerevisiae, # NP_013901.1), and Jhd2 (S. cerevisiae, # NP_012653.1) proteins, respectively.  
The amino acids that make up the characteristic Cys4His1Cys3 structure that defi nes the PHD 
fi nger are highlighted in yellow. For the BPTF, ING2, and Yng1 PHD fi ngers, whose structures 
have been solved, the residues known to interact with H3K4me3 are colored in blue, the 
residues that interact with H3R2 are in green, and the residues that form the separation between 
the H3R2 and H3K4me3 binding pockets are in red.  Corresponding conserved residues in the 
Ecm5 PHD fi nger sequence are also colored in this manner.
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I then set out to characterize the interactions of the Jhd2 and Ecm5 PHD fi ngers with 
histones, using the same in vitro binding assay described earlier in this chapter.  I fi rst purifi ed 
recombinant, GST-tagged Jhd2 and Ecm5 PHD fi ngers (residues G221-L300 and S1232-D1295, 
respectively, of the full-length proteins), as well as GST alone, from E. coli (Figure 2.3).  As 
a positive control for this assay, I used the GST-Yng1-PHD fusion, which again pulled down 
histone H3.  The tagged Jhd2 PHD also pulled-down H3 in this assay (Figure 2.4).  GST alone 
and the GST-Yng1-W180E-PHD fusion, which served as negative controls for this assay, did 
not pull down appreciable levels of any histone.  These results suggest that the Jhd2 PHD fi nger 
interacts with histone H3.
To try to determine whether a specifi c histone modifi cation on H3 mediates the Jhd2-
PHD interaction, I then blotted the eluates from my tagged Jhd2 PHD pull-downs with 
antibodies recognizing specifi c histone modifi cations.  In contrast to the H3 pulled-down by 
the tagged Yng1 PHD, which again was enriched for H3K4me3, the H3 pulled-down by the 
tagged Jhd2-PHD was enriched for H3K36me3 (Figure 2.4, bottom two panels).  To confi rm 
a direct interaction between the Jhd2 PHD and H3K36me3, I next conducted peptide pull-
down experiments with tagged Jhd2 PHD fi nger and biotinylated peptides containing either 
trimethylated or unmodifi ed H3K36.  However, I failed to observe enrichment of the tagged 
Jhd2 PHD in pull-downs with H3K36me3 peptides (data not shown).  Taken together, these data 
suggest an interaction between the Jhd2 PHD fi nger and histone H3 is unlikely to be mediated 
solely by a direct interaction with H3K36me3.  Jhd2 may instead interact with a yet unknown 
histone modifi cation state correlated with high levels of H3K36me3.  Alternatively, Jhd2 may 
require a combination of more than one modifi cation (e.g, H3K4me3 and H3K36me3) to interact 
with H3.
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 Figure 2.3 Recombinant free GST and GST-tagged Jhd2- and Ecm5-PHD fi ngers used for 
pull-downs
Coomassie-stained gels of GST (A), as well as N-terminally GST-tagged Jhd2 (B) and Ecm5 
(C) PHD fi ngers (amino acids G221-L300 and S1232-D1295 of the full-length proteins, 
respectively), which were expressed in E. coli and purifi ed using glutathione sepharose.
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 Figure 2.4 Recombinant, GST-tagged Jhd2-PHD fi nger interacts with histone H3 enriched 
for K36me3 
GST alone or GST-tagged Jhd2-PHD, Yng1-PHD or Yng1-W180E-PHD fusions were 
incubated with acid-extracted yeast histones and pulled-down using glutathione sepharose. 
Western blotting with histone-specifi c antibodies was used to look for histones and 
modifi cations that preferentially associate with the PHD fi ngers.  Inputs (In) are 8% of pull-
downs (PD).
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Next, I performed in vitro binding assays with the GST-Ecm5-PHD fusion.  As was the 
case with the Yng1 and Jhd2 PHD fi ngers, the GST-Ecm5-PHD selectively pulled-down histone 
H3 (Figure 2.5).  Intriguingly, and in contrast to my fi nding with the other PHD fi ngers, I also 
saw enrichment for histone H2A in tagged Ecm5 PHD pull-downs.  Using H3 modifi cation-
specifi c antibodies, I checked whether H3K4 or K36 methylation was enriched in tagged Ecm5 
PHD pull-downs.  The H3 pulled-down by the Yng1 PHD, the Ecm5 PHD-precipitated H3 
did show some enrichment for H3K4me3 compared to the GST control pull-down, although 
the levels of this modifi cation in the GST-Ecm5-PHD pull-down were not higher than in the 
negative control Yng1-W180E-PHD pull-down.  In addition, I found modest levels H3K36me3 
enrichment in the Ecm5 PHD pull-down, though this enrichment was lower than the amount of 
H3K4me3 enriched on H3 pulled-down by the Yng1 PHD fi nger.
I was surprised to not see more H3K36me3 enriched on the H3 pulled-down by the  
Ecm5 PHD fi nger because Or Gozani’s laboratory had reported that the Ecm5-PHD domain 
interacts with this mark (Shi et al., 2007).  Therefore, I decided to look for evidence for this 
interaction  using a peptide pull-down assay, despite not seeing strong enrichment of H3K36me3 
in Ecm5 PHD-precipitated H3.  However, using conditions under which a GST-Yng1-PHD 
fusion is selectively pulled-down with H3K4me3 peptides, I failed to observe enrichment of 
tagged Ecm5 PHD in pull-downs using methylated or unmethylated H3K4 or K36 peptides 
(Figure 2.6).  In summary, while the Ecm5 PHD domain can interact with the H3 and H2A 
proteins under some assay conditions, I could not fi nd any strong evidence for a direct interaction 
between the Ecm5 PHD fi nger and H3K36me3. 
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Figure 2.5 Recombinant, GST-tagged Ecm5-PHD fi nger interacts with histone H3 
GST alone or GST-tagged Ecm5-PHD, Yng1-PHD or Yng1-W180E-PHD fusions were 
 incubated with acid-extracted yeast histones and pulled-down using glutathione sepharose. 
Western blotting with histone-specifi c antibodies was used to look for histones and 
modifi cations that preferentially associate with the PHD fi ngers.  Inputs (In) are 8% of pull-
downs (PD).
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Figure 2.6 Tagged Ecm5 PHD fi nger is not enriched in pull-downs with an H3K36me3 
peptide 
Biotinylated peptides corresponding to the extreme N terminus of H3 or the region of H3 
surrounding K36 and bearing the indicated modifi cations were pre-bound to high capacity 
streptavidin agarose . Peptide-bound beads (or beads alone) were then used in pull-downs with 
GST alone or GST-tagged Yng1 or Ecm5 PHD fi ngers. Input GST fusions and peptide pull-
downs were separated by SDS-PAGE and analyzed by Coommassie staining.  Locations of 
GST and GST-PHD fusions as well as molecular weight markers are indicated to the sides of 
gels.
55
Yeast PHD Fingers as Potential Ubiquitin E3 Ligases
PHD fi ngers are structurally similar to another class of zinc-coordinating domains, 
called RING (really interesting new gene) domains (Figure 2.7A) (Capili et al., 2001; Pascual 
et al., 2000).  Just as a Cys4-His-Cys3 signature is characteristic of PHD fi ngers, a Cys3-His-
Cys4 signature defi nes most RING domains.  Many RING domains act as ubiquitin E3 ligases, 
catalyzing the fi nal step in the cascade that covalently attaches the protein ubiquitin to lysine 
residues within protein substrates (Figure 2.7B) (Jackson et al., 2000; Weissman, 2001).  The fi rst 
step of the ubiquitylation cascade is ubiquitin activation.  In this step ubiquitin forms an ATP-
dependent attachment to a ubiquitin-activating enzyme, or E1, by means of a high energy thiol-
ester bond between a cysteine in the E1 and the C-terminal glycine of ubiquitin.  The ubiquitin 
is then transferred from the E1 to a conserved cysteine in a member of the ubiquitin-conjugating 
E2 enzyme family.  The ubiquitin-charged E2 then associates with a RING-type ubiquitin E3 
ligase. The E3 ligase acts in part as a scaffold, bringing together the ubiquitin-charged-E2 and 
the substrate protein, thus facilitating the transfer of ubiquitin from the E2 to the -amino group 
of a lysine side chain in the substrate.  
In addition to forming attachments to substrate proteins, one ubiquitin moiety can be 
linked to a lysine in a second ubiquitin.  In this way, a single, monoubiquitylated lysine in a 
protein substrate can become the site of a long polyubiquitin chain.  Linkages via ubiquitin 
lysines 48 and 63 (K48 or K63) are the most common types of polyubiquitylation, although 
linkages at the other ubiquitin lysines have been found to exist in vivo (Xu et al., 2009).  
Different types of ubiquitin linkages promote different cellular outcomes.  For instance, K48-
linked polyubiquitin chains often target proteins for degradation by the 26S proteasome (Chau et 
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Figure 2.7 Overview of RING-type ubiquitin ligase function, and comparison with PHD 
fi ngers
A. Connectivity diagrams show the similarity between PHD fi ngers and RING domains. 
Diagrams were adapted from or modeled after Bienz (2006). B. Diagram showing how RING-
type ubiquitin E3 ligases function. A ubiquitin moiety (Ub) fi rst attaches to a cysteine (Cys) 
in an E1 ubiquitin-activating enzyme.  The ubiquitin is then transfered to a cysteine in an E2 
ubiquitin-conjugating enzyme.  The RING domain-containing E3 ligase then brings together 
the ubiquitin-charged E2 and the fi nal substrate, and catalyzes transfer of the ubiquitin to the 
substrate. C. Alignment of the S. cerevisiae Ecm5 PHD and second S. pombe Msc1 PHD fi ngers 
(amino acids K1239-P1289 and H1172-Y1219 of the full-length proteins, respectively), with 
identical residues highlighted in yellow and similar residues in orange.
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al., 1989; Finley et al., 1994).  On the other hand, K63-linked polyubiquitin chains are generally 
associated with cellular signaling functions, including protein traffi cking and DNA repair 
(Clague and Urbe, 2010; Sun and Chen, 2004).  Protein monoubiquitylation also seems to be 
involved in cell signaling rather than targeting proteins for degradation (Hicke, 2001).
 Because of the similarity between PHD fi ngers and RING domains, it was originally 
thought that some PHD fi ngers might function as E3 ligases (Capili et al., 2001).  In support of 
this hypothesis, the PHD fi ngers of the viral MIR1 and 2 (modulator of immune recognition) 
and the mammalian MEKK1 (MAP/ERK kinase kinase 1) proteins were all shown to have E3 
ligase activity (Coscoy et al., 2001; Hewitt et al., 2002; Lu et al., 2002).  However, these PHD 
fi ngers were later shown to be misclassifi ed RING domains, casting doubt as to whether any true 
PHD fi ngers had ubiquitin ligase activity (Aravind et al., 2003; Scheel and Hofmann, 2003).  
Nevertheless, more recently, the three PHD fi ngers of the S. pombe Msc1 (multi-copy suppressor 
of Chk1) protein have been shown to have E3 ligase activity, suggesting that some PHD domains 
may indeed act as ubiquitin ligases (Dul and Walworth, 2007).  Furthermore, the PHD fi nger of 
the KAP-1 corepressor was shown to act as an E3 ligase for the ubiquitin-related SUMO protein, 
facilitating the sumoylation of an adjacent domain on KAP-1, and expanding the potential roles 
for PHD fi ngers to encompass ubiquitylation and sumoylation, as well as histone interaction 
(Ivanov et al., 2007).
While BLAST searching with the Ecm5 PHD sequence I noticed it was strikingly similar 
to the sequence of the second PHD fi nger of the S. pombe Msc1 protein (Figure 2.7C), one of 
the PHD domains mentioned above that was found to have ubiquitin ligase activity.  I therefore 
wondered whether the Ecm5 PHD fi nger might also have this function.  Luckily, when I became 
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interested in this question, Ronen Sadeh, a new postdoctoral fellow with experience in the 
ubiquitin fi eld, had just joined the Allis laboratory, and was also interested in seeing whether the 
Ecm5 PHD fi nger, or for that matter, any yeast PHD fi nger, possessed ubiquitin ligase activity.
Ronen and I were both intrigued with the possibility of a single PHD domain that 
might have the dual ability to bind to methylated histones and act as a ubiquitin ligase.  We 
hypothesized that if this were the case, the presence of histone methylation might compete 
for the same regions of the PHD fold required for E3 ligase activity, and thereby inhibit 
ubiquitylation.  Alternatively, histone methylation could stimulate ligase activity if the methyl-
binding and catalytic regions of the PHD were separate.  We thought this would be a novel and 
interesting way for chromatin modifi cations to regulate protein ubiquitylation.  
Histones themselves are targets of ubiquitylation:  H2B is known to be 
monoubiquitylated at lysine 123 (H2BK123ub) in yeast, and both H2A and H2B are 
ubiquitylated in higher eukaryotes (Goldknopf et al., 1975; Hunt and Dayhoff, 1977; Robzyk 
et al., 2000; West and Bonner, 1980).  Moreover, in yeast and other eukaryotes, H2BK123ub is 
required for H3K4 and K79 methylation, providing precedent for the co-regulation of histone 
ubiquitylation and methylation (Chandrasekharan et al., 2010).  In addition to the two well-
studied ubiquitylation sites on H2A and H2B, H3 and H4 have been reported to be ubiquitylated 
in mammals, suggesting that there may be additional sites of histone ubiquitylation in yeast and 
mammals waiting to be discovered (Chen et al., 1998; Wang et al., 2006).  Since PHD-fi nger 
containing proteins are generally localized in the nucleus, Ronen and I were interested in the 
possibilities that (1) any yeast PHD fi nger might act as a ubiquitin ligase, (2) histone methylation 
might regulate this activity, and (3) the substrate of this activity might be a histone.
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We set out to test whether the fi rst of these hypotheses, using an in vitro auto-
ubiquitylation assay (Figure 2.8) (Ben-Saadon et al., 2006).  In the fi rst part of this assay, a wheat 
germ extract cell-free expression system is used to transcribe and translate a plasmid-encoded, 
HIS-tagged candidate PHD fi nger in the presence of 35S-methionine.  The translation mixture, 
containing the radiolabeled candidate protein to be tested for activity, is then combined with 
all of the components needed for ubiquitylation (E1 and E2 enzymes, ATP, ubiquitin, DTT, 
and ubiquitin-aldehyde to inhibit deubiquitylating enzymes).  After the reaction is allowed to 
proceed, the components are separated on an SDS-PAGE gel which is dried and imaged using a 
phosphorimager.  
In the absence of ubiquitin ligase activity, radiolabeled proteins are expected to appear 
as single bands on the audoradiogram.  However, if the candidate protein has autoubiquitylated 
during the reaction, this protein should appear as a ladder of higher molecular weight bands or 
as a very high molecular weight smear, depending on the extent of ubiquitylation.  Since many 
RING-type E3 ligases will auto-ubiquitylate in vitro, we were reasonably confi dent that if our 
PHD fi ngers possessed E3 ligase activity, we would be able to detect it using this assay, without 
the addition of a separate substrate (Fang and Weissman, 2004).  Because we did not know the 
nature of the E2 that might act together with our PHD domains, we used recombinant human 
UbcH5c, Rad6a, and UbcH13-Uev1a as E2 enzymes for this assay, along with human Ube1 
E1 enzyme.  These human enzymes are extremely similar to their yeast homologs, represent 
most of the known nuclear E2s, and were either commercially available or available as gifts 
from Jaehoon Kim, a former postdoctoral fellow in Robert Roeder’s laboratory.  Throughout 
these assays, we used the full-length human Ring1B protein, a known H2A E3 ligase with self-
ubiquitylation activity, as a positive control.
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Figure 2.8 Diagram of in vitro auto-ubiquitylation assay
The protein or PHD domain (PHD) to be tested for E3 ligase activity is fi rst transcribed and 
translated in the presence of 35S-methionine, using a cell free expression system, generating 
a radiolabeled polypeptide. Ubiquitin reaction components (E1 and E2 enzymes, ubiquitin, 
ubiquitin aldehyde, DTT, ATP) are then added to the tube, which is incubated 1 hour at 30oC 
to allow ubiquitylation to occur. The reaction contents are then separated by SDS-PAGE and 
imaged using a phosphorimager. If the candidate protein has self-directed E3 ligase activity, 
auto-ubiquitylated forms of the protein will be seen as either a few higher molecular weight 
bands or as a very high molecular weight smear .
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When the 18 yeast PHD fi ngers were subjected to this assay, many of the yeast PHD 
fi ngers showed no activity, but the Nto1, Snt2, and Yng1 PHD fi ngers as well as the second 
Msc1 PHD, had a single higher molecular weight band, consistent with a monoubiquitylation 
event (Figure 2.9).  Remarkably, three additional PHD fi ngers, the Ecm5, Spp1, and second Rco1 
PHDs, had multiple higher molecular weight bands, suggesting they were the targets of multiple 
monoubiquitylations, or less likely, polyubiquitylation, in this assay.  As expected, Ring1B ran 
as a high molecular smear, consistent with it having the ability to polyubiquitylate itself.  This 
activity required the presence of ubiquitin (Figure 2.10A) and was proportional to the amount 
of E2 in the assay (Figure 2.10B).  Exogenous E1 was not required for and did not stimulate 
activity, suggesting that a protein within the wheat germ extract could provide this function 
(Figure 2.10B).  Furthermore, the activity was specifi c to the UbcH5c E2, since we did not see 
activity using the Rad6a or UbcH13-Uev1a E2 proteins (Figure 2.10C).  Taken together, these 
data strongly suggested that our radiolabeled PHD fi ngers are the substrates for a ubiquitin ligase 
activity present in this assay.
While the Ecm5, Spp1, and second Rco1 PHD fi ngers were the targets of a specifi c E3 
ubiquitin ligase activity, it was possible that the activity was coming from another protein in 
the assay, separate from the PHD domains.  Given that the wheat germ extract introduces many 
proteins to this assay, and we had already seen that a protein in the assay could function as an 
E1 enzyme, we felt it imperative to determine whether the activity was coming from the PHD 
domains or another protein.  We therefore attempted to recapitulate our results using a bacterial 
S30 expression system instead of the wheat germ system since the ubiquitylation machinery is 
absent in prokaryotes.  Therefore, if we continued to see activity with PHDs translated in this 
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Figure 2.9 The Ecm5, Spp1, and second Rco1 PHD fi ngers are ubiquitylated  in vitro  
Each PHD fi nger was transcribed and translated using a wheat germ extract expression system, 
and then incubated with (+) or without (-) the ubiquitin reaction mixture (rx mix), as described 
in Figure 2.7. The full-length Ring1B protein, which is a known ubiquitin ligase, was used as a 
positive control.
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Figure 2.10 Ubiquitylation activity is ubiquitin- and UbcH5c-dependent
Autoradiograph of  in vitro ubiquitylation assays carried out as in Figure 2.9, with (+) or without 
(-) ubiquitin or reaction mixture (rx mix) (A), using different concentrations of the UbcH5c E2 
(B), or using different E2 enzymes (C).
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extract, we could feel more confi dent that the source of the activity was the PHDs, themselves, 
and not an external, wheat germ extract-born E3.  In in vitro assays using the S30 system, 
Ring1B continued to have activity.  However, the Ecm5, Spp1, and second Rco1 PHD fi ngers 
did not, raising doubts as to whether these domains possessed intrinsic E3 ligase activity  (Figure 
2.11A and data not shown).  Furthermore, when we added some of the wheat germ extract to 
the S30-translated PHD fi ngers, the activity returned, suggesting this activity was present in the 
wheat germ expression system and not intrinsic to the PHD fi ngers, and that the lack of activity 
in the S30 extract system is not due to improper folding of the PHD fi ngers (Figure 2.11A and 
data not shown).
We then mutated six of the eight PHD fi nger cysteines in each of the Ecm5, Spp1, and 
second Rco1 PHD fi ngers, to completely abolish proper folding of these domains.  A mutant 
Ring1B with the RING domain deleted was used as a control.  As expected, mutation of 
Ring1B completely abolished its E3 ligase activity (Figure 2.11B).  Disappointingly, however, 
the mutated Ecm5, Spp1, and second Rco1 PHD fi ngers were still ubiquitylated in this assay, 
and to the same extent as the wild-type PHDs.  Based on these results, we concluded that the 
ubiquitylation of the Ecm5, Spp1, and second Rco1 PHD fi ngers was the result of an 
activity in the wheat germ expression system, for which these particular PHD fi ngers made good 
substrates.  Lacking solid evidence that the yeast PHD fi ngers could act as E3 ligases, Ronen and 
I chose to pursue other avenues of experimental investigation that seemed more promising, rather 
than continuing to seek support for this hypothesis.
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Figure 2.11 PHD-directed ubiquitylation is the result of a factor in the wheat germ 
expression system
A. Ring1B and the second Rco1 PHD were translated using the S30 expression system, and 
then  in vitro ubiquitylation assays were performed in the presence (+) or absence (-) of reaction 
components (rx mix) and wheat germ extract (WGE). B. In vitro ubiquitylation assays were 
performed as in Figure 2.9 on Ring1B and either wild-type (WT) or 6-cysteine mutant (mut) 




The experiments described in this chapter were all performed with isolated purifi ed PHD 
fi ngers, either to look for interactions with histones or to look for ubiquitin ligase activity.  I have 
shown that a tagged Yng1 PHD fi nger preferentially pulls-down histone H3, and that H3K4me3 
is enriched on the co-precipitated H3. These results, combined with other data collected by Sean 
Taverna, strongly support a direct interaction between the Yng1 PHD fi nger and H3K4me3, and 
further support a model in which the NuA3 HAT complex is recruited to or stabilized at sites of 
transcriptionally active chromatin, via interactions between the Yng1 PHD fi nger and H3K4me3, 
a mark known to be enriched in these regions (Pokholok et al., 2005).  This allows NuA3 to 
catalyze histone acetylation at these loci, further promoting transcription.
Because many chromatin effector modules interact with histone modifi cations relatively 
weakly, a combination of many such interactions has been proposed to modulate chromatin 
complex targeting in vivo (Ruthenburg et al., 2007).  While Sean’s fl uorescence anisotropy 
experiments found that the Yng1 PHD domain interacts with H3K4me3 with a Kd more than 
40-fold lower than the Kd for the interaction with unmodifi ed H3K4, showing a clear preference 
for the trimethylated state, this Kd is still relatively high, suggesting that additional histone and 
DNA interactions mediated by other domains within Yng1 or other subunits of NuA3, may also 
contribute to NuA3 localization.  Consistent with this idea, the fi rst 28 amino acids of Yng1 
were recently shown to interact with the unmodifi ed H3 tail (Chruscicki et al., 2010).  The 
Nto1 subunit contains two PHD fi ngers of its own, which also might be involved in chromatin 
interactions.  A recent study of yeast PHD fi ngers found a weak association between the fi rst 
Nto1 PHD fi nger and H3K36me3 (Shi et al., 2007).  Since this modifi cation is enriched within 
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the coding regions of genes (Pokholok et al., 2005), and Sean’s ChIP-chip studies found 
signifi cant NuA3 localization in both the 5’ ends and the middle of genes, an interaction between 
the Nto1 PHD and H3K36me3 might help direct NuA3 to gene coding regions, where levels of 
H3K36me3 predominate over H3K4me3.  In addition, the Taf30 subunit of the NuA3 complex 
contains a YEATS (Yaf9, ENL, AF9, and TFIIF small subunit) domain, another domain known 
to mediate histone interactions, and it is possible that this domain also contributes to NuA3 
complex localization or function (Schulze et al., 2010).
Having successfully used an in vitro binding assay to show interaction between H3 and 
the Yng1 PHD fi nger, I went on to use this assay to show that two additional PHD fi ngers, from 
the yeast Jhd2 and Ecm5 proteins, also interact with histone proteins.  I found that a GST-Jhd2-
PHD fusion was able to preferentially pull-down histone H3.  In agreement with my results, a 
recent report found that the Jhd2 PHD fi nger can interact with nucleosomes, and that mutation of 
the Jhd2 PHD reduced Jhd2 binding to a target gene in vivo (Huang et al., 2010), underscoring 
the importance of this histone-PHD interaction in maintaining proper Jhd2 genomic localization.  
This report also showed that H3K4me3 was not necessary for the interaction between the Jhd2 
PHD fi nger and immobilized nucleosomes, consistent with my own fi nding that H3K4me3 was 
not enriched in the H3 pulled-down by the GST-Jhd2-PHD fusion.  
I did fi nd H3K36me3 enriched in the H3 co-precipitating with the Jhd2 PHD fi nger.  
While it is possible that the Jhd2 PHD fi nger interacts directly with this modifi cation, I was 
never able to confi rm such an interaction using peptide pull-down assays.  Experiments from the 
Gozani lab also did not fi nd an interaction between the Jhd2 PHD fi nger and H3K36me3.   It is 
possible that the Jhd2 PHD interacts with H3 indirectly, by means of an unknown acid soluble 
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protein contaminant (or contaminants) in my histone preparations.  Alternatively, the Jhd2 
PHD may interact with another region of H3 whose modifi cation status is correlated with high 
levels of H3K36me3, require a longer region of the H3 tail than was covered by the H3K36me3 
peptide for interaction, or require more than one histone modifi cation, such as the combination of 
H3K4me3 and H3K36me3, for binding.  
Given that Jhd2 demethylates H3K4, an activity associated with chromatin repression, 
the idea that Jhd2 might be recruited to transcriptionally active loci seems paradoxical.  
However, this paradox makes sense if Jhd2 is recruited to active genes that need to be turned 
off.  Consistent with this idea, a recent study from Oliver Rando’s laboratory found that patterns 
of H3K4me3 generated at genes activated by alpha factor or heat shock are actively removed 
by Jhd2 as these genes are returned to a repressed state (Radman-Livaja et al., 2010).  Another 
study reported that Jhd2 was needed at the GAL1 gene to both prevent over-activation in the 
presence of nonfermentable carbon sources and promote repression in the presence of glucose 
(Ingvarsdottir et al., 2007).  Furthermore, a small-scale ChIP study found Jhd2 enriched in the 5’ 
end of the INO1 gene, consistent with the hypothesis that Jhd2 localizes to gene bodies to help 
maintain the localization differences between H3K4 and K36 methylation (Huang et al., 2010).
I also showed that a tagged Ecm5 PHD fi nger interacts with histone H3.  As I noted 
earlier in this chapter, there was a report that the Ecm5 PHD fi nger weakly interacted with 
H3K36me3 (Shi et al., 2007).  However, I did not fi nd a specifi c enrichment for H3K36me3 in 
Ecm5 PHD-precipitated H3.  Furthermore, peptide pull-downs with H3K4me3 and H3K36me3 
peptides failed to confi rm an association between the Ecm5 PHD and H3K36me3.  The Kd the 
Gozani lab reported for this interaction was 155 M, an order of magnitude weaker than that 
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of the Yng1-PHD H3K4me3 interaction.  It is possible that my pull-down conditions, while not 
very stringent as evidenced by the background level of GST PHD pulled-down by each peptide, 
were still too stringent to detect such a weak interaction.  However, as I will discuss in a later 
chapter of this thesis, my own ChIP experiments have found that Ecm5 localizes mainly to the 
promoter regions of genes, where H3K36me3 levels are low, and only to a small number of gene 
bodies.  As with the Jhd2 PHD pull-down experiment, it is possible that the Ecm5 PHD interacts 
with H3 indirectly.  Alternatively, the Ecm5 PHD fi nger may interact with H3 directly, although 
H3K36me3 is unlikely to be the sole target of this interaction in vivo.  
What might other targets of the Ecm5 and Jhd2 PHDs be?  In their interaction studies, 
the Gozani lab only tested for interactions with methylated and unmethylated H3K4, H3K36, 
and H3K79 peptides.  However, there are a number of other known H3 modifi cations, such as 
H3R2 methylation, and it is possible that the Ecm5 and Jhd2 PHD fi ngers interact directly with 
one or more of these other marks.  It is also possible that a combination of histone modifi cations, 
such as the presence of both H3R2me and H3K4me might be required for Ecm5 or Jhd2 
PHD interaction, something that would have been missed in both the Gozani Lab’s singly-
modifi ed peptide arrays, and my own peptide pull-down experiments.  As newer technologies, 
such as large-scale arrays containing tens or hundreds of peptides with many combinations of 
modifi cations become less costly and easier to generate, it will become easier to determine if this 
is the case.
70
Surprisingly, the Ecm5 PHD fi nger also precipitated histone H2A.  To my knowledge, 
there is no mass spectrometric evidence of specifi c H2A methylation sites in yeast.  However, 
multiple sites of lysine and arginine methylation have been found on mammalian H2A by mass 
spectrometry (Waldmann et al., 2011; Zhang et al., 2003).  Furthermore, yeast incubated with 
3H-S-adenosyl methionine were found to have radioactive H2A, suggesting that yeast may have 
one or more H2A methylation sites (Miranda et al., 2006).  There are 11 lysines and 10 arginines 
in yeast H2A, numbers too high to easily generate and test methylated peptides of each site for 
Ecm5-PHD interaction.  However, in vitro binding assays with histones acid-extracted from yeast 
strains containing H2A point mutations at these sites as well as tail deletions may help isolate 
specifi c H2A modifi cations or regions that interact with the Ecm5 PHD fi nger.
The structural similarities between PHD fi ngers and RING-type ubiquitin ligases, as well 
as the sequence similarities between the Ecm5 PHD and a PHD fi nger shown to have ubiquitin 
ligase activity, prompted me to test all of the yeast PHD fi ngers for E3 ligase activity.  While the 
Ecm5, Spp1, and second Rco1 PHD fi ngers were all ubiquitylated in our in vitro assay, we were 
disappointed to discover that the PHD fi ngers themselves were not the ligases responsible for this 
activity.  Rather, a component (or components) of the wheat germ extract used to express these 
PHDs was the source of this activity.  
It is curious that the Ecm5, Spp1, and second Rco1 PHD fi ngers are particularly good 
substrates for this activity.  These PHD fi ngers do not contain more lysines than the other yeast 
PHD fi ngers, so it is unclear why they would make better substrates.  While this could be solely 
an artifact of our experimental system, it is also possible that these PHD fi ngers are substrates for 
ubiquitylation in vivo.  Owing to the vital nature of the ubiquitin pathway, many of the enzymes 
in this pathway are very highly conserved.  Therefore, it is possible that the protein or proteins 
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in the wheat germ extract responsible for ubiquitin ligase activity have yeast homologs.  Cellular 
Ecm5 protein levels are extremely low, suggesting the protein is expressed at very low levels 
and/or actively degraded.  Experiments looking at Ecm5, Spp1, and Rco1 protein levels before 
and after yeast proteasome inhibition might reveal whether any of these proteins is ubiquitylated 
and degraded.  Alternatively, stringent Ecm5, Spp1, and Rco1 pull-downs from proteasome-
inhibited strains containing tagged ubiquitin, followed by western blotting with ubiquitin-tag 
specifi c antibodies might also reveal whether these proteins are ubiquitylated in vivo.  It should 
be noted that in the Ecm5 pull-downs described in the next chapter of this work, we never 
detected ubiquitin by mass spectrometry.  However, we did not inhibit the proteasome for our 
pull-downs, so if Ecm5 were targeted for degradation, we may not have precipitated enough of 
it to detect a ubiquitylated form.  As an interesting connection to the work in the fi rst part of this 
chapter, Jhd2 has been shown to be ubiquitylated by the RING fi nger ubiquitin ligase Not4 and 
degraded by the proteasome (Mersman et al., 2009). 
Even though we were unable to fi nd evidence for a yeast PHD fi nger possessing ubiquitin 
ligase activity in our in vitro assay, it remains possible that such a PHD might exist in vivo.  If 
one of the yeast PHD fi ngers tested has activity but cannot fold properly as an isolated domain, 
requires another protein for activity, requires a separate substrate for activity, or cannot utilize 
wheat germ and human E1 and E2 homologs, our assay would have been unable to detect 
activity for that domain.  Future in vitro ubiquitylation assays with PHD-containing protein 
complexes purifi ed from yeast, may reveal as yet undescribed ubiquitin ligase functions for some 
of these domains.  Further work may also shed light on our second and third hypotheses, possibly 
fi nding examples of PHD domain ubiquitin ligases that are regulated by histone methylation and/
or catalyze histone ubiquitylation.
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CHAPTER 3: EARLY ATTEMPTS TO DETERMINE ECM5 FUNCTION
Chapter Introduction
In parallel to exploring the chromatin interactions of the Jhd2 and Ecm5 PHD fi ngers, I 
sought to better understand the functions of these two proteins.  Both Jhd2 and Ecm5 were found 
to have nuclear localization (Huh et al., 2003), and they each possess domains that are linked to 
chromatin function, suggesting they might act as chromatin regulators.  In agreement with this, 
just after I started this work, Jhd2 was shown to be an H3K4 demethylase (Liang et al., 2007; 
Seward et al., 2007; Tu et al., 2007).  However, the function of Jhd2-catalyzed demethylation 
remained unclear.  The ECM5 gene was discovered in a screen for mutants with cell wall 
defects, suggesting this protein might help regulate the cell wall (Lussier et al., 1997).  Although 
Ecm5 also possesses a Jumonji C domain, the domain linked to histone demethylase activity, 
this protein was shown not to function as a demethylase, leaving the function of this protein 
unknown.
As part of a broader effort to determine the functions of Ecm5 and Jhd2, I 
immunoprecipitated these proteins and identifi ed their interaction partners using mass 
spectrometry.  These immunoprecipitation experiments, which were performed in collaboration 
with Beatrix (Trixi) Ueberheide in the laboratory of Brian Chait and are discussed in the 
fi rst part of this chapter, culminated in the discovery of a new Rpd3 histone deacetylase 
complex containing Ecm5 and another PHD fi nger protein, Snt2.  Based on the results of these 
experiments, and the PHD fi nger-histone pull-downs described in the previous chapter, I initially 
hypothesized that Ecm5 and Jhd2 might be involved in preventing transcription from cryptic 
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internal promoters within coding regions, similar to the function that has been reported for the 
Rpd3(S) complex (Carrozza et al., 2005b; Joshi and Struhl, 2005; Keogh et al., 2005).  The 
second part of this chapter describes experiments undertaken to test this hypothesis.  However, 
I was not able to fi nd any evidence to support a role for Ecm5 and Jhd2 in preventing cryptic 
transcription, so I decided to focus my attention on the function of Ecm5 in the newly discovered 
Rpd3 complex.  The third and fi nal section of this chapter describes my attempts to screen for a 
function of Ecm5.
Ecm5 interacts with Snt2 and the Rpd3 histone deacetylase
In order to better understand the functions of Jhd2 and Ecm5, I set out to determine 
with which proteins they associated.  Because individual domains within Jhd2 and Ecm5 are 
homologous to different parts of the mammalian JARID proteins, I hypothesized that Jhd2 and 
Ecm5 might interact with one another and function as a complex.  In this model, yeast would use 
two separate but physically associated polypeptides function like a single JARID protein does 
in mammalian cells.  Thus, in addition to looking for new Jhd2 and Ecm5 interaction partners, 
I wanted to test if these two proteins interacted with one another.  To address these questions, I 
initiated a collaboration with Trixi Ueberheide in the Chait laboratory to take advantage of the 
lab’s expertise in protein purifi cation and mass spectrometry. ECM5 and JHD2 were tagged at 
their C-termini with a Protein A (PrA) tag and immunoprecipitated (IPed) from cryogenically-
prepared Ecm5-PrA and Jhd2-PrA lysates, under relatively mild conditions to maintain protein 
associations.
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The cryogenic lysis method  was developed by Michael Rout’s laboratory as a superior 
method for purifying intact protein complexes (Oeffi nger et al., 2007).  This method involves 
spinning down cells to be harvested, resuspending them in a cryoprotectant solution, and then 
pipetting small droplets of cells into liquid nitrogen to quickly freeze them.  Once frozen, 
cells are milled in a liquid nitrogen-cooled metal chamber with ball bearings, lysing them at 
cryogenic temperatures.  Cryogenic lysis was chosen because it offered a number of benefi ts over 
other methods of yeast lysis.  Because cells are rapidly frozen and kept cool during the entire 
lysis, proteases have less time to degrade proteins of interest.  Furthermore, proteins are less 
likely to separate from interaction partners.  In addition, large amounts of starting lysate from 
multiple large batches of cultures can be generated before actually performing the IP, which was 
necessary for us to obtain enough material, because the Ecm5 and Jhd2 proteins are only present 
in low amounts in vivo (Ghaemmaghami et al., 2003). 
We initially focused our attention on the purifi cation of Jhd2-PrA and its interaction 
partners.  However, other than contaminating background proteins known to associate with the 
PrA tag (Gavin et al., 2002; Shevchenko et al., 2008), we failed to identify any other proteins 
co-precipitating with Jhd2-PrA (data not shown). We tried various purifi cation and wash 
conditions, but four separate attempts at the Jhd2-PrA purifi cation failed to identify any credible 
Jhd2-interaction partners.  Thus, we were unable to fi nd support for the idea that Jhd2 and Ecm5 
associate, and could not identify any other proteins stably associated with Jhd2.
We next purifi ed PrA-tagged Ecm5, and resolved Ecm5-PrA co-purifying proteins 
by SDS-PAGE  (Figure 3.1A).  Bands detectable by Coomassie staining were excised and 
analyzed using MALDI mass spectrometry.  We again identifi ed some known contaminants of 
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Figure 3.1 Ecm5 interacts with Snt2 and the Rpd3 histone deacetylase
A. PrA purifi cations from Ecm5-PrA or untagged yeast lysates were separated by SDS-PAGE, 
and stained with Gel Code Blue Protein Stain.  Stained bands were identifi ed using mass 
spectrometry, and identifi ed Ecm5-PrA-interacting proteins are labeled to the right of the 
gel image.  IgG, which elutes from the resin and runs at the same point on the gel as Rpd3, 
is also identifi ed.  Asterisks mark contaminants. B. Diagrams of the Ecm5, Snt2, and Rpd3 
domain structures. ARID: AT Rich Interaction Domian; JmjC: Jumonji C domain; PHD: plant 
homeodomain fi nger; BAH: bromo-adjacent homology domain; SANT: Spt3-Ada3-N’CoR-
TFIIS domain; HDAC: histone deacetylase domain. C. Silver-stained gel of eluate from control 
and Snt2-PrA purifi cations.  Eluate proteins identifi ed by mass spectrometric analysis are 
indicated next to their respective bands, and contaminants are marked with asterisks. D. Eluates 
from an Ecm5-PrA purifi cation  were immunoblotted with an HRP-conjugated-secondary 
antibody (to detect Ecm5-PrA) and an Rpd3 antibody.
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PrA purifi cations, many of which were also present in the control IP from an untagged strain 
(bands marked with asterisk in Figure 3.1A).  We did not detect any band the size of Jhd2 in 
the Ecm5-PrA purifi cation.  However, we did identify two proteins co-purifying with tagged 
Ecm5 that were not in our untagged control purifi cation.  The fi rst, which migrated as a band 
of approximately 160 kDa just below Ecm5-PrA, was identifi ed as the yeast Snt2 protein.  A 
second band around 50 kDa in size, that ran with IgG on the gel, was identifi ed as the histone 
deacetylase Rpd3.  
Snt2 is named after its SANT (Swi3, Ada2, N-CoR, and TFIIB”) domain (Figure 3.1B).  
These domains are found in many HAT and HDAC complexes, and individual SANTs have 
been shown to mediate histone interactions and modulate HAT and HDAC activity (Boyer et 
al., 2004).  Snt2 also contains three PHD fi ngers of its own as well as a BAH (bromo-adjacent 
homology) domain, another known chromatin interaction module (Armache et al., 2011; Kuo 
et al., 2012).  The wealth of domains known to mediate chromatin interaction in the Snt2 
protein suggests this protein is highly likely to have a function on chromatin.  Consistent with 
this idea, Snt2 was found to reside at the promoters of a small number of genes by chromatin 
immunoprecipitation (ChIP), suggesting this protein might function directly in gene regulation 
(Harbison et al., 2004).  
Rpd3 is a histone deacetylase and a key subunit of two other yeast complexes: Rpd3(S) 
and Rpd3(L) (Figure 3.2).  The Rpd3(L) complex is the larger of the two known Rpd3 
complexes, with 12 reported subunits (Carrozza et al., 2005b; Keogh et al., 2005).  This complex 
localizes to the promoters of numerous genes and regulates transcription (Carrozza et al., 
2005a).  Consistent with the known association between deacetylated histones and transcriptional 
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Figure 3.2 The Rpd3 deacetylase is a subunit of two other yeast complexes
Diagram showing subunits of the Rpd3(L) and Rpd3(S) complexes, as well is the Rpd3(T) 
complex described in this thesis. Rpd3 is in red, and other shared components between Rpd3(L) 
and (S) complexes are in blue. 
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repression, the Rpd3(L) complex generally functions as a transcriptional repressor (Allfrey et al., 
1964; Kadosh and Struhl, 1998; Vidal and Gaber, 1991), but the complex also functions as an 
activator at a subset of genes (De Nadal et al., 2004; Ruiz-Roig et al., 2010; Sertil et al., 2007).  
The Rpd3(S) complex was fi rst fully purifi ed and analyzed by mass spectrometry in 2005, and 
found to consist of the subunits Sin3, Ume1, and Rpd3, which are shared with the Rpd3(L) 
complex, as well as the Rpd3(S)-unique subunits Eaf3 and Rco1 (Carrozza et al., 2005b; Keogh 
et al., 2005).  Rpd3(S) localizes to both gene bodies and promoters where it helps suppress 
various types of noncoding or aberrant transcription (Carrozza et al., 2005b; Joshi and Struhl, 
2005; Keogh et al., 2005).  Members of the Rpd3(L) and (S) complexes were not detected in the 
Ecm5-PrA purifi cation, suggesting that Ecm5, Snt2, and Rpd3 constitute a third Rpd3 complex.
In order to confi rm the associations between Ecm5, Snt2, and Rpd3, we fi rst repeated 
our Ecm5 purifi cation.  As expected, we again detected Snt2 and Rpd3 co-purifying with Ecm5 
(data not shown).  To further confi rm these interactions, we PrA-tagged SNT2, and purifi ed this 
protein along with its interaction partners.  A portion of the Snt2-PrA purifi cation was visualized 
by SDS-PAGE analysis followed by silver staining (Figure 3.1C).  We subjected the remainder 
of the eluted proteins for liquid chromatographic-mass spectrometric (LC-MS) analysis, to 
identify any Snt2 co-purifying proteins.  Only peptides from known contaminants were found 
in a control purifi cation from an untagged strain.  In contrast, peptides matching both Ecm5 
and Rpd3, in addition to tagged Snt2 were detectable in the Snt2-PrA purifi cation.  Intriguingly, 
further MS-MS analysis on Snt2 peptides in the purifi cation determined that serine 641 of Snt2 is 
phosphorylated, suggesting a possible method of regulation for this protein.  Peptides matching 
subunits of the Rpd3(L) and (S) complexes were not detected in the Snt2-PrA purifi cation.
79
To fully confi rm these interactions, we purifi ed Rpd3 and its interaction partners using an 
Rpd3-PrA strain.  We were able to identify 10 out of 12 of the known Rpd3(L) subunits and 5 out 
of 5 Rpd3(S) subunits in the Rpd3-PrA purifi cation, confi rming that our purifi cation conditions 
preserved Rpd3 complex associations (Table 3.1).  In addition, peptides matching Ecm5 and 
Snt2 were also identifi ed, although in much lower abundance.  In order to be certain that Ecm5 
and Snt2 co-purifi ed with Rpd3, we separated some of the Rpd3-PrA eluate by SDS-PAGE, 
Coomassie stained the gel, and excised the bands corresponding in size to Ecm5 and Snt2.  Mass 
spectrometric analysis clearly identifi ed Ecm5 and Snt2 (>20 peptides each) in these bands 
(data not shown).  As further confi rmation of these associations, I performed a separate PrA 
purifi cation with lysates from the Ecm5-PrA and untagged strains.  Rpd3 was clearly detected 
in eluates from the Ecm5-PrA purifi cation by immunoblot (Figure 3.1D).  Taken together, 
these experiments show that Ecm5, Snt2, and the Rpd3 histone deacetylase form a third Rpd3 
complex, which I have named the Rpd3(tiny), or Rpd3(T), complex.
Exploring whether Jhd2 and the Rpd3(T) complex repress cryptic transcription
Based on these interaction results, I hypothesized that Ecm5 might help recruit or 
stabilize this new histone deacetylase complex to specifi c genomic locations, where the complex 
might have a repressive function.  I also suspected the Jhd2 H3K4 demethylase would repress 
transcription, because H3K4me is associated with gene activation (Briggs et al., 2001; Nishioka 
et al., 2002; Santos-Rosa et al., 2002; Wang et al., 2001).  As discussed in the previous chapter, 
there was initial reason to believe that both the Jhd2 and Ecm5 PHD fi ngers might interact with 
H3K36me3, suggesting both proteins might be recruited to gene bodies.  (My own peptide pull-
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Table 3.1 Summary of proteins identifi ed by LC-MS analysis of Rpd3-PrA IP a
81
down experiments eventually failed to confi rm associations of these PHDs with H3K36me3-
pepetides, but this work was undertaken before I had completed these experiments.)  The 
possibility of these potentially repressive proteins being recruited to gene bodies immediately 
reminded me of the Rpd3(S) complex, and its recruitment to gene bodies to repress transcription 
in aberrantly initiating from cryptic promoters within genes.
At least two classes of short aberrant transcripts have been described in yeast.  One class 
was fi rst described by Francoise Wyers and colleagues, who noticed that deletion of the nuclear 
exosome exonuclease Rrp6 resulted in accumulation of short transcripts, 250-600 nucleotides 
long, originating from intergenic regions (Wyers et al., 2005).  Because wild-type cells rapidly 
degrade these transcripts, Wyers and colleagues named them “cryptic unstable transcripts” or 
CUTs .  CUTs are capped at their 5’ ends and polyadenylated by the TRAMP (Trf4, Air1/2, and 
Mtr4 polyadenylation) complex, promoting their rapid degradation by the nuclear exosome 
(Rrp6, Mtr4/Dob1, and Rrp47/Lrp1) in wild-type yeast.  Deletion of TRAMP complex subunits, 
as well as subunits of the Nrd1-Nab3-Sen1 complex, which are required for the association 
of CUTs with the exosome, promotes accumulation of these transcripts (Arigo et al., 2006; 
Vasiljeva and Buratowski, 2006; Wyers et al., 2005).  
Not to be confused with CUTs, a second class of aberrant transcripts was fi rst described 
by Fred Winston’s laboratory, who noticed that mutant yeast with reduced levels of the histone 
chaperone Spt6 accumulated short transcripts initiating from the middle of certain genes (Kaplan 
et al., 2003).  This work went on to show that in cells lacking Spt6, chromatin inside of these 
genes was more sensitive to micrococcal nuclease, suggesting that Spt6 is required to restore 
proper chromatin structure in the wake of transcribing RNA Polymerase II (Pol II).  Thus, Craig 
82
Kaplan, Fred Winston, and colleagues proposed that without proper restoration of chromatin 
structure after transcription, inappropriate transcription could initiate from regions within genes 
that happened to resemble promoters.  Like CUTs, these genic cryptic transcripts, which I refer 
to as simply “cryptic transcripts” for the rest of this work, are poly-adenylated and capped on 
their 5’ ends, but in contrast to CUTs, cryptic transcripts are not actively produced and degraded 
at high levels in wild-type cells.  Rather, cryptic transcripts appear to be a phenotypic readout 
for yeast mutants with problems maintaining proper chromatin structure at transcribed genes.  
For this reason, mutations in other proteins involved in chromatin regulation and transcriptional 
elongation also result in accumulation of cryptic transcripts.  For instance deletion of the BUR1 
or BUR2 genes, which encode subunits of a cyclin-dependent kinase important for transcriptional 
elongation, also results in this phenotype (Kaplan et al., 2003).  In addition, a report from Kevin 
Struhl’s laboratory found that a mutation in the SPT16 gene, encoding a subunit of the FACT 
transcriptional elongation complex, results in increased Pol II density at the 3’ ends of genes and 
initiation of cryptic transcripts (Mason and Struhl, 2003).
As mentioned earlier, the Rpd3(S) complex has also been linked to repression of cryptic 
transcripts.  The chromodomain of the Eaf3 subunit  and the PHD fi nger of the Rco1 subunit 
both interact with H3K36me2/3, and both K36me interactions have been shown to work together 
to recruit Rpd3(S) to gene bodies to deacetylate genic histones (Krogan et al., 2003; Li et al., 
2007; Li et al., 2003; Xiao et al., 2003).  Thus, deletion of Rpd3(S) subunits results in increased 
histone acetylation at the 3’ ends of genes, and accumulation of cryptic transcripts (Carrozza et 
al., 2005b; Joshi and Struhl, 2005; Keogh et al., 2005).  I hypothesized that, like Rpd3(S), Jhd2 
and the Rpd3(T) complex might also be recruited to gene coding regions by interactions between 
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H3K36me3 and the Jhd2 and Ecm5 PHD fi ngers.  Once recruited to gene bodies, Rpd3 and Jhd2 
might deacetylate and demethylate histones, respectively, helping to maintain a chromatin state 
inside of gene bodies that is repressive to cryptic transcription (Figure 3.3).  
Testing the 6-azaurcil sensitivity of ecm5 and snt2 mutants
In order to test my hypothesis, I fi rst tested whether ecm5 or jhd2 knockouts had 
differential growth on 6-azauracil (6-AU).  When cells are treated with this chemical, their 
intracellular GTP levels are depleted, slowing down transcriptional elongation (Exinger 
and Lacroute, 1992).  While wild-type cells can grow on 6-AU, mutants with defects in 
transcriptional elongation display sensitivity to this chemical, presumably because the elongation 
defects caused by 6-AU and those caused by the mutation synergistically create a transcriptional 
burden severe enough to impede growth (Archambault et al., 1992).  Conversely, yeast with 
mutations that stimulate transcriptional elongation and promote cryptic transcription have been 
shown be 6-AU resistant (Keogh et al., 2005).  I therefore reasoned that if Ecm5 and Jhd2 are 
involved in repressing cryptic transcription, strains lacking these proteins might show 6-AU 
resistance.
Because 6-AU is most effective when combined with uracil-free media, I fi rst 
transformed wild-type and knockout strains with the high-copy uracil plasmid pRS426 
(Christianson et al., 1992), to allow them to grow without uracil.  I used the set2 
knockout strain as a positive control for these assays, since this mutant has been shown to 
be 6-AU resistant (Keogh et al., 2005; Kizer et al., 2005).  As expected, set2 knockout cells 
consistently showed resistance to 6-AU (Figure 3.4).  Intriguingly, jhd2 mutant cells were also 
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Figure 3.3 Model for how Jhd2 and/or the Rpd3(T) complex could suppress cryptic 
transcription
A. High levels of H3K36me are established within gene bodies by the Set2 methyltransferase, 
which interacts with elongating RNA polymerase II. B. The Rpd3(T) complex might then 
be recruited to open reading frames via interactions between H3K36me3 and the Ecm5 
PHD domain, allowing Rpd3 to deacetylate histones inside of coding sequences, repressing 
cryptic  transcription. C. Similarly, interactions between H3K36me and the Jhd2 PHD fi nger 
might recruit Jhd2 to open reading frames to demethylate H3K4 in these regions and repress 
transcription from cryptic internal promoters.
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Figure 3.4 ecm5 and jhd2 mutants sometimes show enhanced growth on 6-AU
Five-fold serial dilutions wild-type (BY4741) or indicated mutant strains containing the uracil 
plasmid pRS426 were spotted on complete synthetic media lacking uracil (CSM-URA) or 
CSM-URA supplemented with 100 g/mL 6-azauracil (6-AU). Pla tes were imaged after 3 days.
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consistently 6-AU resistant, suggesting that in the absence of Jhd2, transcriptional elongation 
is enhanced.  The rpd3 knockout strain also showed modest 6-AU resistance.  However, the 
ecm5 knockout strain performed inconsistently in this assay, showing 6-AU resistance in some 
assays but not in others.  Thus, while these assays suggested that Jhd2 might function to repress 
chromatin in coding regions, I could not conclude that Ecm5 did the same.
Looking for cryptic transcripts by qPCR
As another way of testing whether Jhd2 and Ecm5 are involved in preventing 
cryptic transcription, I checked for the accumulation of cryptic transcripts in jhd2 and ecm5 
knockout strains, using quantitative RT-PCR (qPCR).  I reasoned that if cryptic transcripts 
are accumulating in these strains, cDNA from jhd2 and ecm5 knockouts would show higher 
qPCR signal at the 3’ end of cryptic transcript genes, compared to wild-type signal, without 
also showing higher signal at the 5’ end of the genes (which would suggest complete gene up-
regulation, rather than a specifi c accumulation of the shorter cryptic transcript).  To test this idea, 
I purifi ed RNA from wild-type yeast as well as  jhd2 and ecm5 knockout strains and converted it 
to cDNA.  The cDNA from jhd2 and ecm5 knockout strains completely lacked detectable signals 
from JHD2- and ECM5-specifi c primers, respectively, confi rming that each gene was deleted 
from its knockout strain (data not shown).  However, in jhd2 and ecm5 knockout cells, levels of 
the STE11 gene, which is known to contain cryptic internal promoters, were similar to wild-type 
at all portions of the gene tested (Figure 3.5A).   Similarly, levels of SPB4, another gene known 
to contain a cryptic promoter, were the same as or lower than wild-type levels, at both the 5’ and 
3’ end of the gene (Figure 3.5B).  Thus, the qPCR assay did not provide any evidence that Jhd2 
and the Rpd3(T) complex repress cryptic transcription.
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Figure 3.5 ecm5 and jhd2 mutants do not show increased expression of the 3’ ends of 
known cryptic transcript genes by qPCR
Random hexamer-primed cDNA from wild-type (BY4741) or indicated knockout strains was 
used for qPCRs with primer pairs corresponding to the 5’ end (5’), 3’ end (3’), or 3’ untranslated 
region (3’ UTR) of the STE11 [A] and SPB4 [B] genes. qPCRs are normalized to signal from 
the AC T1 gene, and graphs show means and SEMs for three biological replicates.
88
Northern blots to assay from cryptic transcripts
While these results suggest that Jhd2 and the Rpd3(T) complex do not suppress 
cryptic transcripts, it was possible that the qPCR-based technique was not sensitive enough to 
detect increases in cryptic transcripts that were in much lower abundance than the full-length 
transcripts.  Therefore, I also assayed for the presence of cryptic transcripts in ecm5 and jhd2 
mutants, using northern blotting, which unlike a qPCR assay, separates different transcripts from 
the same gene by size, allowing detection of shorter transcripts that are far less abundant than 
their full size counterparts.  As a positive control for these assays, I used RNA from set2 and 
eaf3 knockout strains, which as described above, are known to accumulate cryptic transcripts.  
I used oligo-dT beads to enrich for polyadenylated (poly-A+) RNA from total RNA taken from 
wild-type yeast and various knockout strains, and blotted this enriched RNA with probes to the 
3’ ends of STE11 and SPB4.  While this enrichment step did not entirely eliminate rRNA from 
my samples, as can be seen by the two cross-reacting bands in my northern blots (Figure 3.6, 
marked with x’s), cryptic transcripts were clearly detected in cells lacking Set2 or Eaf3 (Figure 
3.6, marked with green arrows).  Cryptic STE11 transcripts were also detected in the rpd3 
strain, albeit at lower levels.  However, cryptic SPB4 transcripts were not detected in this strain, 
possibly as a result of Rpd3 having many cellular functions, resulting in pleiotropic effects when 
this gene is deleted.  In contrast to the set2 and eaf3 knockout strains, knockouts for ecm5, snt2, 
and jhd2, did not show cryptic STE11 or SPB4 transcripts.  
Intriguingly, ecm5 and snt2 mutants did show higher levels of a 6kb RNA species 
cross reacting with the 3’ STE11 and SPB4 probes (Figure 3.6, marked with asterisks).  For 
the ecm5 RNA, this may be partially explained by overloading of the gel, since more ecm5 
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Figure 3.6 Northern blots to look for cryptic transcripts in ecm5 or jhd2 mutants
Poly-A+-enriched RNA from the indicated wild-type (WT) or knockout strains was subjected 
to northern blotting with probes corresponding to the 3’ end of the STE11 or SPB4 genes (top 
panels of A and B, respectively).  A probe to ACT1 was used as a loading control (bottom 
panels).  The full-length transcript and the shorter, cryptic transcripts are marked by red 
and green arrows, respectively.  Contaminating rRNA, which remained even after poly-
A+-enrichment, is marked with x’s, and a longer RNA species enriched in ecm5 and snt2 
knockouts, is marked with asterisks. The sizes from an RNA ladder (in kb) are shown to the left 
of each panel.
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RNA is also detected with the ACT1 loading control probe.  However, the snt2 lane does not 
appear to be overloaded and also shows increased levels of the 6kb species.  This species may 
be longer isoforms of STE11 and SPB4, only present in jhd2 and ecm5 mutants.  It could also 
be an unprocessed rRNA precursor present at higher levels in these mutants, that the poly-A+ 
enrichment failed to fully eliminate and that cross-reacted with the probes.  It remains unclear 
whether this is a true and interesting transcriptional difference between ecm5 and snt2 mutant or 
an artifact of these experiments.  However, taken together, these experiments failed to fi nd any 
evidence that either Jhd2 or the Rpd3(T) complex represses cryptic transcription.
Exploring other possible Ecm5 functions: the ecm5 knockout does not have cell wall defects 
but does show increased expression of a gene encoding a cell wall protein
Unable to fi nd any evidence that Ecm5 was involved in preventing cryptic transcription, 
I next attempted a number of experiments to get at what the function of this protein might 
be.  Many of these experiments involved spotting serial dilutions of wild-type and ecm5 onto 
plates supplemented with chemicals that perturb various pathways, and looking differential 
growth under these conditions.  These plate assays are summarized in Table 3.2.  I fi rst set out 
to confi rm the cell wall defect phenotype that had been reported for the ecm5 knockout strain, 
by seeing if ecm5 knockouts displayed sensitivity to Calcofl uor White, a chemical that binds to 
and interferes with the chitin in the yeast cell wall (Lussier et al., 1997; Ram et al., 1994).  In 
addition to the wild-type strain, a bar1 knockout, which contains the same G418-resistance gene 
as the other knockout strains was used as a negative control for these assays.  This knockout 
lacks an excreted protease only used for mating, and was therefore not expected to have any 
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Table 3.2 Summary of plate spotting assays in which the ecm5 
knockout strain grew no differently than a wild-type strain
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cell wall phenotypes.  As additional controls for this assay, I used knockouts for chs3 and gas1, 
which are known to be Calcofl uor White resistant and sensitive, respectively (Ram et al., 1994; 
Roncero et al., 1988).  As expected, the chs3 strain grew better than wild-type on YPD plates 
supplemented with Calcofl uor White, while the gas1 strain showed little or no growth (Figure 
3.7A).  However, several independently derived ecm5 knockout strains did not show Calcofl uor 
White sensitivity.  Similar results were found with ecm5 knockout strains derived from the W303 
yeast background strain (data not shown).
Growth on media containing sodium dodecyl sulfate (SDS) is another way to assay for 
cell wall defects (Shimizu et al., 1994).  I therefore spotted the same set of strains on YPD plates 
supplemented with 0.015% SDS (Figure 3.7B).  The gas1 mutant again showed sensitivity to 
this cell wall-disrupting treatment.  Again, however, ecm5 knockout strains grew similarly to 
wild-type.  While I was tempted to conclude from these experiments that Ecm5 protein function 
was completely unrelated to the yeast cell well, a microarray experiment I conducted to compare 
gene expression between wild-type and ecm5 mutant cells did fi nd a difference in the expression 
of FIT1, which encodes a cell wall mannoprotein (data not shown) (Protchenko et al., 2001).  I 
was unable to validate most of the hits from this microarray screen, but I did confi rm that cells 
lacking Ecm5 had higher levels of FIT1 mRNA (Figure 3.7C).  Taken together, these results 
suggest that while an ecm5 knockout strain derived from the BY4741 or W303 background strain 
does not have impaired cell walls, Ecm5 may nevertheless have a role in cell wall function by 
ensuring proper expression of certain cell wall genes.
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Figure 3.7 ecm5 and jhd2 knockouts are not sensitive to chemicals that disrupt the cell 
wall
Five-fold serial dilutions wild-type (BY4741) or indicated mutant strains were spotted on rich 
media (YPD) or YPD supplemented with 100 g/mL Calcofl uor White [A] or 0.015% sodium 
dodecyl sulfate (SDS) [B]. Plates were photographed after the number of days indicated under 
each image. C. qPCR analysis of FIT1 expression in wild-type and ecm5 knockout strains.  
Expression values were normalized to  ACT1 expression. Graph shows means and SEMs for 3 
biological replicates.
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Exploring whether Ecm5 is involved in the cellular morphogenesis checkpoint
Without any evidence that Ecm5 is required for intact cell wall, I next turned my attention 
to another phenotype originally reported for the ecm5 knockout strain, elongated bud necks 
with drooping buds.  Cell division in budding yeast is asymmetric: smaller daughter cells bud 
off of larger mother cells.  Each daughter cell then grows into a mother and produces her own 
daughter cells.  During cell division, the bud emerging from the mother cell forms the basis for 
the future daughter cell.  The neck of the bud, the point of attachment between this structure 
the mother cell, is formed by a ring of septin proteins and acts as the conduit through which all 
components that the mother cell partitions to the daughter must pass (Merlini and Piatti, 2011).  
Thus, the proper formation of the bud neck and bud structures is vitally important to proper cell 
proliferation.  In accordance with the importance of these structures, yeast have mechanisms in 
place to ensure that bud and bud neck are structured and properly.  One such mechanism, the cell 
morphogenesis checkpoint, arrests the cell cycle in response to bud neck defect (Theesfeld et al., 
2003).  
The cell morphogenesis checkpoint is triggered by improper arrangement of the septin 
proteins that make up the bed neck. Normally, during late G1 and S phases, the Swe1 kinase 
(the budding yeast homolog of Wee1) accumulates in the nucleus.  During S phase, a ring of 
septin proteins forms at the emerging bud, and a subpopulation of Swe1 leaves the nucleus 
and is recruited to the bud neck by the Hsl7 and Hsl1 proteins.  Once at the bud neck, Swe1 is 
phosphorylated by the kinases Cdc5 and Cla4, promoting its degradation.  As bud-neck localized 
Swe1 is degraded, more Swe1 is recruited from the nucleus, and in this manner, the cellular pool 
of Swe1 is diminished.  If there is a defect in the septin organization at the bud neck or in the 
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actin-mediated transport of components to the emerging bud, Hsl7 is no longer recruited, and the 
Hsl1-Hsl7 complex no longer recruits Swe1 for destruction.  The stabilized Swe1 is then free to 
phosphorylate the mitosis-promoting cyclin-dependent kinase Cdc28, thereby inactivating it, and 
triggering a G2 arrest.
Like the ecm5 knockout strain, the cla4 knockout also has an elongated bud neck 
phenotype (Cvrckova et al., 1995; Schmidt et al., 2003).  Intriguingly, cla4 mutants have 
similar doubling times to wild-type strains, suggesting that mutants that result in morphogenesis 
checkpoint activation can fi nd ways to circumvent this checkpoint and keep dividing. In addition, 
ECM5 gene expression is elevated in a strain lacking Cbk1, a kinase needed for apical bud 
growth, further linking Ecm5 with bud regulation (Bidlingmaier et al., 2001).  Rpd3 has also 
been linked with bud regulation: combining the rpd3 knockout with either cla4 or hsl7 mutants 
results in synthetic lethality (Ruault and Pillus, 2006; Ye et al., 2005).
To test whether ECM5 deletion results in morphogenesis checkpoint activation, I 
immunoblotted whole cell extracts from wild-type and ecm5 cells with antibodies that 
recognize unmodifi ed or phosphorylated Cdc28 (Figure 3.8).  Consistent with the known 
function of Cla4 in this checkpoint, lysates from a cla4 strain had higher levels of Cdc28 
phosphorylation.  Cells lacking Hsl1, another protein needed to promote Swe1 degradation, also 
had higher levels of Cdc28 phosphorylation.  However, cells lacking Ecm5, Snt2, or Rpd3 did 
not, suggesting deletion of Rpd3(T) complex members does not result in constitutive activation 
of the cellular morphogenesis checkpoint.
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Figure 3.8 Cellular morphogenesis checkpoint signaling is not activated in ecm5, snt2, or 
rpd3 knockouts
Whole cell extracts from a wild-type strain (WT) and the indicated knockout strains were 
blotted with antibodies against the Cdc28 cyclin, Cdc28 phosphorylated in tyrosine 19 (Cdc28 
Y19p). A histone H4 blot and a Direct Blue 71 stain of the membrane are shown as loading 
controls.  The hsl1 and cla 4 knockout strains, which are known to have activated cell integrity 
checkpoints, are used as positive controls.
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Exploring whether Ecm5 might be involved in the cell cycle or the DNA damage response
Hoping to get clues to the function of Ecm5 and the Rpd3(T) complex, I turned to 
publicly available high-throughput datasets.  In particular, I focused on a study from Nevan 
Krogan’s laboratory in which large numbers of yeast double knockout strains were screened for 
synthetic growth phenotypes (Collins et al., 2007).  The ecm5 knockout was one of the strains 
used in this screen, although the snt2 knockout was not included.  This study found a number of 
genes that showed synthetic genetic interactions with ECM5 (Table 3.3).  
I immediately noticed that the TOP3 and RMI1 genes, which encode two subunits of 
the DNA topoisomerase III complex, were both strongly synthetically sick in combination with 
ECM5 deletion.  This complex is involved in homologous recombination and DNA double strand 
break repair (Cejka et al., 2010; Hickson and Mankouri, 2011).  Rpd3 has also been reported to 
antagonize the DNA damage response (Scott and Plon, 2003).  I therefore wondered whether 
Ecm5 might be involved in DNA damage repair.  In order to explore this, I spotted wild-type 
and ecm5 knockout yeast strains onto plates treated with the DNA damaging agents (MMS and 
UV radiation) or chemicals that induce DNA replication stress (hydroxyurea or camptothecan).  
However, the ecm5 knockout grew similarly to the wild-type strain under all these conditions 
(summarized in Table 3.2 and data not shown).  After I completed these assays, I discovered 
that the TOP3 and RMI1 knockout strains were only pulled out of the Krogan laboratory screen 
because these mutants require a suppressor mutation in a gene near ECM5 for vitality (Chang et 
al., 2005; Gangloff et al., 1994).  ECM5 is synthetically sick with these mutants because double 
mutants containing ecm5 no longer carry this suppressor mutation, and not due to the ecm5 
mutation, itself.
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Table 3.3 ECM5 Synthetic Genetic Interactionsa
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The ecm5 knockout was also synthetically sick with cells lacking the CDK inhibitor 
Sic1, whose phosphorylation and destruction triggers the start of S phase (Verma et al., 1997).  
In addition, numerous studies have linked Rpd3 regulation of cell cycle genes (Bernstein et 
al., 2000; Robert et al., 2004; Takahata et al., 2009; Wu et al., 1999).  I therefore wondered 
whether, as part of the Rpd3(T) complex, Ecm5 might play a role in the yeast cell cycle.  I set 
out to characterize the cell cycle profi les of control and ecm5 knockout strains using FACS cell 
cycle analysis.  I arrested both strains using -factor and monitored the arrest by looking for the 
presence of shmoos and the absence of buds in the microscope.  I then released the synchronized 
cells into the cell cycle, and took aliquots every 20 minutes for cell cycle analysis, using fl ow 
cytometry.  As can be seen in Figure 3.9, before release, wild-type cells had almost exclusively 
1C DNA content, consistent with their arrest G1 phase.  Within 40 minutes after release, many 
wild-type cells had 2C DNA content, indicating they had completed S phase.   Between 60 and 
80 minutes post-release, the number of cells with 1C DNA content increases again, consistent 
with cells that have completed mitosis.  The profi les of the ecm5 knockout strain were almost 
identical to wild-type profi les, showing that ecm5 mutants have no obvious cell cycle defects.  
In addition, I tested growth on the microtubule inhibitor benomyl to see if the ecm5 knockout 
had defects in mitosis, but again, the ecm5 knockout strain grew similarly to wild-type in this 
assay (data summarized in Table 3.2).  Consistent with these results, ecm5 mutants had similar 
doubling times to wild-type cells in both rich (YPD) and less rich (synthetic defi ned with 
complete supplement mixture, or SD CSM) media (Table 3.4).
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Figure 3.9 Cell cycle analysis of ecm5 knockout cells
The bar1 knockout strain (“Wild-type”) and the bar1ecm5 double knockout 
(“ecm5”) were synchronized using -factor, and cells were taken at the indicated time points, 
stained with SYTOX green and analyzed by fl ow cytomet ry.  Histograms of cell fl uorescence at 
each timepoint are shown, with the positions of 1C and 2C DNA content indicated.  Cells from  
asynchronously growing strains (async) were also analyzed.
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Table 3.4 Growth rates in rich and moderate mediaa
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While Ecm5 is not required for cell cycle progression, it is possible that this protein is 
still involved in this process.  Since the levels of many cell cycle proteins fl uctuate over the 
course of the cell cycle, I checked whether Ecm5 protein levels changed at any point in the 
cycle.  To that end, I synchronized a tagged Ecm5 strain, and immunoblotted cell lysates taken 
at various points after release to look for changes in Ecm5 protein levels (Figure 3.10).  Levels 
of H3S10p, which are known to peak during mitosis (Wei et al., 1998), were clearly enriched 
starting between 40 and 60 minutes post-release, showing that these cells were well synchronized 
going into mitosis, although less so at later time-points.  In contrast, levels of tagged Ecm5 
protein remained constant throughout the cell cycle.  Taken together, the results of these 
experiments do not provide any evidence that Ecm5 is involved in cell cycle progression, or 
DNA repair and replication.
Exploring whether Ecm5 is required for sporulation
Since Ecm5 protein levels are low in yeast grown under normal conditions, I wondered 
whether the primary function of this protein might be in a pathway not normally needed during 
vegetative growth, such as sporulation.  Intriguingly, around this time, we received word that 
unpublished work from Marc Meneghini’s laboratory had found that Jhd2 is required for proper 
sporulation.  In addition, the Rpd3(L) complex is known to repress meiosis genes in vegetatively 
growing yeast, and rpd3 mutants have sporulation defects (Bowdish and Mitchell, 1993; Dora 
et al., 1999; Lamb and Mitchell, 2001; Strich et al., 1989; Strich et al., 1994; Vidal and Gaber, 
1991).  I therefore tested whether an Ecm5 mutant has any defect in sporulation.  Because 
the BY4741 background strain that I have used for most of this work is known to be poor at 
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Figure 3.10 Ecm5-TAP protein levels over the course of the cell cycle
Whole cell extracts from an ECM5-TAP bar1 strain synchronized using -factor were 
immunoblotted with antibodies against the TAP tag (to detect Ecm5-TAP levels) and H3S10 
phosphorylation (H3S10p, a mitosis-specifi c mark). Numbers at the top show minutes after 
-factor release . Bottom panels are amido black stains, used as a loading control.
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sporulation, I created a homozygous diploid ecm5 knockout strain on the highly-sporulating 
SK1 genetic background, and grew wild-type and ecm5 SK1 strains in 1% potassium acetate 
solution to promote sporulation.  However, the ecm5 mutant showed no defects in tetrad 
formation (Figure 3.11A), and individual spores from sporulated ecm5 mutant tetrads were fully 
viable (Figure 3.11B), showing Ecm5 is not required for sporulation.
Chapter 3 Discussion
The experiments described in this thesis chapter were all undertaken with the goal of 
better understanding the functions of Ecm5 and Jhd2.  In order to achieve this goal, I fi rst set out 
to determine Ecm5- and Jhd2-interacting proteins.  Despite multiple attempts, Trixi and I were 
unable to identify any proteins interacting with Jhd2.  While we tried a variety of purifi cation 
conditions, it is possible that we failed to utilize the specifi c condition under which associations 
between Jhd2 and its interacting proteins were maintained.  Alternatively, Jhd2 may function 
independently of other proteins in a stable complex.  Trixi and I were able to show that Ecm5 
interacts with Snt2 and the Rpd3 deacetylase.  In good agreement with my results, shortly after I 
identifi ed this complex, Anna Shevchenko and A. Francis Stewart reported identifying a complex 
consisting of Ecm5, Snt2, and Rpd3, which they called the Snt2 complex (Snt2C) (Shevchenko 
et al., 2008).  Because Rpd3 is currently the only subunit in this complex known to have 
enzymatic activity, I favor the use of the name Rpd3(T) complex, which highlights the likely 
function of this complex as a deacetylase and promotes comparison to the other Rpd3 complexes. 
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Figure 3.11 The ecm5 knockout strain does not have sporulation defects
Wild-type (WT) SK1 and ecm5::G418/ecm5::HYG mutant yeast were transferred to 2% 
potassium acetate to induce sporulation. A. After 3 days, the number of tetrads was counted 
and divided by the total number of tetrads and unsporulated diploid cells in the sample to 
determine % sporulation.  The graph shows the mean and standard deviation of 3 independently 
sporulated wild-type colonies and 4 independently sporulated ecm5 knockout colonies.  B. 
Representative tetrad dissections show that ecm5/ spores are viable.  Replica platings of 
the ecm5/ tetrads onto plates containing G418 and hygromycin B (HYG, bottom panels), to 
select for each ecm5 knockout allele, show the ecm5 deletion segregates normally.
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Based on the Ecm5 and Snt2 domain structures, and the known deacetylase activity of 
Rpd3, the Rpd3(T) complex is highly likely to function at chromatin.  Regardless of whether 
we treated our extracts with DNAse, micrococcal nuclease, or nothing (in which case the DNA 
was partially sheared due to cryogenic lysis procedure), histones were never observed in our 
purifi cations.  It is possible that this complex does not interact with chromatin.  However, I 
believe it is more likely that our purifi cation conditions promoted dissociation of the Rpd3(T) 
complex from nucleosomes.  In support, experiments I described in Chapter 2 of this thesis 
found that the Ecm5 PHD fi nger could interact with histone H3.  Additionally, in experiments 
I describe in the next Chapter of this work, I was able to clearly and repeatedly fi nd Ecm5 and 
Snt2 localized to specifi c genomic regions by ChIP.  
The existence of a third Rpd3 complex immediately prompts the question: how do the 
functions of these three complexes compare?  Because of initial data suggesting the Ecm5 
and Jhd2 PHD fi ngers could interact with H3K36me3, I immediately thought of the Rpd3(S) 
complex, which also contains subunits that interact with H3K36me2/3, and is required to prevent 
initiation from cryptic promoters within certain genes.  I initially hypothesized that Jhd2 and 
the newly discovered Rpd3(T) complex might also prevent cryptic transcription.  However, I 
was unable to fi nd any evidence that levels of known cryptic transcripts were higher in strains 
lacking Ecm5 or Snt2, leaving no support for this hypothesis.  It remains possible that Jhd2 or 
the Rpd3(T) complex does prevent cryptic transcription within coding sequences, but at different 
target genes than the two that I studied in these assays, or that higher levels of cryptic transcripts 
present in strains lacking these proteins are still too low to be detected in my assays.  The cryptic 
transcripts in the rpd3 knockout were just at the limit of detection in my northern blots, so levels 
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of cryptic transcripts lower than these would likely have been below the level of detection by 
this assay.  It is also possible, that the Rpd3(T) complex acts redundantly with other factor(s) 
such that cryptic transcripts are only detectable ecm5 or snt2 knockouts also deleted for this 
other factor(s).  To that end, it would be interesting to see whether deletion of ecm5 enhanced the  
cryptic transcript phenotype of the eaf3 and rco1 knockout strains.  However, it should be noted 
that in ChIP experiments that I will describe in the next chapter of this work, I did not see any 
Ecm5 or Snt2 enrichment at STE11 or SPB4 coding regions or promoters, making it unlikely that 
the Rpd3(T) complex has any direct function at these genes (data not shown).
In addition to preventing aberrant transcription from initiating within genes, a recent 
report shows that the Rpd3S complex plays a role in suppressing transcription of CUTs initiating 
from promoter regions (Churchman and Weissman, 2011).  These authors report that rco1 and 
eaf3 knockouts have higher levels of antisense CUTs, initiating from the same start sites used by 
the coding transcripts.  Since deletion of Set2 (but not Set1) also increases CUT transcription, the 
authors suggest that Rpd3(S) is recruited to the promoter regions where these CUTs are known 
to initiate through interactions with Set2-deposited H3K36me3 at the 3’ ends of nearby genes.  
However, even the authors note that this model does not explain how the Rpd3(S) complex 
prevents CUT transcription at promoters that are not close to the 3’ end of another gene.  This 
new work affi rms that aberrant transcription within coding regions is just the tip of the iceberg 
when it comes to noncoding transcription in yeast.  Because my experiments only focused 
on a role for the Rpd3(T) complex in preventing aberrant transcripts within coding regions, I 
cannot say whether this complex is involved in other types of noncoding transcription, although 
the intriguing 6kb RNA species enriched in ecm5 and snt2 knockouts may point to some role 
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for Rpd3(T) in the pathways.  Future experiments looking for altered levels of other kinds of 
noncoding transcripts in ecm5 and snt2 knockouts, either in combination with TRAMP and 
exosome mutants, or by directly sequencing RNA Pol II-associated transcripts, may uncover 
a role for the Rpd3(T) complex in regulating non-coding transcription.  In addition, a northern 
blot with an rRNA proble, to look at whether ecm5 and snt2 knockout strains have altered rRNA 
processing, might be worthwhile.
While I was unable to confi rm a role for the Rpd3(T) complex in suppressing cryptic 
transcription, I remained interested in gaining insight into the function(s) of this complex.  
Because of the cell wall phenotypes reported for the ecm5 mutant, I thought that Ecm5 might 
be involved in regulating this structure, possibly by regulating expression of genes involved 
in cell wall maintenance.  However, my own ecm5 knockout strains showed no sensitivity to 
the cell wall disrupting agents calcofl uor white and SDS.  This discrepancy in fi ndings may be 
due to the differences in genetic backgrounds used between this work and the previous Ecm5 
study.  My studies have all been conducted with mutants made in the S288C (BY4741) and 
W303 background strains, while the original isolation of the Ecm5 mutant was done using the 
AWM3C630 background strain.  There are at least a few reported examples of different mutants 
having different phenotypes in different genetic backgrounds (de Jesus Ferreira et al., 2001; 
Kucharczyk et al., 1999; Schoch et al., 1997; Trachtulcova et al., 2003).  While I did not fi nd 
any evidence that the cell walls of ecm5 knockout cells were grossly defective, I did fi nd up-
regulation of a cell wall mannoprotein gene in the ecm5 knockout strain, suggesting at least one 
link between Ecm5 and the yeast cell wall.  
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Cells lacking Ecm5 have also been reported to have elongated bud necks and drooping 
buds, suggesting Ecm5 might be required for proper formation of the bud or bud neck, 
and deletion of this gene might activate the cellular morphogenesis checkpoint.  However, 
ecm5 knockout cells did not have higher levels of Cdc28 phosphorylation, showing that this 
checkpoint is not constitutively active in ecm5 knockouts.  I have never noticed an elongated 
bud neck or drooping buds in my own microscopic examinations of ecm5 mutants.  However, 
the elongated bud neck phenotype is fairly subtle to detect using normal light microscopy, and I 
have trouble recognizing it even when pointed out in micrographs in published papers.  Notably 
the elongated bud neck phenotype for ecm5 mutants was reported by the same group who found 
the ecm5 mutant had a cell wall defect, so it is also possible that this phenotype is only present in 
ecm5 knockouts from the AWM3C630 background.
As another means of getting at Ecm5 protein function I made use of a high-throughput 
screen for genes that synthetically interact with the ecm5 knockout strain.  There were many 
interesting genes pulled out from this screen.  For instance deletion of ECM5 relieved the growth 
defects associated with loss of Sin3, a subunit of both the other Rpd3 complexes, suggesting that 
Rpd3(T) may function in opposition to the Rpd3(S) and Rpd3(L) complexes.  Because three of 
the genes in this screen had functions relating to DNA damage repair or cell cycle progression, I 
checked whether ecm5 mutants had any defects in these pathways.  However, I showed that the 
ecm5 knockout strain is not sensitive to chemicals that disrupt DNA replication, trigger DNA 
damage, or interfere with mitotic microtubules and that ecm5 knockout cells have normal cell 
cycle profi les, suggesting Ecm5 is not necessary for any of these processes. In addition, ecm5 
knockout cells have no discernible defects in sporulation.  While it remains possible that Ecm5 
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plays a subtle and non-essential role in any of these processes, it seemed unwise to experiment 
further along these lines without a clear indication of involvement.
These early experiments into Ecm5 function were not very successful.  However, there 
were other genes with ECM5 synthetic phenotypes found in the Krogan laboratory’s screen that I 
had yet to interrogate (Table 3.3).  This screen found a genetic interaction between ECM5 and the 
SAS2 gene, which encodes a H4K16 acetyltransferase known to oppose transcriptional silencing.  
In contrast to the SIN3 genetic interaction data discussed above, this genetic interaction suggests 
that the Rpd3(L) and (S) complexes might function similarly with regard to transcriptional 
silencing, since the Rpd3(L) complex has been shown to antagonize silencing (De Rubertis et 
al., 1996; Rundlett et al., 1996; Smith et al., 1999; Sun and Hampsey, 1999; Vannier et al., 1996). 
ECM5 also had genetic interactions with ASK10 and GCN1, genes which encode oxidative stress 
and amino acid starvation sensors, respectively, hinting that the Rpd3(T) complex might function 
in stress and metabolism signaling, an idea that forms the basis for the next chapter of this work.
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CHAPTER 4: EXPLORING THE ROLE OF THE RPD3(T) COMPLEX IN THE 
OXIDATIVE STRESS RESPONSE AND METABOLIC REGULATION
Chapter Introduction
Despite obtaining some negative results in my early Ecm5 functional experiments, I 
remained eager to determine a function for the Rpd3(T) complex.  Based on a genetic interaction 
reported by the Krogan laboratory, between ECM5 and the ASK10 oxidative stress sensor gene 
(Collins et al., 2007), I formed a new hypothesis that the Rpd3(T) complex might function in the 
yeast oxidative stress response.  The fi rst part of this chapter will focus on initial experiments 
I performed to look for evidence that Ecm5 and Snt2 are involved in this pathway, and the 
discovery that the snt2 knockout strain is resistant to hydrogen peroxide (H2O2)-mediated 
oxidative stress.  I will then discuss genome-wide chromatin immunoprecipitation (ChIP) 
experiments undertaken to map Ecm5 and Snt2 localization before and after oxidative stress.  
Because the results of this mapping found Ecm5 and Snt2 localized to gene promoter regions, 
I next wanted to determine whether there were any differences in gene expression in ecm5 and 
snt2 knockout strains before and after H2O2 stress.  The third part of this chapter will describe 
RNA sequencing experiments undertaken to look for gene expression differences in these 
mutants, and to determine whether Ecm5 and Snt2 regulate the expression of their target genes.
While these ChIP and gene expression analyses isolated many genes involved directly in 
the oxidative stress response, they also identifi ed genes involved in cellular metabolism functions 
such as protein translation, amino acid uptake and synthesis, and carbon usage.  The association 
of the Rpd3(T) complex with metabolism genes suggests that rather than functioning solely in 
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detoxifying oxidative stress, this complex might function more broadly at the interface between 
cellular stress and nutrient metabolism.  In order to see whether the Rpd3(T) complex also 
responds to metabolic stress, I conducted studies in the more nutrient-limited stationary phase 
of growth and with the TOR pathway inhibitor rapamycin, which is known to promote cellular 
changes that mimic amino acid starvation.  The fourth part of this chapter will summarize these 
experiments, and show that the Rpd3(T) complex responds to nutrient stress.  
Genetic links between the Rpd3(T) complex and oxidative stress
In the synthetic genetic screen performed by the Krogan laboratory, discussed in the 
previous chapter, one of the genes whose deletion showed synthetic sickness when combined 
with the ecm5 knockout was ASK10 (also known as RGC2).  This gene was fi rst discovered 
in a screen for mutants that result in transcriptional activation of SKN7, a transcription factor 
involved in the oxidative and heat stress responses (Page et al., 1996).  A later report found 
that Ask10 associates with the RNA pol II holoenzyme and is phosphorylated in response to 
oxidative stress, suggesting that Ask10 may help regulate the yeast oxidative stress response 
(Cohen et al., 2003).  More recently, Ask10 was shown to be involved in regulating the response 
to hyperosmotic stress, a condition that also triggers Ask10 phosphorylation (Beese et al., 2009).  
Because of the genetic link between Ecm5 and Ask10, I hypothesized that the Rpd3(T) 
complex might help to mediate the oxidative stress response, or possibly a more general response 
to stress.  In support of this, cells lacking Snt2 have higher levels of phosphorylated Slt2 (de 
Groot et al., 2001), a mitogen activated protein kinase (MAPK) homologous to the mammalian 
p42/p44 MAPK, that is activated in response to diverse extracellular stresses, including oxidative 
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and osmotic stress.  In addition, many of the genes whose levels change in response to osmotic 
stress are genes whose promoters were found to contain Snt2 by ChIP-chip (Harbison et al., 
2004; Miller et al., 2011).  Thus, there were multiple lines of evidence to connect Ecm5 and Snt2 
to cellular stress response.
Work from several groups has implicated Rpd3 and the Rpd3(L) complex in yeast stress 
response function.  Cells lacking Rpd3 or Sin3 are sensitive to osmotic stress, and in response 
to high levels of NaCl, these proteins are recruited to the promoters of osmotic stress genes 
where they are required for gene activation (De Nadal et al., 2004).  The Rpd3(L) complex is 
also recruited to stress response genes in response to heat shock, where it mediates both gene 
activation and repression (Kremer and Gross, 2009; Ruiz-Roig et al., 2010).  In addition, Rpd3 is 
required for the activation of certain cell wall mannoproteins in response to hypoxia stress (Sertil 
et al., 2007).  While Rpd3 is generally thought of as a transcriptional repressor, these reports 
suggest that in some cases, this protein can also activate transcription.  Consistent with this idea, 
a microarray study found that Rpd3 is required for both activation and repression of the many 
genes whose expression change in response to heat shock, osmotic stress, or oxidative stress 
(Alejandro-Osorio et al., 2009). 
Because of the genetic evidence linking Ecm5 to oxidative stress, and because of the 
connection between the Rpd3(L) complex and stress response pathways, I set out to determine 
whether the Rpd3(T) complex also functioned in the yeast oxidative stress response.  I initially 
checked whether tagged Ecm5 and Snt2 protein levels change in response to treatment with 0.5 
mM H2O2.  While Ecm5 and Snt2-PrA levels did not change within the fi rst couple of hours of 
H2O2 treatment, they each increased 4 hours after H2O2 treatment relative to the loading controls 
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(Figure 4.1A).  No western blot signal was seen before or after treatment in whole cell extracts 
from an untagged strain, confi rming that the Ecm5- and Snt2-PrA signal on these western blots 
was specifi c to the tagged proteins.  In a second experiment, where a single Ecm5-PrA culture 
was grown and divided into two separate cultures, one receiving 0.4 mM H2O2, and the other 
receiving no treatment, Ecm5-PrA levels increased in response to H2O2 treatment but not in the 
no treatment control (Figure 4.1B).  The increase in Ecm5 protein levels was not seen in every 
experiment I tried, but it was repeatable: 6 out of 8 experiments involving treatment with 0.4-
0.5 mM H2O2 resulted in an increased in tagged Ecm5 protein levels.  In contrast, the increase 
in Snt2-PrA after H2O2 treatment was only seen in 1 out of 4 experiments.   The increased Ecm5 
protein levels in response to oxidative stress could be explained by increased transcription, 
increased translation, or decreased degradation of Ecm5.  However, qPCR experiments found 
that ECM5 mRNA levels do not change signifi cantly 30 minutes or 4 hours after H2O2 treatment 
(Figure 4.1C), suggesting the increases in Ecm5-PrA were the result of post-transcriptional 
mechanisms.  SNT2 mRNA levels did increase slightly 0.5 hours after H2O2 treatment but 
returned to baseline by 4 hours post-treatment (Figure 4.1D).  
Because these results provided an early confi rmation that Ecm5 and Snt2 might 
function in the oxidative stress response, I then tested whether ecm5 and snt2 knockouts 
showed differential growth on plates supplemented with H2O2.  As a control for this assay, I 
used a strain lacking the Yap1 H2O2-response transcription factor, which is known to be H2O2-
sensitive (Schnell et al., 1992).  When plated on YPD containing moderate concentrations of 
H2O2 (concentrations in which the wild-type strain grew as well as on untreated plates, but the 
oxidative stress-sensitive yap1 knockout could not grow), the ecm5 and snt2 knockout strains 
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Figure 4.1 Ecm5 and Snt2 protein and mRNA levels before and after H2O2 stress
A. Protein A-tagged (and untagged control) strains were grown to mid-log phase in rich media, 
and treated with 0.5 mM H2O2.  PrA western blots of whole cell extracts show Ecm5- and Snt2-
PrA levels before and at indicated times (hrs: hours) after treatment.  Blots for histone H3 and 
tubulin, as well as Direct Blue 71 membrane straining are shown as loading controls. B. PrA 
western blots on whole cell extracts as in A, except cells were treated with either 0.4 mM H2O2 
or water alone (no treatment) as a control.  C and D. qPCR expression analysis of ECM5 (C) 
and SNT2 (D) mRNA levels in wild-type cells and after 0.4 mM H2O2 treatment.  Expression 
values were normalized to ACT1 expression, and average expression in the wild-type untreated 
sample was set to 1. Graphs show averages and SEMs of qPCRs from 3 biological replicates. * 
p<0.05 by paired two-tailed t test.
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grew very similarly to wild-type (Figure 4.2A, compare left and middle panels).  Surprisingly 
however, on higher H2O2 concentrations, the snt2 knockout strain was H2O2-resisitant, growing 
almost as well as on the untreated YPD control plate while the wild-type strain could barely 
grow (Figure 4.2A, right panel).  A similar level of growth was seen with a strain lacking Gpr1, 
a G protein glucose sensor which was recently reported to be H2O2-resistant (Molin et al., 2011).  
Unlike the snt2 knockout, the ecm5 knockout strain had similar H2O2 sensitivity to the wild-type 
strain.  The rpd3 knockout strain has a known growth defect which can be seen by the smaller 
rpd3 colony size on the YPD control plate.  While this strain also had smaller sized colonies 
on the 3.0 mM H2O2 plate, there were more rpd3 colonies than wild-type colonies on this plate, 
showing that like the snt2 knockout, this mutant also was resistant to oxidative stress.
Having performed a great many plate spotting assays by this point in my graduate 
research without ever having seen a strong phenotype for the ecm5 and snt2 knockout strains, 
I was cautiously excited to fi nally see a phenotype for one of my mutants.  However, I wanted 
to be sure this phenotype was truly due to deletion of SNT2, and not just an artifact of this 
particular strain.  I therefore constructed new ecm5, snt2, and rpd3 deletion strains on the 
BY4742 background and subjected them to the same plate assay.  The snt2 knockout strain again 
showed resistance to high levels of H2O2 (Figure 4.2B).  The rpd3 strain also showed moderate 
H2O2-resistance in this assay.  To determine whether this result was specifi c to the oxidative 
stress response or was a more general stress resistance, I subjected these cells to osmotic stress 
by plating them on plates containing 1.2 M NaCl.  Consistent with previous reports, the rpd3 
mutant showed a strong growth defect on high salt.  However, the snt2 mutant also grew better 
than wild-type and the ecm5 knockout strain under these conditions, suggesting this knockout 
displays resistance to multiple kinds of stresses (Figure 4.2C).
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Figure 4.2 snt2 mutants are resistant to oxidative and osmotic stress
A. Five-fold serial dilutions of mid-log phase cultures of wild-type (BY4741) or indicated 
knockout strains were spotted on rich media (YPD) or YPD supplemented with 2.4 or 3.0 mM 
hydrogen peroxide (H2O2). Plates were imaged after 2 days. B. Spotting assay as in A, with 
a separate set of knockout strains derived from the BY4742 background strain. C. Spotting 
assay as in A on YPD or YPD supplemented with 1.2 M NaCl. YPD control and NaCl plates 
were imaged after 2 and 3 days, respectively.  D. The wild-type (BY4741) or knockout strains 
indicated were grown to mid-log phase, and cultures were treated with 0.4 mM H2O2 for 4 
hours.  Percent su rvival was determined by plating 1000 cells from each culture before and 
after treatment and counting viable colonies after two days’ growth. Shown are means and 
SEMs from 3 biological replicates.
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To further confi rm that the snt2 mutant was resistant to oxidative stress, I subjected the 
wild-type and ecm5, snt2, and rpd3 knockout strains to a liquid survival assay.  In this assay, 
each strain was grown to mid-log phase in YPD and treated with 0.4 mM H2O2 for 4 hours.  
Before and after treatment 1000 cells from each culture were plated onto YPD, and the number 
of colonies visible after 2 days’ growth was counted to determine the number of viable cells at 
the time of plating.  The percentage of cells alive after treatment, relative to the number of live 
cells before treatment was then determined.  Under these conditions, the wild-type strain and 
the ecm5 knockout strain each had about 20% survival (Figure 4.2D).  Consistent with the plate 
assays, the rpd3 and snt2 knockouts showed enhanced survival in this assay, with 58% of snt2 
cells and 41% of rpd3 cells surviving 4 mM H2O2 treatment.  Taken together, these experiments 
show that both the snt2 and rpd3 knockout strains are resistant to H2O2-mediated oxidative stress, 
with the snt2 strain showing higher levels of resistance than the rpd3 strain.
Mapping the genomic localization of Ecm5 and Snt2 before and after oxidative stress
In order to get a better understanding of how the Rpd3(T) complex might function in 
the response to oxidative stress, I sought to map this complex’s genomic localization using 
chromatin immunoprecipitation followed by deep-sequencing (ChIP-seq).  Since Rpd3 is a 
constituent of at least two other chromatin-associated complexes, I set out to map the localization 
of the Rpd3(T)-unique Ecm5 and Snt2 subunits.  A previous study had mapped genome-wide 
Snt2 associations using ChIP followed by microarray analysis, and found Snt2 at the promoters 
of a small number of genes (Harbison et al., 2004).  Using this data, a separate group determined 
a binding motif for Snt2 and reported enrichment of this motif at the promoters of amine 
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transmembrane transporters (Ward and Bussemaker, 2008).  While these studies offered some 
insight into the potential functions of Snt2 and the Rpd3(T) complex, the use of microarrays 
containing only a single probe for each promoter region limited the spatial resolution of this 
mapping.  I therefore felt it necessary to map the localization of Snt2 myself using the newer 
ChIP-seq technology favored by the Allis laboratory, which provides better resolution, higher 
sensitivity, and more complete genome coverage than most microarrays.  In addition, to my 
knowledge, no ChIP for Ecm5 had ever been performed, and I wanted to determine whether 
Ecm5 and Snt2 colocalized, as would be predicted if they are part of the same complex.  Lastly, 
neither protein’s localization has been mapped under conditions of oxidative stress, and given 
my genetic results, I was curious to see whether Ecm5 and Snt2 would respond H2O2 stress by 
localizing to new regions of the genome.
Ecm5 and Snt2 are highly colocalized by ChIP-seq
For these ChIP studies, I generated new strains in which ECM5 or SNT2 was tagged with 
13 copies of the Myc epitope (hereafter referred to as the Myc tag).  I grew both tagged strains 
along with an untagged control strain to mid-logarithmic (mid-log) phase in rich media, and 
harvested and fi xed cells for ChIP.  I then treated the remaining cultures with 0.4 mM H2O2, and 
harvested cells 30 minutes and 4 hours after treatment.  I chose these two time-points because 
the former would allow me to look at the acute stress response, which has been shown to occur 
5-30 minutes after H2O2 stress (Gasch et al., 2000) , while the latter coincided with the time 
when I found an increase in Ecm5 protein levels.  Since H2O2 is a highly reactive chemical, the 
majority of H2O2-infl icted damage is likely to occur within minutes of addition of this chemical 
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to the media.  However, cells given a mild dose of H2O2 are known to undergo adaptive changes 
that render them more resistant to larger doses of this stress in the future (Collinson and Dawes, 
1992; Jamieson, 1992).  Another reason I chose to map Ecm5 and Snt2 localization 4 hours after 
H2O2 treatment was to see whether there were any localization changes specifi c to this late time-
point that might suggest Ecm5 and Snt2 involvement stress adaptation.  While I never tested 
ecm5 and snt2 knockout strains for enhancement or loss of the adaptation, I was curious to see 
whether localization changes in these two proteins might reveal something about this process.
I then performed ChIP on these cells using an anti-Myc, and submitted both the input and 
the ChIP DNA from all samples for sequencing.  Here, I was fortunate to work with Scott Dewell 
in Rockefeller University’s Genomics Resource Center who performed the actual sequencing 
and analyzed and mapped the initial sequencing reads.  The number of sequencing reads for each 
sample in this experiment are summarized Table A.1, in the Appendix of this work.  In addition, 
Deyou Zheng, a computational biologist at Albert Einstein Medical College, provided assistance 
with data analysis.  
Consistent with Ecm5 and Snt2 being members of the same complex, the ChIP-seq 
profi les of Ecm5 and Snt2 were almost identical.  Before treatment, Ecm5 and Snt2 localized 
to a limited number of regions in the genome, in tight peaks, and regions containing high 
numbers of sequencing reads in the Ecm5 ChIP almost always had high read counts in the Snt2 
ChIP (see Figure 4.3A for a representative chromosome).  In almost all cases, regions of the 
genome containing high numbers reads in the Ecm5 and Snt2 ChIP tracks, had low read counts 
in the input and untagged control ChIP, confi rming the specifi city of these ChIP experiments.  
To quantitate the extent of Ecm5 and Snt2 colocalization, I used the MACS algorithm to 
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Figure 4.3 Ecm5 and Snt2 are highly colocalized
A. Ecm5- and Snt2-Myc ChIP profi les in untreated cells along a representative chromosome. 
The Y axis of each track represents the number of reads (in millions) spanning a genomic 
position normalized to the total number of reads for each sample. The numbers in square 
brackets above and to the right of the panel denote the scale [baseline, maximum] which is the 
same for all tracks.  Input and no tag control tracks are shown under the ChIP tracks, and the 
location of yeast genes and genomic coordinates are shown at the bottom of the panel.  B. Venn 
diagrams showing peaks of Ecm5 and Snt2 ChIP reads that overlapped by at least 200 bp.
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computationally defi ne peaks of ChIP enrichment – genomic loci with high numbers of Ecm5 
and Snt2 sequencing reads compared to the untagged control ChIP (Zhang et al., 2008).  This 
analysis found 430 and 420 peaks of Ecm5 and Snt2 reads, respectively, before treatment.  I then 
determined the number Ecm5 and Snt2 peaks that overlapped by at least 200 bp.  Remarkably, 
both before and after treatment, the majority of Ecm5 and Snt2 peaks overlapped, with 315 of the 
Ecm5 and Snt2 peaks overlapping in the untreated cells (Figure 4.3B).  Taken together, the visual 
inspection of the ChIP-seq tracks and the computational peak calling both show that Ecm5 and 
Snt2 are highly colocalized, consistent with their functioning in the same complex.
Ecm5 and Snt2 localize to many new regions a half hour after H2O2 treatment
Surprisingly, 0.5 hours after H2O2 treatment, Ecm5 and Snt2 localized to many genomic 
loci.  For example, in the representative region shown in Figure 4.4, arrows mark peaks of Ecm5 
and Snt2 ChIP-seq reads that were either not present before treatment or strongly enriched after.  
The peaks are not present, or are much less enriched in the input and untagged control ChIP 
tracks, again showing the appearance of these peaks after treatment is specifi c to Ecm5 and Snt2.  
The computational peak calling confi rmed that there were many more peaks of Ecm5 and Snt2 
binding after treatment, fi nding 817 Ecm5/Snt2 shared peaks 0.5 hours after treatment, compared 
with 315 before (Figure 4.3B, and bottom tracks in Figure 4.4).  This dramatic reassortment of 
Ecm5 and Snt2 was only transient, and by 4 hours after H2O2 treatment, Ecm5 and Snt2 profi les 
resembled those of untreated cells.  Furthermore, 4 hours after treatment, the number of peaks 
called by the algorithm was reduced, with 276 only Ecm5/Snt2 shared peaks called, similar to 
the number of peaks found in untreated cells.  Of those, about half, or 137 peaks overlapped 
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Figure 4.4 Ecm5 and Snt2 localize to many new regions after H2O2 treatment
Ecm5- and Snt2-Myc ChIP-seq tracks from both untreated and H2O2-treated yeast, depicted as 
in Figure 4.3, with arrows marking new or enhanced peaks in the 0.5 hour ChIPs (bracketed 
tracks). Peaks called by the MACS algorithm for each ChIP are shown under the tracks.
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with peaks called before treatment.  Peaks that were not shared between the two timepoints 
refl ect mistakes in the peak calling (e.g. a weak peak that was called in one timepoint and not the 
other), and not differences in Ecm5 and Snt2 localization before and 4 hours after treatment.  In 
summary, Ecm5 and Snt2 do not show localization changes 4 hours after treatment that would 
suggest they mediate adaptation to stress, but these proteins do localize to new regions of the 
genome as part of the acute response to H2O2 stress.  
To confi rm the ChIP-seq fi ndings, I performed separate small-scale ChIP-qPCRs 
experiments, following the same H2O2 treatment protocol described above.  I fi rst focused on the 
promoter of the ERG6 and YAP1 genes, a region which shows a modest increase in Ecm5 and 
Snt2 localization 0.5 hours after H2O2 treatment by ChIP-seq (Figure 4.5A, left panel).  ERG6 
encodes an enzyme that helps to synthesize ergosterol, a sterol that accumulates in yeast cell 
membranes after stress and promotes resistance (Lees et al., 1995; Swan and Watson, 1998).  As 
described in the introduction to this work, YAP1 encodes a transcription factor that is known 
to respond to oxidative stress (Rodrigues-Pousada et al., 2010).  Since both YAP1 and ERG6 
have been linked to stress, I was eager to confi rm that Ecm5 and Snt2 were localized to these 
promoters after H2O2 treatment.  In accordance with these results, in ChIP-qPCR experiments 
Ecm5- and Snt2-Myc were enriched (3- to 5-fold above an untagged control strain) at this 
promoter only after H2O2 treatment (Figure 4.5B, left panel).  
I next focused on the CYC3 and the IPI3/YNL181W shared promoters, which both 
had very high numbers of Ecm5 and Snt2 reads before and after treatment in the ChIP-seq 
experiment (Figure 4.5A middle and right panels).  CYC3 encodes an enzyme that helps generate 
active cytochrome C, one of the components of the mitochondrial ETC (Dumont et al., 1987).  
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Figure 4.5 Small-scale confi rmation of ChIP-seq
A. Ecm5 and Snt2 ChIP-seq enrichment before and after H2O2 treatment at the ERG6/YAP1, 
CYC3, and IPI3/YNL181W promoters, depicted as in Figure 4.3.  B. Confi rmation of the ChIP-
seq results in [A] using using ChIP-qPCR.  The relative ChIP enrichment was calculated by 
dividing the percent input for each replicate at the region of interest by the percent input in the 
middle of the ACT1 gene, where Ecm5/Snt2 enrichment is low.  Graphs show mean and SEM 
from 3 biological replicates.
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IPI3 encodes a member of the Rix1 complex, responsible for processing rRNA (Krogan et al., 
2004; Nissan et al., 2004), while YNL181W is believed to encode an oxidoreductase (Giaever 
et al., 2002).  Thus, CYC3, IPI3, and YNL181W were all functionally linked to either cellular 
redox reactions or protein synthesis.  Before and after treatment, at both promoters, the signal 
from the untagged control ChIP was almost undetectable (Figure 4.5B).  In contrast, Ecm5 
and Snt2 were clearly enriched at these promoters, and the enrichment was slightly higher 30 
minutes after treatment.  These fi ndings confi rm the reproducibility of the ChIP-seq fi ndings, and 
also demonstrate the large dynamic range in the levels of Ecm5 and Snt2 enrichment found at 
different regions of the genome, which may refl ect differences in the affi nities of different sites 
for these proteins or differential Ecm5/Snt2 binding in different subsets of cells.
Ecm5 and Snt2 localize primarily to gene promoters and for a small number of highly 
expressed genes, to gene bodies
Both before and after treatment, Ecm5 and Snt2 were localized primarily to promoter 
regions of genes.  As an example, Ecm5 and Snt2 localization to the FUI1 and PRE7 genes 
0.5 hours after H2O2 treatment is clearly constrained to these genes’ shared promoter (Figure 
4.6A).  In addition, as described above, Ecm5 and Snt2 are enriched in the promoter regions 
of the ERG6/YAP1, CYC3 and IPI3/YNL181W genes (Figure 4.5A).    To further analyze this 
trend, Scott Dewell aligned every yeast gene around its transcription start site (TSS), and then 
determined the average number of sequencing reads in 50 bp windows relative to the TSS’s.  
This analysis found a very slight enrichment of Ecm5 and Snt2 reads approximately 250 bp 
upstream of the TSS before or 4 hours after H2O2 treatment (Figure 4.6C, left panels).  The level 
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Figure 4.6 Alignment of H2O2 ChIP-seq reads around transcription start sites
A and B. Representative ChIP-seq tracks as in Figure 4.3, showing a typical (A) or a highly-
expressed (B) Ecm5/Snt2 target gene.  (C) All yeast genes (left panels) or the 100 most highly-
expressed yeast genes (Miller et al., 2011; right panels) were aligned by their transcri ption start 
sites (TSSs) and the average number of Ecm5 (top panels) or Snt2 (bottom panels) ChIP-seq 
reads per 50 bp window relative to the TSSs for each ChIP experiment was calculated.  Each 
average value was normalized to the total number of mapped reads for that experiment and 
divided by 1,000,000 to get normalized average numbers of reads at positions relative to the 
TSS.
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of enrichment is small because at these time-points Ecm5 and Snt2 only localize to a small 
number of genes, and the signal from these genes is drowned out by the lack of enrichment at all 
the other yeast genes.  However, 0.5 hours after H2O2 treatment, an enrichment of Ecm5 and Snt2 
ChIP-seq reads is clearly visible 250 bp upstream of the TSS.
I also noticed a small number of genes enriched for Ecm5 and Snt2 in their coding 
regions in untreated cells.  Intriguingly, in many of these examples, 0.5 hours after H2O2 
treatment, Ecm5 and Snt2 were no longer enriched within the bodies of these genes, and were 
instead enriched at the 5’ (and in some cases 3’) ends.  The RPS13 gene is an example of one 
such gene (Figure 4.6B).  I noticed that many of the genes displaying this trend were coded for 
either ribosomal proteins or metabolic enzymes, two categories of highly transcribed genes.  At 
the same time that I observed this trend, Scott independently obtained a list of the 100 most 
highly expressed yeast genes, based on a recent yeast gene expression study (Miller et al., 2011), 
and repeated his TSS localization analysis using only these genes.  Remarkably, his TSS profi les 
matched what I had been seeing: at highly expressed genes, there is signifi cant enrichment 
of Ecm5 and Snt2 reads 250-1000 bp downstream of the TSS before H2O2 treatment, and 0.5 
hours after treatment, this enrichment has shifted to approximately 300 bp upstream of the TSS 
(Figure 4.6C, right panels).  Taken together, these data show there are two patterns of Ecm5/Snt2 
binding: Ecm5 and Snt2 localize to discrete peaks within promoters of most target genes, but 
also localize to gene bodies in some highly expressed genes.  In the latter case, Ecm5 and Snt2 
redistribute away from gene bodies and to the 5’ and 3’ ends of genes in response to H2O2-stress.
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Ecm5 and Snt2 target genes have functions in stress response and metabolism
I next determined what categories of genes Ecm5 and Snt2 were targeting.  To sort out 
which genes were targeted by Ecm5 and Snt2 generally, and which were specifi c to the H2O2 
response, I next compared the 315 shared Ecm5/Snt2 ChIP peaks before H2O2 treatment with 
the 817 shared peaks 0.5 hours after treatment and determined which peaks in these two sets 
overlapped by at least 200 bp (Figure 4.7A).  This analysis generated three lists of peaks: the 151 
peaks of Ecm5/Snt2 binding present before H2O2 treatment but not after, the 652 peaks present 
only after treatment, and the 164 peaks present both before and after treatment.  The fi rst two 
lists of peaks represent regions of Ecm5 and Snt2 binding that are either enhanced or diminished 
by H2O2 treatment.  In contrast, the last set of peaks represents constitutive Ecm5/Snt2 ChIP 
targets.  
To compile lists of Ecm5/Snt2 target genes, I defi ned each gene’s promoter as the 
region from 500 bp upstream of the start codon to the start codon.  I then determined which 
gene promoters overlapped Ecm5/Snt2 shared peaks by at least 200 bp before and after H2O2 
treatment, and used these gene lists as input for the FuncAssociate program which determines 
functional categories of genes enriched among each set (Berriz et al., 2009).  This analysis 
found that target genes that only contained promoter-bound Ecm5 and Snt2 before treatment 
were enriched for translation and ribosome genes.  The translation and ribosome gene categories 
were also enriched among targets with Ecm5 and Snt2 present only before or both before and 
after H2O2 treatment (Figure 4.7B, yellow and orange bars).  In addition, genes involved in 
sugar metabolism (hexose biosynthetic process, gluconeogenesis) and retrotransposon function 
(transposition) were enriched among the general Ecm5/Snt2 targets, but not among H2O2-
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Figure 4.7 Gene ontology analysis of promoters containing peaks of Ecm5 and Snt2 ChIP -
seq reads
A. Venn diagram showing the overlap between Ecm5 and Snt2 shared peaks before and 0.5 
hours after H2O2 treatment. B. Categories of genes signifi cantly over-represented among genes 
whose promoters contained Ecm5/Snt2 peaks before H2O2 treatment only (yellow), both before 
and after H2O2 treatment (orange), or after H2O2 treatment only (red).
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specifi c targets, suggesting that regulation of carbohydrate metabolism and transposition genes 
may be general functions of the Rpd3(T) complex.  The presence of retrotransposons among 
Ecm5 and Snt2 target genes is especially interesting, since recent studies have linked stress and 
nutrient starvation to retrotransposon activation (Morillon et al., 2000; Stamenova et al., 2008), a 
response that Ecm5 and Snt2 may help regulate.  
Among the genes containing Ecm5 and Snt2 at their promoters only after H2O2 treatment, 
genes involved in the oxidative stress response, oxidation-reduction processes, plasma membrane 
functions, and amino acid transport and synthesis were enriched (Figure 4.7B, red bars).  These 
are all categories of genes that would be expected to be up- or down-regulated to help cells 
recover from oxidative stress: in addition to the up-regulation of oxidative stress response 
genes to help yeast repair damage caused by the H2O2, genes involved in oxidative-reductive 
metabolism would be expected to be up- or down-regulated to help the cell maintain the proper 
redox state in response to H2O2-triggered oxidation.  Furthermore amino acid transporters and 
genes involved in amino acid biosynthesis might be important in helping cells remake proteins 
damaged by H2O2.  Lastly, while not signifi cant among the H2O2-specifi c Ecm5 and Snt2 
target genes, functional analysis of the complete list of Ecm5 and Snt2 target genes 0.5 hours 
after H2O2 treatment revealed that cell wall genes are enriched among this set (p=4.5x10
-7).  
Approximately half of these genes had peaks of Ecm5 and Snt2 binding both before and after 
treatment, while the other half only had binding after, explaining why this category was not 
found signifi cant when these two lists were separated.  The regulation of cell wall genes by Ecm5 
and Snt2 might explain the cell wall phenotypes reported for some ecm5 mutants (Lussier et al., 
1997).  In summary, Ecm5 and Snt2 generally localize to genes involved in translation and sugar 
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metabolism, and in response to H2O2, these proteins localize to additional genes, whose functions 
directly refl ect the needs of a cell trying to respond to and repair oxidative stress-induced 
damage.
Gene expression analysis of the ecm5 and snt2 knockout strains before and after H2O2 stress
Because Ecm5 and Snt2 localize to many gene promoters, I hypothesized that they might 
function in gene regulation.  More specifi cally, because these proteins are in a complex with the 
Rpd3 histone deacetylase, and histone deacetylation and Rpd3 have both been linked to gene 
repression (Allfrey et al., 1964; Kadosh and Struhl, 1998; Vidal and Gaber, 1991), I thought 
the Rpd3(T) complex might repress genes in response to H2O2 stress.  I therefore used RNA-
sequencing (RNA-seq) to look for expression differences in cells lacking Ecm5 or Snt2, before 
and 0.5 hours after H2O2 treatment.  I chose to only focus on the 0.5 hour time-point, because all 
of the Ecm5 and Snt2 localization changes happened at within this window, and were returned 
to the pre-treatment state by 4 hours.  With Scott’s help, cDNA from three biological replicates 
of each strain before and after H2O2 treatment was sequenced and aligned using the TopHat 
software, and genes showing differential expression from wild-type were identifi ed using the 
Cuffdiff software (Trapnell et al., 2009; Trapnell et al., 2010).  The numbers of sequencing reads 
for each sample are summarized in Table A.2, in the Appendix.  I fi rst sought to confi rm the 
RNA-seq results by performing qPCRs on cDNA made from the same RNA samples submitted 
for sequencing, and found both techniques were in good agreement (Table 4.1).  
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Table 4.1 Comparison of expression ratios 0.5 hours after H2O2 
treatment determined by RNA-seq and qPCR a
134
In wild-type cells, 3127 genes had signifi cant expression changes in response to H2O2 
treatment (Table 4.2, statistical signifi cance determined by Cuffdiff software).   In comparison, a 
separate study reported 1294 genes up- or down-regulated at least two-fold after H2O2 treatment 
(Gasch et al., 2000).  My study identifi ed a larger number of genes in part because Cuffdiff 
uses a more lenient cut-off for signifi cance: fold differences as low as 1.3 as can be considered 
signifi cant if there are enough reads for the model to statistically call a difference.  In addition, 
the slightly higher concentration of H2O2 I used (0.4 mM in my study compared to 0.32 mM in 
the Gasch study) may have accounted for larger number of genes changing in my experiment.  
Importantly, 1031 of the 1294 genes (80%) identifi ed as responding to H2O2 in wild-type cells in 
the Gasch et al. study were also signifi cantly up- or down-regulated in my study, confi rming that 
my H2O2 treatment produced similar expression changes to what has been previously reported.
Because Ecm5 and Snt2 are part of the same complex, and localize to the same regions 
of the genome, I initially expected that knockouts for these two proteins would show similar 
gene expression changes.  However, consistent with the lack of phenotype for the ecm5 knockout 
strain I saw in my genetic assays, this strain had only a very limited effect on gene expression: 
before H2O2 treatment only 33 genes were signifi cantly up- or down-regulated in the ecm5 
knockout strain relative to expression in the wild-type stain, and after treatment, only 7 genes had 
altered expression (Table 4.2).  Both before and after treatment ECM5 was the most signifi cantly 
down-regulated gene in the ecm5 knockout strain.  Interestingly, 5 out of the 14 genes up-
regulated in the ecm5 knockout strain before treatment, were cell wall mannoproteins genes, 
including the FIT1 gene, whose up-regulation in ecm5 cells I discussed in the previous chapter.  
The up-regulation of these cell wall proteins in the ecm5 knockout strain may be responsible for 
the cell wall phenotypes reported in this mutant (Lussier et al., 1997).
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Table 4.2 Summary of Gene Expression Differences a
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In contrast, the snt2 knockout strain had a much larger number of genes differentially 
expressed, with 172 genes signifi cantly up- or down-regulated compared to wild-type expression 
before treatment and 737 genes up- or down-regulated compared to wild-type after treatment 
(Table 4.2).  SNT2 was the most down-regulated gene in the snt2 knockout strain before and 
after treatment.  At both time-points, there was little to no overlap between the genes in the 
ecm5 strain and the genes in the snt2 strain that were misexpressed, suggesting that despite 
being associated with Snt2, Ecm5 does not function in the same manner as Snt2 with respect to 
gene regulation.  Of the 737 genes with up- or down-regulated in the snt2 knockout compared 
to wild-type expression 0.5 hours after H2O2 stress, 573 (78%, p = 4.1x10
-75) were also genes 
whose expression was up- or down-regulated in wild-type cells 0.5 hours after H2O2 treatment, 
compared to wild-type expression before treatment.  The high degree of overlap between genes 
misregulated in the snt2 knockout strain and genes whose expression change as a part of the 
wild-type response to H2O2 treatment further implicate Snt2 in the oxidative stress response.  
Genes showing differential expression in the snt2 knockout fall into the same functional 
categories as genes found to be Ecm5/Snt2 targets by ChIP
Using FuncAssociate, I identifi ed categories of genes showing expression changes in 
the snt2 knockout before and after H2O2 stress.  Similar to the sets of genes identifi ed as Ecm5/
Snt2 ChIP targets, many of these genes had roles in metabolism.  For instance, many of the 
genes up- or down-regulated in the snt2 mutant before H2O2 treatment were involved in energy 
homeostasis functions such as acetyl-CoA metabolism, NAD metabolism, oxidation-reduction 
processes, and the tricarboxylic acid (TCA) cycle (p values: 8.8x10-7, 5.5x10-5, 1.3x10-6, and 
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5.8 x10-8, respectively).  After treatment, many of the genes showing expression differences fell 
into categories related to protein synthesis, including ribosome, translation, rRNA processing, 
nucleolus, and amino acid biosynthesis (p values: 1.3x10-16, 2.1x10-9, 1.37x10-16, 1.18x10-19 
4.4x10-8, respectively).  In addition, genes involved in the yeast cell wall (p value 1.2x10-5) were 
also enriched in the set of genes showing expression differences after H2O2 treatment.
Direct comparison of ChIP and Expression Data
Surprisingly, many of the gene targets of Ecm5/Snt2 binding either before or after 
H2O2 treatment showed no expression differences in the ecm5 or snt2 knockout strains at either 
time-point.  Of the 312 Ecm5/Snt2 target genes in untreated cells, only 25 were over- or under-
expressed at least 1.5-fold in the snt2 strain at that time-point.  After H2O2 treatment 98 of the 
312 genes were 1.5-fold over- or under-expressed in the snt2 knockout strain compared to wild-
type expression after treatment, suggesting that Ecm5 and Snt2 may mark some gene targets 
before Snt2 is required for their regulation.  There were 1205 genes with Ecm5/Snt2 peaks in 
their promoters after H2O2 treatment, and of those, 403 were over- or under-expressed at least 
1.5-fold in the snt2 strain at that time.  In summary, only some of the Ecm5/Snt2 target genes 
require Snt2 for proper expression, and almost none require Ecm5.
To look more carefully at target genes most likely to be directly regulated by Snt2, 
I focused my attention on the 1205 genes that were found to have Ecm5/Snt2 peaks at their 
promoters 0.5 hours after H2O2 treatment.  Of those, 813 (66%) changed expression at least 1.5 
fold in wild-type cells in response to H2O2 stress, and 403 (33%) were misexpressed in the snt2 
strain after H2O2 treatment.   There were 309 target genes that were on both lists, and I felt these 
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would be most interesting for future study (Figure 4.8A).  Thus, I was able to identify 309 genes 
that contained Ecm5 and Snt2 at their promoters after H2O2 treatment, changed expression in 
wild-type cells in response to H2O2, and were also misexpressed in snt2 cells 0.5 hours after 
treatment.
As discussed above, I originally expected that direct targets of Snt2 would have higher 
expression levels in the snt2 knockout strain than in wild-type.  Surprisingly, however, the gene 
expression patterns proved much more complicated.  To get a broad sense of gene expression 
patterns before and after treatment, Deyou generated heatmaps, showing the expression profi les 
of these genes clustered into 4 groups (Figure 4.8B, with clusters labeled above the heatmap).  
The fi rst group is made up of genes whose expression levels were low before H2O2 treatment, 
were induced in wild-type cells after treatment, and were induced even more strongly in the snt2 
knockout.  The second group of genes also had low basal expression that was induced in wild-
type cells after treatment, and in snt2 knockout cells, these genes were either not induced at all 
in response to treatment or were induced less in the wild-type strain.  In contrast, the third and 
fourth groups were genes repressed upon H2O2 treatment that were either repressed more weakly 
or more strongly than wild-type levels, respectively in snt2 cells after treatment.  Since direct 
targets of the Snt2 could be either activated or repressed in the snt2 knockout strain, Snt2 seems 
likely to be capable of promoting both transcriptional activation and repression, depending on the 
context.
As another way to look at this data, I plotted the log2 expression ratios of each of the 309 
genes on a two-dimensional plot (Figure 4.9, top left panel).  In this plot, each dot represents one 
gene, and the x-axis represents the log2 ratio of expression in wild-type cells 0.5 hours after H2O2 
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Figure 4.8 Ecm5 and Snt2 ChIP target genes that change expression in wild-type cells in 
response to H2O2 and are misexpressed in the snt2 strain after H2O2 treatment
 A. Genes with shared peaks of Ecm5 and Snt2 ChIP-seq reads at their promoters 0.5 hours 
after H2O2 treatment were selected.  Of those, genes whose expression was 1.5-fold higher 
or lower in the snt2 knockout strain after H2O2 treatment compared to wild-type expression 
levels at that time (genes misexpressed in snt2) were isolated (red circle), and genes whose 
expression was 1.5-fold higher or lower after H2O2 treatment in wild-type cells compared to 
wild-type expression before treatment (H2O2 response genes) were isolated (purple circle).  The 
Venn diagram shows the overlap of these two gene sets (309 genes). B. Heatmap showing the 
RNA-seq expression levels of the 309 shared genes descrived in (A) in the indicated strains 
before and 0.5 hours after H2O2 treatment.  The color key for the heatmap is shown below the 
panel. The heatmap can be roughly divided into 4 clusters, labeled above the panel, based on 
whether genes increase or decrease expression in wild-type cells after treatment, and whether 
expression in the snt2 knockout strain after treatment is higher or lower than wild-type 
expression at that timepoint.
140
Figure 4.9 Different subsets of the 309 genes respond differently to the absence of Snt2
Dot plots showing the log2 expression ratios of the 309 genes identifi ed in Figure 4.8.  The 
xaxis for these plots is the log2  ratio of expression in wild-type cells 0.5 hours after H2O2 
treatment compared to expression in wild-type cells before treatment.  The y axis is the log2 
ratio of expression in the snt2 knockout strain 0.5 hours after treatment compared to expression 
in wild-type cells after treatment.  The top left panel shows all 309 genes in black, with regions 
of the graph corresponding to the four clusters described in Figure 4.9 labeled in blue.  The 
remaining panels have points representing genes that are part of the indicated functional 
categories highlighted in red.
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treatment compared with wild-type expression before treatment.  Similarly, the y-axis represents 
the log2 ratio of expression in the snt2 strain after H2O2 treatment compared with wild-type 
expression values after treatment.  Thus, genes that fall in the top right quadrant of the plot, 
for example, represent genes that are induced in wild-type cells in response to H2O2 stress, and 
over-expressed in snt2 cells after stress.  This quadrant roughly corresponds to group 1 in the 
heatmap in Figure 4.8B.  Based on this plot, it is clear that while there are slightly more genes 
in the top-left quadrant of the plot (or group 3 the heatmap), overall, there is no strong pattern of 
expression.
I next looked for categories of genes whose members were enriched among these 309 
genes, to see if distinct patterns of gene expression could be discerned for different types of 
genes.  I identifi ed genes involved in the plasma membrane, cellular biosynthesis, and translation 
as being over-represented among the 309 genes.  Interestingly, these different categories of 
genes showed different expression patterns.  The biosynthesis genes, were largely repressed in 
wild-type cells following H2O2 stress, consistent with the cell halting new biosynthesis until 
damaged molecules could be repaired.  In snt2 knockout cells, these genes were both up- and 
down-regulated relative to wild-type, showing no clear pattern of regulation (Figure 4.9, bottom 
left panel).  In contrast, most plasma membrane genes were over-expressed in the snt2 knockout 
strain after treatment, suggesting that overall, Snt2 functions to repress genes in this category 
after H2O2 stress (Figure 4.9, top right panel).  The clearest expression pattern could be seen for 
translation genes, which were almost all down-regulated in wild-type cells in response to H2O2, 
and under-expressed (down-regulated too much) in snt2 cells, suggesting that Snt2 might be 
needed for activation of this set of genes (Figure 4.9, bottom right panel).  Notably many of these 
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genes were the highly expressed genes enriched for Ecm5 and Snt2 in their gene bodies before 
treatment at their 5’ and 3’ ends after, suggesting that this localization pattern is correlated with 
Snt2 activation function.  In summary, Snt2 can function to both activate and repress genes, with 
different functional categories associated with different Snt2 behavior.
Comparing nutrient stress and oxidative stress responses
Despite treating cells in the experiments described above with an agent to induce 
oxidative stress, every experiment identifi ed genes with metabolic functions.  This is perhaps 
unsurprising given that, as discussed in the introduction to this thesis, stress and metabolism are 
highly linked.  In addition, there is genetic evidence linking the Rpd3(T) complex to metabolism. 
The synthetic genetic screen I described in the previous chapter found that the ecm5 knockout 
is synthetically sick in combination with deletion of the amino acid starvation sensor Gcn1 
(Table 3.3).  Furthermore, a newer ECM5 synthetic genetic screen (Zheng et al., 2010), the 
results of which are listed in Table 4.3, also uncovered multiple genes linked to oxidative stress 
and nutrient metabolism, including GLN3 and GAT2, transcription factors that regulate genes 
involved in amino acid metabolism.  I therefore wondered whether Rpd3(T) complex function 
could be directly linked to nutrient metabolism. 
Ecm5 protein levels decrease in stationary phase
To investigate whether the Rpd3(T) complex has a role in nutrient metabolism, I fi rst 
determined whether levels of these complex members change as cells enter stationary phase.  In 
contrast to the logarithmic phase of yeast growth, in which yeast have abundant nutrients and 
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Table 4.3 Knockouts that have synthetic growth phenotypes in 
combination with ecm5 a
144
grow and divide at their maximal rate, stationary phase occurs when yeast cells have exhausted 
most of the nutrients in their media (generally within 12-24 hours of inoculation in rich media), 
and do not have enough nutrients left to synthesize the precursors needed for growth.  Many 
cellular and metabolic changes occur as yeast shift to stationary phase, including the transition 
from anaerobic glycolysis to aerobic fermentation known as the diauxic shift (Galdieri et 
al., 2010).  In addition stationary phase yeast have thicker cell walls, accumulate storage 
carbohydrates, and are more resistant to stress (Werner-Washburne et al., 1993).  Despite not 
actively dividing, yeast can remain viable in stationary phase for signifi cant periods of time, 
and will resume growth and division if supplemented with nutrients (Lillie and Pringle, 1980).  
Because yeast in stationary phase remain alive but are quiescent, stationary phase growth has 
been suggested to be a good model for aging in mammalian systems (Chen et al., 2005).  To 
determine whether protein levels of the Rpd3(T) complex members change during stationary 
phase, I cultured PrA-tagged Ecm5, Snt2, and Rpd3 strains in YPD for 7 days, taking aliquots of 
cells each day for whole cell extracts.  Snt2 and Rpd3 protein levels remained roughly constant 
at all time-points (Figure 4.10 A and B).  In contrast, levels of tagged Ecm5 decreased starting 
around 24 hours after the initial culture inoculation (Figure 4.10C).  This result was opposite to 
what happened to Ecm5 protein levels upon acute H2O2 treatment.  It is possible that the same 
mechanisms that render stationary phase cells more resistant to oxidative stress underlie this 
difference in Ecm5 reaction to H2O2 (Galdieri et al., 2010).
Levels of H4K16 acetylation are known to increase as yeast cells reproductively age (have 
many daughters) (Dang et al., 2009).   Because of the link between this histone modifi cation and 
yeast aging, I thought it would be interesting to check whether H4K16ac levels increase as cells 
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Figure 4.10 Comparison of H4K16ac and tagged Ecm5, Snt2, and Rpd3 protein levels 
before and during stationary phase
A-C. PrA-tagged Snt2, Rpd3, or Ecm5 strains as well as an untagged control strain were 
cultured for one week in rich media (YPD). Whole cell extracts taken at the indicated times 
after inoculation were analyzed by immunoblotting to measure tagged Snt2 (A) Rpd3 (B) and 
Ecm5 (C) protein levels.  Direct Blue 71-stained membranes and immunoblots for histone 
H3 are shown as loading controls. (D) An immunoblot showing H4K16ac levels in a wild-
type strain at the indicated times post-inoculation. An H4 immunoblot and Direct Blue stained 
membrane are shown as loading controls.  Numbers to the left of blots denote molecular 
weights.
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enter stationary phase, which is a model of chronological aging.  Surprisingly, I saw a decrease 
in H4K16ac as cells entered stationary phase (Figure 4.10D).  A recent publication also reported 
fi nding decreased H4K16ac levels by mass spectrometry, in stationary phase cells, consistent 
with my fi ndings (Ngubo et al., 2011).  Usually replicative lifespan and chronological lifespan 
models of aging in yeast are thought of as being similar, but these results suggest there are 
meaningful differences between these two aging models.
Mutants lacking Snt2 are resistant to the TOR pathway inhibitor rapamycin
The ChIP and gene expression studies described earlier in this chapter link Ecm5 and 
Snt2 to genes involved in many aspects of metabolism, including sugar utilization, amino acid 
transport, as well as the TCA cycle and redox reactions.  However, the categories of genes that 
seemed to come up most often were translation and ribosome.  I therefore chose to extend these 
studies to involve direct perturbation of protein metabolism using the chemical rapamycin.  
Rapamycin is an inhibitor of the yeast target of rapamycin complex 1, or TORC1, which is 
responsible for sensing and signaling the availability of extracellular nutrients such as amino 
acids (Wei and Zheng, 2011).  When nutrients are abundant, TORC1 signaling is active, telling 
yeast cells to keep growing while there are enough raw materials to do so, and promoting 
translation initiation and ribosome biogenesis.  In addition, active TORC1 represses cellular 
stress response and nitrogen-catabolite repression (NCR) genes.  However, when nitrogen-rich 
nutrients become scarce, the TOR pathway is inhibited, leading to the repression of translation 
and ribosome genes and the activation of stress and NCR genes.  By inhibiting this pathway, 
rapamycin treatment mimics this amino acid starvation response.  As with the oxidative stress 
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response, several studies have already implicated Rpd3(L) complex function in the response to 
rapamycin (Humphrey et al., 2004; Rohde and Cardenas, 2003; Tsang et al., 2003).
I fi rst wanted to see whether the snt2 knockout strain showed any resistance to 
rapamycin.  I spotted wild-type or ecm5, snt2, or rpd3 knockout strains onto SD CSM (synthetic 
defi ned with complete supplement mixture) plates supplemented with either DMSO or 50 nM 
rapamycin.  I chose to use the less nutrient rich SD CSM, instead of YPD, for these experiments 
because I was concerned that cells grown in rich media might have a chance to accumulate 
nutrient reserves that would allow them to be more resistant to nutrient stress in ways that 
would mask true stress-resistant phenotypes.  All strains grew similarly to wild-type in SD CSM 
supplemented with DMSO alone, and the growth defect seen when the rpd3 knockout strain was 
grown in YPD was almost completely gone on the SD CSM media (Figure 4.11).  Consistent 
with what has been reported in the literature, the rpd3 knockout strain was resistant to rapamycin 
treatment (Tsang et al., 2003).  In addition, the snt2 strain also showed resistance, linking Snt2 
protein function to metabolic as well as oxidative stress.
Mapping Ecm5 and Snt2 localization before and after rapamycin treatment
I next mapped Ecm5 and Snt2 localization before and after rapamycin treatment using 
ChIP-seq.  This experiment was done similarly to the H2O2 ChIP-seq experiment, except that for 
reasons mentioned above, strains were grown in SD CSM media, and after harvesting the cells at 
the initial time-point, each culture was split into two and treated either with DMSO, as a control, 
or with rapamycin.  The rapamycin treatment clearly had an effect on the cells, since cells 
receiving this treatment had slower growth (based on OD600 measurements) than cells treated 
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Figure 4.11 The snt2 knockout strain is resistant to rapamycin
Five-fold serial dilutions of mid-log phase cultures of wild-type (BY4741) and ecm5, snt2, 
and rpd3 strains were spotted on the SD CSM plates supplemented with either DMSO or 50 
nM rapamycin. Plat es were photographed 3 days later.
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with DMSO (data not shown).  The ChIP-seq read counts for this experiment are summarized in 
Table A.3, in the Appendix.  
Interestingly, cells grown in SD CSM media without any additional treatment did not 
show the same patterns of Ecm5/Snt2 enrichment found in cells grown in YPD.  Rather, the ChIP 
profi les of untreated cells grown in SD CSM were actually more similar to the H2O2-treated cells 
grown in YPD (see Figure 4.12A for a representative region of the genome).  Of the 278 Ecm5/
Snt2 shared peaks in cells grown in SD CSM before rapamycin treatment, almost half overlapped 
with peaks only found in YPD-grown cells 0.5 hours after H2O2 treatment (Figure 4.12B).  The 
similarities in Ecm5/Snt2 localization in cells grown in less rich media and H2O2-treated cells 
suggest that that H2O2 stress and the stress of not having as many nutrients trigger some of the 
same responses.
Just as H2O2 treatment triggered new sites of Ecm5/Snt2 ChIP enrichment, so too did 
rapamycin treatment, resulting in 558 shared peaks 0.5 hours after treatment, compared to 278 
peaks before treatment.  Most of these new sites of Ecm5/Snt2 enrichment were also enriched 
after H2O2 treatment, suggesting that both treatments lead to a similar response, with regard to 
Ecm5 and Snt2.  I compared peaks of Ecm5/Snt2 binding 0.5 hours after rapamycin treatment 
with peaks found in DMSO-treated cells to generate three lists of peaks – those that were only 
seen in rapamycin-treated cells (rapamycin-specifi c targets), those that were seen in both DMSO- 
and rapamycin-treated cells (general targets), and those that were only seen in DMSO-treated 
cells (targets that Ecm5 and Snt2 leave in response to rapamycin treatment) (Figure 4.13A).  
Different types of genes were targeted by the peaks in each list (Figure 4.13A).  General targets 
of Ecm5/Snt2, tended to be genes involved in sugar metabolism, amino acid transport, as well 
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Figure 4.12 Ecm5 and Snt2 ChIP profi les in less rich media resemble profi les 0.5 hours 
after H2O2 treatment in rich media
A. Ecm5- and Snt2-Myc ChIP-seq tracks from both untreated and H2O2-treated yeast grown 
in YPD, and untreated yeast grown in SD CSM. B. Overlap between Ecm5/Snt2 ChIP peaks 
seen in YPD-grown cells only after H2O2  treatment and peaks in SD CSM-grown cells prior to 
rapamycin treatment.
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Figure 4.13 Rapamycin-specifi c peaks are involved in amino acid metabolism
A.  Overlap between Ecm5/Snt2 ChIP peaks 0.5 hours after rapamycin treatment and peaks 
0.5 hours after DMSO control treatment. Categories of genes enriched among the three sets of 
genes whose promoters contain each set of ChIP peaks are listed next to their corresponding 
section in the diagram. B. Specifi c examples of genes showing changes in Ecm5/Snt2 ChIP 
enrichment in response to rapamycin treatment at the promoter and/ or ORF region.
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as cell wall and membrane maintenance.  Genes whose promoters were enriched for Ecm5/Snt2 
before treatment and in DMSO-treated cells, but not in rapamycin treated cells were involved in 
the ribosome and translation.  For instance, YEF5, a gene which encodes a translation elongation 
factor, is enriched for Ecm5 and Snt2 throughout its gene body before and 0.5 hours after 
DMSO-treatment, but this enrichment is gone in cells treated with rapamycin (Figure 4.13B, 
left panel).  (While the majority of Ecm5/Snt2 enrichment at the gene is seen within the coding 
region of YEF5, enough of this peak overlapped with the promoter region that it was pulled out 
in this analysis).  In contrast, genes involved in amino acid metabolism and nutrient transport 
were enriched among the rapamycin-specifi c targets.  For instance, the gene body and promoter 
of the gene encoding the Dur3 nitrogen transporter, and the promoter of the gene encoding 
the Gat1 transcriptional activator of involved in nitrogen signaling, only show Ecm5 and Snt2 
enrichment after rapamycin treatment (Figure 4.13B, middle and right panels).  In summary, 
consistent with rapamycin treatment inhibiting protein synthesis and promoting nitrogen uptake 
and metabolism, this chemical caused Ecm5 and Snt2 to relocate away from genes involved in 
translation and to genes involved in amino acid metabolism and nutrient transport.
Unlike H2O2, which only induces transient changes in Ecm5 and Snt2 localization, 
rapamycin treatment led to changes in localization that were more long lasting: the ChIP-seq 
profi les of Ecm5- and Snt2-tagged strains 4 hours after treatment were very similar to those 
seen at the earlier, 0.5 hour time-point (data not shown).  Curiously, there were approximately 
40 genes that showed increased levels of Ecm5 and Snt2 localization in their gene bodies 4 
hours after DMSO treatment.  For instance, high numbers of Ecm5 and Snt2 reads were found 
in the gene bodies of the MET6 and MET3 genes 4 hours after DMSO treatment, but not after 
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rapamycin treatment (Figure 4.14A and B).  I noticed that many of these genes were known to 
be involved in the biosynthesis of the sulfurous amino acids methionine or cysteine.  Indeed, an 
analysis of genes known to be involved in the sulfur metabolism pathway revealed that all but 
2 genes were enriched for Ecm5 and Snt2 4 hours after DMSO treatment (Figure 4.14C).  Since 
the DMSO-control cells were able to grow and divide at a normal rate, they were quite dense 
when I harvested them.  In contrast, cells that received rapamycin treatment slowed down their 
cycling and had not gotten as dense at this late time-point.  Therefore, the localization of Ecm5 
and Snt2 to these sites may be part of some kind of response to the cultures getting dense and 
beginning to undergo the diauxic shift.  More likely, Ecm5 and Snt2 may be localizing to sulfur 
metabolism genes as a direct response to prolonged exposure DMSO, which itself is a sulfur-
containing molecule, suggesting that caution should be used when using DMSO as a control.
Chapter 4 Discussion
The experiments described in this chapter present multiple lines of evidence that the 
Rpd3(T) complex functions in the yeast oxidative stress and metabolic stress response pathways.  
First, Ecm5 protein levels were found to respond to changes in stress and nutrient levels.  Ecm5 
levels increased in some experiments in response to H2O2 treatment.  In contrast, Ecm5 protein 
levels decreased as cells entered stationary phase of growth, a state where nutrients are limiting.  
Given that stationary phase is generally thought to be a state in which cells are exposed to 
increased levels of oxidative stress, presumably because of the increased amount of respiration 
occurring during this phase (Galdieri et al., 2010), it is somewhat surprising that Ecm5 protein 
levels would respond differently to entry into stationary phase and H2O2 treatment.  However, 
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Figure 4.14 Ecm5/Snt2 localize to sulfur metabolism gene bodies in DMSO-treated cells 
A. Examples of sulfur metabolism genes with increased numbers of Ecm5/Snt2 ChIP-seq reads 
4 hours after DMSO treatment. ChIP-seq tracks are as in Figure 4.3. B. Diagram of sulfur 
metabolism with genes involved in boxes.  Boxes around genes enriched for Ecm5/Snt2 ChIP 
reads 4 hours after DMSO treatment  are colored yellow.
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unlike cells growing exponentially and suddenly encountering an unexpected dose of H2O2, 
stationary phase cells are known to be resistant to stress (Galdieri et al., 2010).  This difference 
between stationary phase growth and acute H2O2 stress may underlie the differential Ecm5 
protein response to these two states.  Furthermore, some studies have called into question the 
idea that cells undergoing respiration have increased levels of oxidative stress.  One study found 
that cells undergoing respiration as a response to calorie restriction actually had lower levels 
of H2O2 released per O2 consumed (Barros et al., 2004).  The authors of this study suggest 
that active respiration may promote effi cient electron fl ow through the mitochondrial electron 
transport chain and prevent electron leakage that leads to ROS formation.
Second, I have shown that the snt2 knockout strain is resistant to H2O2-mediated 
oxidative stress, both on solid media and in liquid culture.  The increased growth of the snt2 
knockout on H2O2-containing plates could be because snt2 cells divided more rapidly than 
wild-type cells once plated or because more snt2 cells survived the initial plating.  The results 
of the liquid survival assay, which measures survival independent of growth rate, support the 
latter possibility.  These fi ndings suggest that the Rpd3(T) complex might actively promote cell 
death in response to H2O2 treatment.  While yeast are not normally associated with programmed 
cell death, prior research from former Allis laboratory graduate student Sung Hee Ahn Upton 
showed that H2O2 can trigger an apoptosis-like cell death process in yeast, and that a knockout 
for the rpd3 histone deacetylase has increased survival in H2O2 (Ahn et al., 2006; Ahn et al., 
2005).  My experiments confi rmed this fi nding and found that the snt2 knockout had even better 
survival, suggesting that in response to H2O2 the Rpd3(T) complex has a role in promoting 
apoptosis.  
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The higher level of stress resistance seen with the snt2 knockout strain compared to that 
of the rpd3 knockout was surprising given that they are members of the same complex.  It is 
possible that Snt2 has a function in the oxidative stress response that is independent from Rpd3’s 
role.  Alternatively, since Rpd3 is known to have many cellular roles, and functions in two 
complexes separate from the Rpd3(T) complex, the less severe stress resistance seen with the 
rpd3 knockout may refl ect pleiotropic effects simultaneously promote and impede resistance to 
oxidative stress.
As a third piece of evidence that the Rpd3(T) complex functions nutrient metabolism, I 
have shown that in unstressed cells, the genes whose promoters are enriched for Ecm5 and Snt2 
have translation and carbohydrate metabolism functions.  Furthermore, Ecm5 and Snt2 ChIP 
profi les were shown to be radically different 0.5 hours after H2O2 treatment.  In response to H2O2, 
Ecm5 and Snt2 were found to localize to many new gene promoters and to redistribute away 
from the gene bodies and into 5’ and 3’regions of certain highly expressed genes.  Moreover, the 
types of genes that Ecm5 and Snt2 localize to in untreated cells were functionally distinct from 
the H2O2-specifi c targets.  In contrast with the genes involved in translation and carbohydrate 
metabolism that were general Ecm5 and Snt2 targets, after H2O2 stress Ecm5 and Snt2 localized 
to genes involved in amino acid metabolism, transmembrane transport, oxidation-reduction 
reactions, cell wall and plasma membrane function, and response to oxidative stress.  H2O2 
treatment is known to inhibit protein translation, which allows cells time to clear proteins 
and metabolites damaged by H2O2 before resuming biosynthesis (Shenton et al., 2006).  This 
inhibition of protein synthesis requires Gcn1, one of the proteins whose deletion that was found 
to result in synthetic sickness in combination with an ecm5 knockout (Collins et al., 2007).  The 
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presence of Ecm5 and Snt2 at amino acid metabolism genes and the redistribution of Ecm5 and 
Snt2 from gene bodies to promoter regions of ribosomal protein genes after H2O2 treatment 
may refl ect a potential role for Ecm5 and Snt2 in regulating this translational inhibition and the 
subsequent cellular need to generate new amino acids for when translation resumes.
As further evidence that the Rpd3(T) complex functions in the oxidative and nutrient 
stress pathways, rpd3 and snt2 mutants were also resistant to the TOR inhibitor rapamycin, 
which promotes an amino acid starvation response in yeast.  Furthermore, just as H2O2 treatment 
stimulated many new Ecm5/Snt2 genomic associations, so too did rapamycin treatment.  While 
the H2O2-specifi c Ecm5 and Snt2 targets were involved in myriad stress and metabolism 
functions, the smaller number of rapamycin-specifi c targets tended to be genes involved in amino 
acid metabolism.  Even before rapamycin treatment, the mere growth of cells in the less rich SD 
CSM media already prompted Ecm5 and Snt2 association with more targets than the number of 
genes targeted when cells are grown in YPD, and many of these targets were genes that Ecm5 
and Snt2 localize to in response to H2O2 treatment.  These results suggest that whatever cellular 
state is triggered by H2O2 treatment resembles the state of cells without an abundance of nutrients 
around.  In support of this idea, one study found that cells starved for an essential amino acid had 
increased levels of reactive oxygen species, suggesting that lack of nutrients can directly promote 
oxidative stress (Eisler et al., 2004).  More recently, starving yeast were shown to up-regulate 
oxidative stress response genes (Petti et al., 2011).  One open question from this work is whether 
the relocalization of Ecm5 and Snt2 upon H2O2 treatment is a direct consequence of oxidative 
stress signaling or a secondary consequence of the high degree of crosstalk known to exist 
between the stress and nutrient signaling pathways.
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A fi nal piece of evidence linking the Rpd3(T) complex to oxidative and nutrient stress 
is that the genes over- or under-expressed in the snt2 knockout strain are also involved in these 
pathways.  Moreover, there is a high degree of overlap between genes misexpressed in the 
snt2 strain after H2O2 treatment and genes whose expression levels change in wild-type cells in 
response to H2O2.  In contrast to the gene expression changes seen in the snt2 strain, the ecm5
strain had very few genes misexpressed, consistent with the genetic data showing that deletion of 
Ecm5 did not promote H2O2 or rapamycin resistance.  More discussion of the potential reasons 
why deletion of ECM5 does not show the same striking phenotypes as SNT2 deletion will be 
presented in the fi nal discussion chapter to this thesis.
Of course, the key question is whether the Rpd3(T) complex localizes to target genes 
to regulate gene expression.  The majority of Ecm5 and Snt2 target genes both before and after 
H2O2 treatment show no expression differences in the snt2 strain.  While surprising, this result 
is consistent with two other reports about the Rpd3(L) complex, which showed this complex 
is localized at the promoters of ribosomal protein genes whose expression do not change when 
Rpd3 is deleted (Kurdistani et al., 2002; Rohde and Cardenas, 2003).  These studies and my own 
fi ndings suggest that in many cases the Rpd3(T) complex may be poised at target genes, waiting 
for a signal or additional factor needed for the complex to affect gene expression.
I did isolate a subset of 309 genes that contained Ecm5 and Snt2 at their promoters, 
changed expression in wild-type cells, and were also differentially expressed in the snt2 
knockout strain after H2O2 treatment.  While I initially thought Rpd3(T) would be a repressive 
complex, I found that while some of these genes were over-expressed in the snt2 strain, others 
were repressed, suggesting that the link between Rpd3(T) function and gene expression is 
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complicated.  Again, previous studies of the Rpd3(L) complex have paved the way for these 
fi ndings, showing that this complex is needed for both activation and repression of target genes 
in response to stress (Alejandro-Osorio et al., 2009; De Nadal et al., 2004).  Genes falling within 
the same functional category were more likely to be regulated by Snt2 in similar ways.  While 
not defi nitive, this result is consistent with a model in which different factors associate with the 
Rpd3(T) complex at different gene targets and modulate its activity, an idea I will discuss further 
in the next chapter.
Surprisingly, Ecm5 and Snt2 showed two distinct modes of binding.  While in most cases, 
these proteins were localized in gene promoters, there were a number of genes that contained 
Ecm5 and Snt2 within their gene bodies in untreated cells.  This pattern of binding was often 
correlated with highly expressed genes, so it would be interesting to see if H3K36me3 levels, 
which are known to correlate with transcription level (Pokholok et al., 2005), are higher at these 
genes, which would be consistent with the Rpd3(T) complex being recruited to these genes 
through the reported weak interaction between the Ecm5 PHD fi nger and this mark (Shi et al., 
2007).  After H2O2 treatment, Ecm5 and Snt2 were no longer enriched in the coding regions 
of these genes, but rather appeared to relocalize to the 5’ and 3’ ends.  Intriguingly, genes that 
had this pattern of localization were generally repressed upon H2O2 treatment, and in many 
cases were even more repressed after treatment in the snt2 strain, suggesting that this pattern 
of localization is correlated with Rpd3(T) acting as a transcriptional activator.  In summary, 
Ecm5 and Snt2 localize to promoters and some coding regions of genes involved in stress and 
metabolism, and Snt2 is required for the proper expression levels of a subset of the Ecm5 and 
Snt2 target genes, suggesting that the Rpd3(T) complex may function to regulate gene expression 
in response to metabolic and oxidative stress signals.
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CHAPTER 5: GENERAL DISCUSSION
The study of yeast PHD fi ngers led to the discovery of a new chromatin regulatory complex
 The research described in this thesis was undertaken with the goal of learning more 
about the functions of the PHD fi nger-containing proteins Jhd2 and Ecm5.  Because of the 
domain structures of Ecm5 and Jhd2, and because both proteins are localized to the nucleus, I 
hypothesized that they would function to regulate chromatin.  Early support for this hypothesis 
came from my own pull-down experiments showing that the PHD fi ngers of both proteins 
interact with histone H3.  In addition, studies from other laboratories have successfully mapped 
Jhd2 on chromatin using the ChIP technique (Ingvarsdottir et al., 2007; Radman-Livaja et al., 
2010), and shown that this protein can act as an H3K4 demethylase (Liang et al., 2007; Seward 
et al., 2007; Tu et al., 2007).  My own ChIP experiments have successfully mapped the genomic 
localization of Ecm5, as well as its interaction partner, Snt2.  In addition, I have characterized 
an Ecm5-containing complex that also contains Snt2 and the Rpd3 deacetylase.  I have chosen 
to call this complex the Rpd3(T) complex, to highlight its catalytic deacetylase subunit.  This 
allows the reservation of the term Snt2C to refer to a possible subcomplex containing Ecm5 and 
Snt2 only, which I will discuss more below.  Thus, both Ecm5 and Jhd2 bind to chromatin and 
contain or are associated with histone-directed enzymatic activity.
 I have shown that members of the Rpd3(T) complex are not required to prevent cryptic 
transcription, a known function for another Rpd3-containing complex, Rpd3(S).  In addition, I 
have demonstrated that ecm5 knockout cells do not have obvious defects in the cell wall, DNA 
damage repair, the cell cycle, the cellular morphogenesis checkpoint, meiosis, or sporulation.  
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Rather, a genetic interaction between ECM5 and a gene required for the yeast oxidative stress 
response led me to uncover a role for Rpd3(T) in regulating the yeast oxidative stress and 
nutrient metabolism pathways.
The many domains in Ecm5 and Snt2 are likely to work in combination to recruit or 
stabilize the Rpd3(T) complex on chromatin
 Many of the domains in Ecm5 and Snt2 are part of families with known functions in 
chromatin interaction, including the PHD fi nger, a domain that has been a focus of this research.  
It is likely that these domains help promote or stabilize Rpd3(T) complex binding on chromatin.  
I have shown that the Ecm5 PHD fi nger interacts with histone H3 and have found a moderate 
enrichment for H3K36me3 in the H3 pulled-down.  The Gozani lab has also reported that the 
Ecm5 PHD interacts with H3K36me3, albeit weakly (Shi et al., 2007).  While I was unable to 
confi rm a direct association between the Ecm5 PHD and H3K36me3, possibly because of the 
weakness of this reported interaction, I did fi nd that Ecm5 and Snt2 localize to the gene bodies of 
highly transcribed genes, which are known to have the highest levels of H3K36me3 (Pokholok et 
al., 2005).  At these genes, the high levels of this mark may compensate for a weak Ecm5-PHD 
interaction in helping this complex bind to or remain at these chromatin regions.  
 In an interesting twist for a project that was initiated because of PHD fi ngers, Snt2 has 
three PHDs of its own.  Gozani and colleagues reported that the second Snt2 PHD could interact 
very weakly with H3K36me as well as with an H3 peptide centered around K79, irrespective of 
methylation status (Shi et al., 2007).  They were unable to fi nd associations between the other 
two Snt2 PHDs and the chromatin marks they tested.  These domains may interact with some 
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of the more recently described sites of yeast lysine methylation mentioned in the introductory 
chapter, with arginine methylation, or with non-histone proteins.  In addition to PHD fi ngers, 
Ecm5 contains an ARID domain, and Snt2 contains BAH and SANT domains.  In other 
proteins, these domains have been shown to mediate DNA or histone interactions (Armache 
et al., 2011; Boyer et al., 2004; Kuo et al., 2012), and it is likely that multiple weak DNA or 
histone interactions mediated through these individual domains work in combination to recruit 
Ecm5 and Snt2 to specifi c chromatin locations, or to stabilize these proteins on chromatin once 
recruited.  The kinetic and thermodynamic cases for how multiple weak interactions allow 
chromatin regulators to bind tightly but reversibly to their substrates has been well described 
in a review on the topic of “multivalency” in chromatin associations from Dr. Alex Ruthenburg 
and colleagues, and the references therein (Ruthenburg et al., 2007).  In the future, it would be 
interesting to produce the Snt2 BAH, SANT, and three PHD domains recombinantly, singly 
and in combination, and to test them all for histone binding in pull-down assays.  Future ChIP 
experiments with tagged Ecm5 or Snt2 strains containing point mutations in these various 
domains may also reveal interesting functions for these domains in mediating interactions 
between Rpd3(T) and chromatin.
Potential models for the role of Rpd3(T) in regulating stress and metabolism
 In the previous chapter, I presented multiple lines of evidence that the Rpd3(T) complex 
regulates yeast metabolism and the oxidative stress response.  A key question that is unresolved 
in this work is what is the exact mechanism for this regulation.  The exact nature of the signal 
that promotes Ecm5 and Snt2 localization to new promoter regions in less rich media and after 
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oxidative stress remains unclear, as does the mechanism by which Ecm5 and Snt2 promote 
changes in gene expression at a subset of their targets.  The simplest model for the latter question 
would be if Rpd3(T) were recruited to gene promoters (and sometimes coding regions) so that 
Rpd3 could deacetylate these regions and repress the gene targets.  However, there is no clear 
pattern of expression differences of these genes in the snt2 knockout: some genes are up-
regulated in the absence of Snt2, while others are down-regulated.  Furthermore, I identifi ed a 
large number of Ecm5 and Snt2 target genes whose expression was no different than wild-type 
expression levels either before or after stress.  These fi ndings demonstrate that the link between 
Rpd3(T) complex function and gene regulation is more complicated than the simple model that 
Rpd3(T) represses target genes. 
 Precedence for more complicated types of gene regulation exists in the literature. For 
example, a single factor in yeast can be associated with both activating and repressing activity, 
depending on the context.  A study from Fred Winston’s laboratory has shown that the yeast 
Hap1 protein, which is known to activate genes during aerobic growth, also directly represses 
ergosterol biosynthesis genes during hypoxia (Hickman and Winston, 2007).  Hap1 localizes 
to the promoters of the ergosterol genes both during hypoxia, when it is needed for repression, 
and during aerobic growth, when it is needed for activation of these genes, and cellular 
concentrations of heme dictate whether Hap1 acts as an activator or a repressor.  In this example, 
whether Hap1 activates or represses genes depends on the state of the entire cell, whereas my 
data suggest Snt2 function might be capable of activating or repressing genes in the same cell, 
although it is possible that genes that were over- or under-expressed in the snt2 knockout strain 
came two a different subpopulations of cells within the culture (e.g. cells that experienced high 
levels of H2O2 vs. cells that received lower doses). 
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 There are other possible models for how Snt2 could promote both gene activation and 
repression (Figure 5.1).   Snt2 may exist as part of two distinct complexes, one whose sole other 
member is Ecm5, and one that also contains Rpd3 – Rpd3(T).  The mass spectrometric results 
I discussed in the third chapter show that Rpd3 can associate with Ecm5 and Snt2, but they do 
not rule out a possible subcomplex consisting of Ecm5 and Snt2 only.  The Rpd3(T) complex 
may localize to the promoters that require Snt2 for repression, while and Ecm5 Snt2 subcomplex 
localizes to other promoters and gene bodies to promote activation (possibly by recruiting 
additional transcription factors) (Figure 5.1A).  An Rpd3-indendent function for Snt2 might 
explain why the snt2 knockout strain has markedly better survival in response to H2O2 stress 
than the rpd3 knockout, although it is also possible that pleiotropic effects of RPD3 deletion are 
responsible for this result.  In theory, Ecm5 and Snt2 could also have functions independent from 
one another.  However, within the genome, I do not see regions where one is bound without the 
other, suggesting Ecm5 and Snt2 function as a unit on chromatin.  One of the most important 
next experiments for this work will be to use ChIP to map Rpd3 localization before and after 
oxidative stress, and see whether some targets of Ecm5 and Snt2 binding are not Rpd3 targets.
 Another possibility is that the Rpd3 localizes to all the same genes that Ecm5 and Snt2 
localize to, and depending on which other factors are present, can promote gene activation 
or repression.  As mentioned earlier, other studies have found examples of genes containing 
Rpd3 at their promoters that require Rpd3 for activation (De Nadal et al., 2004; Ruiz-Roig 
et al., 2010; Sertil et al., 2007; Sharma et al., 2007).  This could be the result of the Rpd3(T) 
complex recruiting different factors that either promote or repress transcription (Figure 5.1B).  
It is possible that in some cases, deacetylation of specifi c histone lysines might promote 
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Figure 5.1 Models for possible ways that Snt2 might directly regulate both gene activation 
and repression
A. Ecm5 and Snt2 might be recruited without Rpd3 to promoters that require Snt2 for 
activation, subsequently recruiting transcription factors, while other promoters might recruit the 
entire Rpd3(T) complex for HDAC-mediated repression. B. The Rpd3(T) complex might be 
recruited to promoters that require Snt2 for activation, where the complex functions primarily 
to recruit other transcription factors (Txn factor), while at promoters that require Snt2 for 
repression,  Rpd3(T) might recruit transcriptional repressors (Rep). C. Different regulatory 
factors (Factor) interacting with Rpd3(T) may change the preferred histone lysine substrates 
of Rpd3, with deacetylation of specifi c histone lysines potentially promoting transcription and 
deacetylation of other histone lysines repressing it. D. Different regulatory factors (Factor) 
interacting with Rpd3(T) may change the preferred substrate of Rpd3 to a n on-histone protein, 
with deacetylation of the non-histone substrate potentially promoting transcription and 
deacetylation of a histone substrate repressing it.
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Figure 5.1 Models for possible ways that Snt2 might directly regulate both gene activation 
and repression 
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transcriptional activity (Figure 5.1C).  It also remains possible that despite being bound to 
chromatin, Rpd3(T) does not affect histone acetylation at the genes it activates, but rather 
deacetylates non-histone factors that are recruited in the vicinity of this complex, which then 
promote transcription (Figure 5.1D).  These models are not exclusive, and combinations of two 
or more of them, could be happening in vivo.
 Another Rpd3-containing complex, Rpd3(L), has also been shown to regulate stress 
and metabolism genes (De Nadal et al., 2004; Humphrey et al., 2004; Kremer and Gross, 2009; 
Rohde and Cardenas, 2003; Ruiz-Roig et al., 2010; Tsang et al., 2003).  Like the snt2 knockout 
strain, knockouts for Rpd3(L) subunits have been shown to be rapamycin resistant (Rohde 
and Cardenas, 2003).  In addition, a recent study has found that in response to TOR pathway 
activation, the Rpd3(L) complex localizes to and represses ribosomal biogenesis and ribosomal 
protein gene promoters (Huber et al., 2011).  In this research, I have also found Ecm5 and Snt2 
localized at promoters and in some cases, gene bodies, of these types of genes.  Therefore, 
the Rpd3(T) complex could possibly be a subcomplex of Rpd3(L) that only associates under 
conditions of oxidative or nutrient stress.  This could explain why Ecm5 and Snt2 were never 
detected in IPs for Rpd3(L) subunits, and why Rpd3(L) subunits were not detected in my own 
Ecm5 and Snt2 IPs, all of which were performed in lysates from unstressed cells.  It would 
be interesting to repeat these IPs in cells treated with H2O2 or rapamycin to look for new 
associations. 
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Could plant homeodomain fi ngers act as redox sensors?
 Reactive oxygen species (ROS) are damaging to cells in part because they can directly 
oxidate cysteine side chains of proteins.  While this oxidation generally renders proteins 
nonfunctional, and is therefore deleterious, cysteine oxidation can have a positive role in 
regulating cellular response to redox status.  In yeast, the Yap1 transcription factor is one of the 
better examples of this type of regulation.  As discussed in the introductory chapter, Yap1 is 
normally exported from the nucleus, but when intracellular levels of H2O2 are high, two cysteines 
in Yap1 are oxidized, forming an intramolecular bond.  This results in a conformation change 
that masks Yap1’s nuclear export sequence, allowing it to accumulate in the nucleus and activate 
oxidative stress response genes.  
 The PHD fi nger is a domain defi ned by the presence of multiple cysteine residues, which 
are required for the proper folding of this module.  Oxidation of PHD cysteines, which would be 
expected to perturb these folds, would likely alter or prevent the chromatin associations of these 
modules.  Not all cysteines are equally good substrates for oxidation (Le Moan et al., 2006).  
Nevertheless, I speculate that if PHD domains can become oxidized in response to higher levels 
of cellular ROS, the proteins or complexes containing these domains might then rely more on 
their other chromatin-interacting motifs for chromatin localization, and might therefore localize 
to different regions of the genome.  Cells might use PHDs as redox sensors as a mechanism to 
alter the genomic associations of PHD fi nger proteins, resulting in differential gene regulation in 
response to oxidative stress.
 If such a mechanism does exist in yeast cells, the Rpd3(T) complex would be a good 
candidate complex for redox sensing.  While Ecm5 appears to be dispensable for complex 
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function, the three Snt2 PHD domains may not be.  I have already demonstrated that Ecm5 and 
Snt2 localize to new loci in response to H2O2 treatment.  This might be an indirect effect of H2O2 
treatment, but it is possible that H2O2 treatment directly oxidizes one or more Snt2 PHD fi ngers, 
resulting in a conformational change that allows Ecm5 and Snt2 to bind to new regions in the 
genome.  Future experiments that map complex localization before and after oxidative stress 
in cells with mutations in the Snt2 PHD cysteines might provide evidence for this mechanism.  
Because of the concern that cysteine mutation might just destabilize or unfold Snt2, it would be 
important to establish that the localization of Snt2 containing PHD point mutations was normal 
in the absence of oxidative stress.  In addition, it would be interesting to perform western blots 
for tagged Snt2 on whole cell extracts from untreated and H2O2-treated cells, using non-reducing 
conditions, to look directly for evidence of disulfi de bond formation. 
What does Ecm5 do, and why does the mutant lack a phenotype in these assays?
 The ultimate goal that drove this research was to gain insights into the function(s) of 
Ecm5, and it was a genetic interaction with ECM5 that led me to test whether the Rpd3(T) 
complex was involved in the oxidative stress response.  I was therefore surprised to fi nd that 
the snt2 knockout strain had such dramatic phenotypes while the ecm5 knockout strain did not.  
The high degree of genomic colocalization these two proteins have made this result all the more 
surprising.  Thus, in spite of great strides in identifying interaction partners for Ecm5 and fi nding 
roles for them in oxidative stress and cellular metabolism pathways, at the end of this project, I 
am left facing the same question I had when I began: just what exactly does Ecm5 do?
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 It is possible that Ecm5 physically associates with Snt2 and Rpd3, but is not needed for 
their genomic localization or association with one another.  If this is the case, Snt2-mediated 
gene regulation would not be expected to be perturbed in cells lacking Ecm5, which would 
explain how so few genes’ expression levels differ from wild-type in ecm5 knockout cells.  
Future ChIP experiments in strains where one member of the Rpd3(T) complex is tagged and one 
member is deleted could help to unravel the mechanism for this complex biology.  
 While very preliminary, in H2O2 plate assays, the ecm5snt2 double mutants have 
phenotypes more similar to ecm5 cells, or somewhere in between ecm5 knockouts and snt2 
knockouts, suggesting that the functions of Ecm5 and Snt2 might be opposed (Figure 5.2A).  
It is possible that in wild-type cells, Ecm5 functions to inhibit Rpd3 activity and that Snt2 
prevents Ecm5 from doing this, allowing Rpd3 to remain active at Rpd3(T) target genes, and 
enact gene expression changes that cause cells to be sensitive to H2O2 (Figure 5.2B).  Under this 
model, in ecm5 cells, Rpd3 would be active, and would sensitize cells to H2O2.  In snt2 cells, 
there would be nothing protecting Rpd3 from Ecm5-mediated repression, causing Rpd3 to be 
inactivated.  Without Rpd3-mediated changes in gene expression, cells would remain resistant to 
H2O2.  In rpd3 cells, the gene expression changes that promote H2O2-mediated cell death would 
not occur, resulting in H2O2-resistant cells.  However, other effects from the loss of Rpd3(L) and 
Rpd3(S) complex function may blunt the H2O2 resistance, explaining why rpd3 cells are less 
resistant than snt2 cells.  In ecm5snt2 double mutants, Rpd3 would be active, promoting 
cell death in response to H2O2 stress, explaining why this double mutant phenotypically is more 
similar to wild-type and ecm5 yeast strains and not the snt2 knockout strain.  This model would 
also suggest that in certain cell states, Ecm5 could be freed from Snt2-mediated repression, and 
could actively inhibit Rpd3.
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Figure 5.2 Preliminary evidence that Ecm5 and Snt2 might oppose one another and a 
model for how this might work 
A. Dilutions of saturated overnight cultures of the indicated mutant strains were spotted onto 
YPD alone or YPD supplemented with 4 mM H2O2.  Plates were imaged after 2 days. B. The 
phenotypic resemblance of the ecm5 snt2 double knockout strain to the ecm5 single knockout 
strain could be explained by a model where Ecm5 represses Rpd3 function and Snt2 represses 
Ecm5.  In wild-type cells, these activities would result in active Rpd3, which could promote 
changes that sensitize cells to H2O2.  The corresponding states for each mutant are diagramed 
below the wild-type case.
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 At the moment, this model is speculative, and will require further testing to confi rm.  
To that end, it will be important to determine what happens to Rpd3(T) complex composition 
when one member of the complex is deleted.  In addition, in vitro histone deacetylation assays 
with Rpd3(T) complex purifi ed from cells lacking either Ecm5 or Snt2 could test whether Ecm5 
represses Rpd3 activity, and whether Snt2 inhibits this repression.  Because of the diffi culties of 
purifying large quantities of Rpd3(T) complex, in vitro deacetylase assays with fully recombinant 
Rpd3 alone, or in complex with recombinant Ecm5 and/or Snt2, may be a more feasible way to 
see whether Ecm5 and Snt2 affect Rpd3 activity.  In support of this model, Yi Zhang’s laboratory 
has shown that the presence of the non-Rpd3 subunits of the Drosophila homolog of the Rpd3(T) 
complex inhibits Rpd3 activity (Lee et al., 2009).
 As I mentioned in the introductory chapter, Ecm5 contains a JmjC domain that seemingly 
does not have demethylase activity.  While this domain lacks the conserved residues predicted to 
interact with Fe(II), it retains some of the residues predicted to bind to  -ketoglutarate (Figure 
5.3).  The JmjC domain is part of a larger superfamily of domains with oxygenase activity 
(Loenarz and Schofi eld, 2008).  Other functions for domains in this family include the post-
translational modifi cation of proteins by prolyl-hydroxylation and arginine demethylation.  While 
the Fe(II)-binding triad of histidine, aspartate or glutamate, and histidine is conserved in most 
members of this family, this triad is not universal.  Therefore, an intriguing possibility is that 
the Ecm5 JmjC possesses a catalytic activity distinct from lysine demethylation.  Future in vitro 
reactions with Ecm5 purifi ed from yeast, may reveal such an activity.
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Figure 5.3 The Ecm5 JmjC domain possesses many of the residues predicted to bind 
-ketoglutarate
JmjC domain alignments consisting of amino acids 470-575, 486-591, 414-521, and 509-667 of 
the full-length RBP2 (Homo sapiens, NCBI accession # NP_00103068), PLU1 (Homo sapiens 
# NP_006609), Jhd2 (S. cerevisiae, # NP_012653.1), and Ecm5 (S. cerevisiae, # NP_013901.1), 
respectively, with askterisks, colons , and periods under fully, strongly, and weakly conserved 
residues, respectivel y. Predicted Fe(II) binding residues are highlighted in light red, and 
predicted -ketoglutarate-binding residues are in light blue. Predicted residues come from 
Klose et al., 2007; Yamane et al., 2007; and Li et al. 2008.
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Evolutionary reasons for the snt2 mutant phenotype and competitive fi tness of this strain
 I have shown that increased numbers of cells survive H2O2-mediated stress when SNT2 or 
RPD3 is deleted, compared to survival in a wild-type strain, suggesting that part of the function 
of the Snt2 and Rpd3 is to inhibit cell division and promote cell death in response to high 
levels of oxidative stress.  Unlike H2O2 treatment, rapamycin treatment, which mimics nutrient 
stress, does not promote cell death, but rather just slows cell division (data not shown), and 
strains lacking Snt2 or Rpd3 are resistant to rapamycin.  These results suggest that in response 
to oxidative stress Rpd3 and Snt2 act to promote cell death, while in response to nutrient stress 
Rpd3 and Snt2 act to inhibit cell division.  
 It might at fi rst, seem counterintuitive that yeast would evolve a protein complex that 
would slow down their growth or promote cell death.  In multicellular organisms, the case can be 
made that the quiescence or death of one cell may be important for the survival and reproductive 
success of the whole organism, and so makes good evolutionary sense.  Yeast, on the other 
hand, are only single cells, and should therefore have evolved mechanisms that promote the 
fastest growth and reproduction.  Nonetheless, the existence of a cell death pathway in yeast 
has now been well-documented, and scientists have speculated that death of chronogically aged 
or stressed yeast cells may allow for the release of nutrients into the media which promote the 
growth and survival of healthier yeast cells within the population as a whole (Herker et al., 2004; 
Madeo et al., 2004).  While this strategy is disadvantageous for the dying cell, it benefi ts the 
rest of the population, and given that yeast cells within a population are genetically similar, a 
population benefi t also helps the cell that has died to pass on its genes.  A similar mechanism is 
known to occur in the bacterium Bacillus subtilis.  When Bacillus cells are starved for nutrients, 
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a fraction of the cells undergo a switch that allows them to secrete extracellular factors that kill 
the cells around them (Claverys and Havarstein, 2007).  The secreting cells can then feed on the 
remains of their dead siblings.  This behavior has been delightfully named “cannibalism,” and is 
also proposed to help this species survive extreme stress.
 In keeping with these ideas, I hypothesize that Rpd3 and Snt2 inhibit cell growth in 
response to nutrient stress because in the long run, continuing to divide under such stress would 
be deleterious to the yeast population.  Inhibiting growth in response to low levels of stress 
allows cells time to repair damage, conserve energy, and regenerate key molecules.  In cells 
too damaged to successfully keep reproducing, cell death allows that other cells to at least gain 
a nutritional benefi t, which may provide them with the energy needed to activate their own 
stress defense pathways.  Based on these hypotheses, I expect that snt2 cells would have a 
fi tness defect compared to wild-type cells.  To test this idea, I have performed a preliminary 
competition experiment, in which equal numbers of wild-type and snt2 cells were inoculated 
into SD CSM and cultured over several days. Cultures were diluted with fresh media each day, to 
avoid looking for differences in chronological age.  Surprisingly, under these conditions, snt2 
cells out-competed wild-type cells, as measured by the proportion of total cells in the culture 
that possessed the G418 resistance marker and therefore were deleted for SNT2 (Figure 5.4).  
In hindsight, this may be because the conditions of this experiment were conducive to growth.  
Perhaps only under extreme stress conditions, where it is vital that cells not divide until damage 
is repaired, and that damaged cells clear the way for intact ones, would a fi tness defect emerge 
for the snt2 knockout strain.  Future competition experiments that test various stress conditions, 
such as repeated exposure to H2O2, rapamycin treatment, starvation media, or chronological 
aging, may reveal such a defect. 
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Figure 5.4 The snt2 knockout strain out-competes the wild-type strain
Equal numbers of wild-type and either ecm5 or snt2 knockout cells were co-inoculated into 
the same SD CSM cultures.  Immediately and 12 hours after inoculation, samples were taken, 
diluted, and plated to determine the numbers of wild-type and knockout cells in each culture.  
After 24 hours in culture, and each subsequent day, cultures were diluted to 2x105 cells/mL in 
fresh media, and samples were taken, diluted, and plated for counting.  Dilutions of cultures 
were plated on both knockout-selective and non-selective media, and viable colonies were 
counted two days post-plating.  The number of viable knockout cells in a sample was then 
divided by the total number of cells in that same sample.  Graphs show the means and SEMs 
of these ratios for 3 replicates each for competitions between snt2 and wild-type and between 
ecm5 and wild-type strains .
177
The implications of this research: live long, stay healthy, and drink up!
 I initially embarked on this project with the hope that anything I learned about Jhd2 or 
Ecm5 might be applicable to their human homologs, the JARID proteins.  Excitingly, there is 
evidence for human complex similar to Rpd3(T).  The human RBP2/JARID1A protein has been 
shown to be a member of a large complex that includes a PHD fi nger-containing protein called 
Pf1 and the Rpd3 homolog HDAC2 (Hayakawa et al., 2007).  It would be interesting to use 
ChIP-seq to map the localization of subunits of this complex in human cell lines before and after 
exposure to ROS or nutrient starvation conditions to see if this complex associates with different 
genomic regions in response to these insults.  It is now well established that increased exposure 
to oxidative stress and perturbed cellular metabolism contribute to numerous human disease 
states, including cancer, diabetes, and age-related neuropathies (Alic and Partridge, 2011; Dazert 
and Hall, 2011; Lin and Beal, 2006; Roberts and Sindhu, 2009).  Therefore, if humans contain a 
pathway analogous to Rpd3(T) that is responsible for regulating metabolism and stress response, 
understanding this complex may have important implications for understanding the factors that 
contribute to these diseases.
 This research may also have applications in combatting pathogenic fungi.  There are 
numerous species of fungi that can infect the human body.  Candida albicans is the most 
common human fungal pathogen, causing opportunistic infections in humans (Beck-Sague and 
Jarvis, 1993).  C. albicans populates the gastrointestinal tract, and oral and vaginal mucosa of 
most people.  For healthy individuals, and this does not generally pose a problem (Kim and 
Sudbery, 2011).  However, in patients whose immune systems are compromised, as a result 
of diseases like AIDS, blood cancers, or the use of immunosuppressive therapies, C. albicans 
178
infections can escape immune control, causing infection of the skin, infection of the mouth 
(thrush), infection of the throat (esophagitis), and infection of the bloodstream (candidimia).  
Even though anti-fungal treatments for Candida are available, once this pathogen has infected 
the bloodstream, it is fatal in more than 50% of cases (Andes et al., 2012).  In healthy 
individuals, macrophages fi ght infections of this fungus by generating ingesting C. albicans 
cells and generating superoxide (Vazquez-Torres and Balish, 1997), so the oxidative stress 
response pathways of this fungus act as key virulence factors.  A better understanding of how 
these pathways allow Candida to resist stress could be used to design new treatments for this 
pathogen.
 While the human health implications for the research described in this thesis should 
not be belittled, these fi ndings may also have relevance outside of the biomedical sphere.  The 
production of beer, wine, and other alcoholic beverages depends on the effi cient fermentation 
of sugars into alcohol by S. cerevisiae.  In fact, the word “cerevisiae” comes from the Latin 
“of beer.”  Yeast are known to actively up-regulate oxidative stress response genes during beer 
fermentation (Higgins et al., 2003; James et al., 2003).  Furthermore, the oxidation of compounds 
in the beer can have profound effects on the beer’s fl avor (Bamforth and Lentini, 2009; 
Vanderhaegen et al., 2006).  Therefore, the beer industry actively researches the yeast oxidative 
stress response, seeking strains that have a strong oxidative stress response and that also secrete 
antioxidants that will prevent oxidation of compounds in the beer (Berner and Arneborg, 2012).  
The research described in this thesis regarding how yeast regulate their sugar metabolism and 
respond to oxidative stress may have important implications for helping to craft a better beer.  
While no beer made from genetically-modifi ed yeast is currently sold commercially, this is likely 
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to change in the future, and genetic alterations that tinker with Rpd3(T) function may create a 
yeast strain that makes a better beer.  Even without genetically engineering, screening wild yeast 
isolates for strains with altered levels of the proteins in this pathway, may lead to the discovery 
of exciting new beer strains.  Lastly, understanding the environmental factors that contribute to 
Rpd3(T) mediated response may help brewers fi nd small changes they can make to their beer-
making procedures that can result in tastier outputs. 
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MATERIALS AND METHODS
Yeast strains and culture conditions
All S. cerevisiae strains used for this research are listed in Table M.1.  With the exception of 
the strains used for sporulation assays, which were made on the SK1 background, all strains 
are isogenic to BY4741 or BY4742, which are derivatives of S288C.  Transformation of yeast, 
culturing, media preparation, and general strain handling were all performed using the methods 
described in Methods in Yeast Genetics and the references therein (Amberg et al., 2005).  The 
uracil plasmid pRS426  was transformed following a previously published protocol for yeast 
plasmid transformation (Elble, 1992).  Where indicated in Table M.1, deletion strains come 
from the S. cerevisiae haploid nonessential genome deletion library (Winzeler et al., 1999), 
and all deletions were verifi ed by PCR.  Additional deletion strains were created by targeting 
the kanMX4 or hphMX4 antibiotic resistance cassettes to the genes of interest (Goldstein and 
McCusker, 1999; Wach et al., 1994).  Yeast were cultured in either YPD (1% yeast extract, 2% 
peptone, 2% dextrose) or Synthetic Defi ned Media with Complete Supplement Mixture [SD 
CSM, 0.17% yeast nitrogen base without amino acids or ammonium sulfate, 0.5% ammonium 
sulfate, 0.079% complete supplement mixture (CSM, MP Biomedicals), 2% dextrose].  Cultures 
were grown at 30oC with 200 rpm shaking.
Recombinant PHD Preparation
Yng1, Jhd2, and Ecm5 PHDs (amino acids 141-219, 221-300, and 1232-1295 of the full-length 
proteins, respectively) were cloned into pGEX-6P-1 (Amersham Pharmacia) which added an 
N-terminal gluthathione S-transferase (GST) tag.  Constructs were transformed into BL21 E. 
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Table M.1 Yeast strains used in this research a
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coli, and induced by adding isopropyl--D-thiogalactopyranoside (IPTG) (fc 0.2 mM) and 
incubating 15-20 hours.  E. coli containing GST fusion proteins were lysed using sonication 
and lysates were purifi ed using Glutathione Sepharose 4B (Amersham Pharmacia) following 
manufacturer’s recommendations.  The Yng1 W180E point mutation was created using 
QuikChange Site-Directed Mutagenesis Kit (Stratagene).
In vitro histone binding assays
To prepare histone acid extract, wild-type yeast were lysed by cryogenic lysis method (described 
below), and lysates were resuspended in 0.4 N H2SO4 and incubated for 30 minutes with rotation 
at 4oC.  Acid-soluble histones were separated from insoluble pellet and precipitated with TCA.  
Binding assays were performed by mixing acid extracts from 5.5x108 cell equivalents with 1 
g GST-tagged PHD fi nger or GST alone in binding buffer (150 mM NaCl, 20 mM HEPES 
pH7.9, 25% glycerol, 1.5 mM MgCl2, 0.2 mM EDTA, 1 mM PMSF, 0.2% Triton X-100) for 1 
hour at room temperature with nutation.  Glutathione Sepharose 4B resin (Amersham Pharmacia 
– 25 L) was then added and assays were nutated for 1 hour.  Resin was washed 3 times with 
wash buffer (300 mM KCl, 20 mM HEPES pH 7.9, 0.2% Triton X-100) and one time in fi nal 
wash buffer (4 mM HEPES pH 7.5, 10 mM NaCl).  Reactions were separated on 12% SDS-
PAGE gels, and transferred to PVDF membranes by dry transfer method.  Antibodies used to 
probe membranes were: -H3 (Abcam ab1791), -H4 (Abcam ab10158), -H2A (UBI ab07-
146), -H2B (UBI 07-371), -H3K4me3 (Abcam ab8580), -H3K4me2 (Abcam ab7766), 
-H3K36me3 (Abcam ab9050), and -GST (RPB1236, Amersham).
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Peptide pull-down assay
High capacity streptavidin agarose (Thermo/Pierce) was washed 2x in PBS and mixed with 
excess amounts of the following peptides in PBS: H3(1-20), H3(1-20)K4me3, H3(27-46), and 
H3(27-46)me3.  Peptides and resin were incubated 3 hours at room temperature, and washed 
3x PBS with 1% Triton X-100, and 1x in PBS.  For pull-downs, 20 L 50% bead slurries were 
mixed with 10g GST-tagged PHD or GST alone in peptide binding buffer [20 mM HEPES 
pH 7.9, 125 mM KCl, 0.1% Triton X-100, Complete Protease Inhibitor (Roche)] and incubated 
2 hours at 4oC.  Pull-downs were washed 3x in wash A [20 mM HEPES pH 7.9, 300 mM KCl, 
0.1% Triton X-100], 1x in wash B [4 mM HEPES pH 7.9, 10 mM KCl], and eluted in boiling 
SDS-Loading Buffer.  Elutions were separated on 4-20% Tris-Glycine Gels (Invitrogen) and 
stained with Coomassie.
In vitro translation and ubiquitylation assays
PHD fi ngers from S. cerevisiae Ecm5 (amino acids 1210-1318 of the full-length protein), Snt2 
(289-397 – PHD1, 1010-1125 – PHD2, and 1148-1279 – PHD3), Set3 (89-194), Yng1 (127-219), 
Jhd2 (227-313), Yng2 (200-282), Pho23 (252-330), Jhd1 (1-100), Set4 (132-238), Nto1 (235-
341 – PHD1 and 345-469 – PHD2), Rco1 (232-337 – PHD1 and 386-500 – PHD2), Bye1 (44-
162), Cti6 (44-151), Spp1 (1-100), and S. pombe Msc1 (1143-1248) were cloned into a pCS2+ 
vector with a 6-Myc tag and an SP6 promoter (Ben-Saadon et al., 2006).  pCS2+-Ring1B and 
pCS2+Ring1B with the RING domain deletion were gifts from Ronen Sadeh.  Cysteine point 
mutations were introduced using the QuikChange Site-Directed Mutagenesis Kit (Stratagene).  
In vitro translations were performed using the Promega Tnt SP6 High-Yield Wheat Germ 
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Protein Expression System per manufacturer’s instructions with the following specifi cations: 
250 ng plasmid were used, reactions were supplemented with 35S methionine, and reactions were 
incubated at 30oC for 2 hours.  
For ubiquitylation assays, translated PHDs or Ring1B were added to a reaction mix consisting 
of 40 mM Tris pH 7.5, 5 mM MgCl2, 2 mM DTT, 2.5 M ubiquitin aldehyde (Enzo Life 
Sciences), 5 g recombinant ubiquitin (Sigma), 3 M E2 enzyme, and 5 mM ATPS (Roche), 
to a fi nal volume of 10 L and incubated at 30oC for 1 hour.  Reactions and input translations 
were separated on 4-12% Bis-Tris gels (Invitrogen) which were dried and imaged using a 
phosphorimager.  For experiments testing ubiquitin or E1 requirements, and E2 concentrations, 
reaction mixes were altered as indicated in the fi gures.  Recombinant human UbcH13/Mms2 
and hHR6A were purchased from Enzo Life Sciences, and recombinant human E1 was a gift 
from Jaehoon Kim from Robert Roeder’s laboratory.  For reactions with bacterial S30 system, 
PHDs (same amino acids listed above) were cloned into the pT7-7 vector (Tabor and Richardson, 
1985), and translated using the S30 T7 High-Yield Protein Expression System (Promega) per 
manufacturer’s instructions with the following modifi cations: 11 ng plasmid was used, and 35S 
methionine was added to the translations which were incubated for 1 hour at 37oC.
Purifi cation of Jhd2 interaction partners and Rpd3(T) complex
Yeast strains in were constructed containing a Protein A (PrA) tag (Aitchison et al., 1995) at 
the C terminus of Jhd2, Ecm5, Snt2, or Rpd3.  Tagged strains as well as an untagged control 
strain, were grown in 10L batches to mid log phase.  Cells were collected by centrifugation and 
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prepared for cryolysis as described previously (Oeffi nger et al., 2007).  Briefl y, pellets were 
mixed with freezing solution [1.2% polyvinyvinylpyrrolidone (PVP), 20 mM HEPES pH 7.4, 10 
mg/mL PMSF, 0.04 mg/mL pepstatin], in a ratio of 100 L solution per mL of cell pellet.  This 
mixture was frozen in small droplets in liquid nitrogen, and frozen cell droplets were stored at 
80oC before lysis.  For lysis, ~10g frozen cells at a time were milled in a Retsch PM100 Mill, 
using the 125 mL-sized chamber.  Mill settings were 3 minute cycles at 400 rpm, switching 
directions at 1 minute intervals.  Mill chamber and ball bearings were cooled in liquid nitrogen 
before milling, chamber was recooled in liquid nitrogen between 3 minute cycles.  This was done 
for 8-12 total cycles, until very few intact cells were visible when samples of the lysate were 
viewed under the microscope.
Cryolysates from tagged strains or untagged control (20-30g each, depending in the IP, 34.5x1011 
cell equivalents) were resuspended in IP Buffer [20 mM HEPES pH 7.4, 2 mM MgCl, 300 mM 
NaCl, 0.1% Triton X-100,  0.1% Tween-20, 110 mM potassium acetate, 0.1 mg/mL PMSF, 2 ug/
mL pepstatin, 0.5% protease inhibitor cocktail for fungal and yeast cells (Sigma)] in a ratio of 
25 mL of buffer to 5 g lysate.  Recombinant DNase I was added (Roche, 30 units/g lysate), and 
lysates were rocked 10 minutes at room temperature.  Lysates were then homogenized using a 
Polytron homogenizer on setting 4 for 10 seconds and centrifuged for 10 minutes at 2300 g to 
precipitate insoluble material.  Buffer equilibrated, IgG-conjugated Dynabeads, made following 
the protocol of Cristea et al. (2005), were added to each clarifi ed lysate (10 uL beads/g lysate), 
and IPs were incubated 1 hour at 4oC with nutation.  IPs were washed 5 times in IP Buffer, and 2 
times in IP Buffer lacking detergents.  Samples were eluted by incubating twice in 0.5 N NH4OH, 
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0.5 mM EDTA for 15 minutes at room temperature with agitation, and eluted samples were dried 
in a speedvac.
For the Ecm5-PrA IP, eluted proteins were reduced with dithiothreitol (DTT), alkylated with 
iodoacetamide, and separated on 1D SDS PAGE.  Protein bands were stained with Gel Code 
Blue Stain Reagent (Thermo Scientifi c), and bands were excised for mass spectrometric 
identifi cation.  For the Snt2-PrA and Rpd3-PrA IPs, 5% of each elutate was analyzed by silver 
stain gel and 50% was reserved for mass spectrometry.  The remaining Rpd3-PrA eluate was later 
separated on a gel and stained with Gel Code Blue.  Stained bands on the gel were excised for 
additional mass spectrometric identifi cation.  
To confi rm Rpd3 association with Ecm5, eluate from a separate, small-scale Ecm5-PrA IP was 
separated on a 4-20% Tris Glycine gel (Invitrogen), and transferred to PVDF membranes by wet 
transfer method.  The membrane was cut in two and probed with the antibodies that recognize 
the PrA tag (rabbit--goat-IgG-HRP secondary antibody, Dako P0160) or Rpd3 (sc6654, Santa 
Cruz Biotechnology).
Mass spectrometric identifi cation of immunoprecipitated proteins
For the Ecm5-PrA and untagged control IPs, excised bands were destained with 50% methanol 
in 100 mM ammonium bicarbonate.  The gel bands were dehydrated and digested overnight at 
room temperature in 100 mM ammonium bicarbonate with 50 ng sequencing-grade modifi ed 
trypsin (Promega).  The digestion was stopped and the tryptic peptides extracted by adding 
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an aqueous solution of 5% formic acid, 0.2% trifl uoroacetic acid (v/v) and reverse phase resin 
(POROS 20 R2, Perseptive Biosystems).  After light shaking at 4°C for 4 hours the resin 
was washed with 0.5% acetic acid and the bound peptides were eluted with 40% acetonitrile 
followed by elution with 80% acetonitrile in 0.5% acetic acid.  The eluents were combined and 
concentrated in a speedvac.  
The concentrate was pressure-loaded onto a nano-HPLC column with integrated 15m emitter 
(360 x 75 m PicoTip emitter, New Objective) packed with 6 cm of 5m C18 beads (YMC ODS 
AQ).  The peptides were eluted with a linear gradient of 0-40%B in 50 min and 40-100%B in 
70 min (A = 0.1M acetic acid, B = 70% acetonitrile in 0.1M acetic acid) using an Agilent 1100 
binary HPLC and analyzed on a Finnigan LTQ-XL mass spectrometer (Thermo Fisher) equipped 
with a nano-HPLC microelectrospray ionization source.  The mass spectrometer was operated in 
a data dependent mode were one full scan mass spectrum was followed by 10 collision activated 
dissociation (CAD) mass spectra of the 10 most abundant ions.  The fragmented ions were set on 
an exclusion list for 40 s and the cycle repeated throughout the data acquisition.  The resulting 
spectra were searched against the Saccharomyces cervisiae database using the search program X! 
tandem. 
For Snt2-PrA, Rpd3-PrA, and control IPs, after elutions were dried by speedvac, samples were 
resuspended in 100 mM ammonium bicarbonate, reduced and alkylated (same procedure as for 
the gel) and digested with trypsin for 8 hours at 37oC digested overnight.  The digestion was 
stopped by acidifying the solution with glacial acetic acid. The solution was pressure loaded 
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onto self-packed pre columns (360x75 um), rinsed with 0.5% acetic acid to remove salt and 
butt-connected to the nano-HPLC column.  Peptides were separated, eluted and identifi ed as 
described above.  For further validation of the Rpd3-PrA IP results, the remaining 50% of this IP 
was treated as described for the Ecm5-PrA IP, with focus on excising the bands corresponding in 
molecular weight to Ecm5 and Snt2.
Plate spotting assays
YPD, SD CSM, or SD CSM-URA media containing 2% agar was autoclaved, media was allowed 
to cool to approximately 60oC, and supplements were added to the fi nal concentrations indicated 
in tables and fi gures.  Saturated overnight cultures (for spotting assays in Chapters 3 and 5) or 
exponentially-growing mid-logarithmic (mid-log) phase cultures (for assays in Chapter 4) were 
diluted to 5x106 cells/mL in YPD, and this was diluted 1:5 in YPD 4 more times, for a total of 
5 serial dilutions.  4 L of each dilution were spotted onto control or treated plates, which were 
incubated at 30oC (unless otherwise indicated) for 2-5 days, and imaged once spots or colonies 
were clearly visible.  
Rapamycin, 6AU (6-azauracil), calcofl uor white (fl uorescence brightener 28), caffeine, MMS 
(methyl methanesulfonate), benomyl (methyl 1-(butylcarbamoyl)-2-benzimidazolecarbamate), 
BCS (bathocuproinedisulfonic acid), and BPS (bathophenanthroline disulfonate) were purchased 
from Sigma-Aldrich.  HU (hydroxyurea) was purchased from Acros.  Camptothecan was 
purchased from Calbiochem/EMD chemicals.  Hygromycin B was purchased from Invitrogen, 
and H2O2 was purchased from Fisher.
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Yeast RNA Preparation
For RNA preparations, wild-type and knockout strains were grown to mid-log phase in YPD, 
and harvested by centrifugation followed by fl ash freezing in liquid nitrogen.  Cells were stored 
at 80oC before RNA was prepared.  RNA was extracted using hot acid phenol, as previously 
described (Collart and Oliviero, 2001).  RNA quality was assessed using the Nanodrop 
spectrophotometer (Thermo Scientifi c), by measuring the 260 nM wavelength absorption, by 
checking for a clean peak of absorption, and by ensuring that the 260nm/280 nM ratio was 
>1.8.  RNA was also assessed by separation on formaldehyde agarose gels followed by ethidium 
bromide staining to examine rRNA bands for degradation.  For qPCR, total RNA was treated 
with DNase I (Ambion).  For northern blots, Poly-A+ RNA was enriched from total RNA using 
an Oligotex mRNA kit (Qiagen).  
For RNA-sequencing experiments, wild-type, ecm5, and snt2 yeast strains were grown in 
YPD to mid-log phase (~1x107 cells/mL), at which point 40 mL of each strain were separated, 
centrifuged to isolate cells, and fl ash frozen.  H2O2 was added to each culture to a fi nal 
concentration of 0.4 mM, and cultures were harvested 0.5 and 4 hours later.  Cells were stored at 
80oC before RNA was prepared as described above.
Reverse transcription and quantitative PCR-based expression analysis
DNase I treated RNA was converted to cDNA using the Superscript III First Strand Synthesis 
Kit (Invitrogen), following manufacturer’s instructions.  For quantitative PCR (qPCR) assays in 
Chapter 3, random hexamers were used to prime cDNA formation, while oligo dT was used to 
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prime the cDNA used for the qPCRs in Chapter 4.  Reverse transcribed cDNA was then used in 
qPCR reactions with SYBR Green reagent (Applied Biosystems), and incorporated fl uorescence 
was measured either on a Strategene Mx3000p Instrument (for qPCR assays in Chapter 3) or 
on an Applied Biosystems StepOnePlus Real Time PCR System(for qPCR assays in Chapter 
4).  Primers for all qPCR reactions are listed in Table M.2.  Dilutions of pooled cDNAs were 
used to generate standard curves for each primer set, and qPCR reactions were quantitated based 
on comparison to the standard curve, and normalized to the relative expression of ACT1.  All 
expression experiments were done with three biological replicates.
Northern blots
1 g of poly-A+-enriched RNA from each strain was separated on a formaldehyde agarose gel 
and transferred to Hybond membrane (GE Healthcare) using capillary transfer, after denaturing 
gel in 0.05 N NaOH for 30 minutes and neutralizing in 0.1 M Tris-HCl pH7.5 for 30 minutes.  
After UV-crosslinking RNA to the membrane, the membrane was incubated on top of boiling 
water for 1 minute, and incubated in prehybridization solution (50% formamide, 10% dextran 
sulfate, 1M NaCl, 0.05M Tris HCl pH 7.5, 0.1% SDS, 0.1% sodium pyrophosphate, 0.26% 
polyvinylpyrolidone, 0.26% BSA, 0.26% Ficoll, 0.33 mM EDTA, and 500 g/mL boiled ssDNA) 
for 42oC for 6 hours.  Membrane was then incubated in hybridization solution (50% formamide, 
10% dextran sulfate, 1M NaCl, 0.05M Tris HCl pH 7.5, 0.1% SDS, 0.1% sodium pyrophosphate, 
0.2% polyvinylpyrolidone, 0.2% BSA, 0.2% Ficoll, 0.25 mM EDTA, and 500 g/mL boiled 
ssDNA) containing boiled radiolabeled probe, at 42oC for 20-24 hours.  The membrane was 
washed 2x in 2X SSC for 15 minutes at room temperature, 2x in 2X SSC, 0.5% SDS at 65oC for 












































Double-stranded northern probes designed to hybridize to the 3′ ends of STE11 and SPB4 (bases 
1641-2153 and 1604-1812, respectively, relative to the ATG start codon) were amplifi ed by PCR 
from genomic DNA.  A probe for ACT1 (bases 36-640) was used as a loading control.  Probes 
were radiolabeled using the RadPrime DNA Labeling System (Invitrogen), by incubating PCR 
fragments with Klenow, random hexamers, dATP, dGTP, dTTP, and 32P-dCTP overnight at room 
temperature.  
Yeast whole cell extract preparation and immunoblotting
The indicated strains were grown to mid-log phase in YPD at 30oC, and either harvested or  
treated as indicated in the text and then harvested by centrifugation.  Whole cell extracts were 
prepared by resuspending cells in 20% TCA, adding glass beads (425-600 M, Sigma), and bead 
beating in a Mini Bead Beater (Biospec Products).  Extracts from 1x107 cell equivalents were 
separated on 4-20% Tris Glycine gels (Invitrogen), and transferred to PVDF membranes by wet 
transfer method (300 mAmp, 90 minutes).  Antibodies used to probe membranes were: -Cdc2 
(sc-53, Santa Cruz Biotechnology), -Cdc2 Y19 phos (#9111S, Cell Signalling), -H4 (ab10158, 
Abcam), -H3S10p (12261), -TAP (CAB10001, Open Biosystems), -H4K16ac (#39167, 
Active Motif), -H3 (ab1791, Abcam), --Tubulin (T5201, Sigma).  Membranes washed, 
incubated with secondary antibodies (swine--rabbit-IgG-HRP, Dako P0399 sheep--mouse-
IgG-HRP, GE Healthcare NA931; and rabbit--goat-IgG-HRP, Dako P0160), incubated with 
Immobilon Western Chemiluminescent HRP Substrate (Millipore), and imaged with a Fujifi lm 
LAS3000 Camera.
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For immunoblot analysis of tagged protein levels before and after H2O2 treatment, Ecm5-PrA or 
Snt2-PrA yeast strains were inoculated into YPD and grown 5 hours until they were in mid-log 
phase, at which point samples were taken for the 0 hour timepoint.  H2O2 was then added to a 
fi nal concentration of 0.4 or 0.5 mM (as indicated in fi gures), and cells were harvested 2 hours, 
4 hours, and 6 hours later.  In one experiment an untagged strain was used as a control, while in 
another, the Ecm5-PrA strain was grown but treated with water as a control.  For immunoblot 
analysis of stationary phase yeast, untagged, Ecm5-PrA, Snt2-PrA, and Rpd3-PrA strains were 
inoculated into YPD.  Cultures were allowed to grow for 7 days, and cells were harvested at the 
times indicated in Figure 4.10.  Whole cell lysates were obtained and immunoblots performed as 
described above.
Yeast cell cycle analysis
Cultures of bar1, ecm5 bar1, and ECM5-TAP bar1 strains were grown to mid-log phase in 
YPD, and synchronized using -factor, which was purchased from GenScript, using a previously 
published protocol (Amberg et al., 2005).  Synchronies were monitored in the microscope, to 
look for very few or no budded cells and shmoo formation.  Synchronized cells were collected 
by centrifugation, washed in pre-warmed media, and resuspended in fresh media to release cells 
from arrest.  Samples were taken every 20 minutes for fl uorescence activated cell sorting (FACS) 
analysis, or every 10 minutes for immunoblot analysis.  For the latter, whole cell extracts were 
obtained and immunoblots performed as described above.  Cells taken for FACS analysis were 
fi xed in 67% ethanol overnight and prepared for FACS using the SYTOX Green (Molecular 
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Probes) DNA-binding dye as following a previously published protocol (Haase, 2004).  FACS 
was performed in the Rockefeller University Flow Cytometry Resource Center.  A FACSCalibur 
instrument (BD Biosciences) was used to collect the data, using the 488 nM laser for excitation 
and the FL2 detector.
Sporulation assays and spore analysis
For sporulation analysis, the ECM5 gene was deleted from wild-type haploid MATa and MAT 
SK1 background strains (strains SKY163 and SKY164, respectively – gifts from Scott Keeney), 
generating MATa ecm5::kanMX4 and MAT ecm5::hphMX4.  These two strains were mated 
to make an ecm5/ diploid strain.  The wild-type diploid SK1 strain (165) and the ecm5/ 
diploid strain were struck on YPG (YP Glycerol) just prior to sporulating to ensure their 
respiratory competence.  Cells were then patched onto YPD plates and incubated overnight at 
30oC.  Cells were transferred to sterile 1% potassium acetate solution, and incubated at 30oC for 
3 days.  The number of tetrads was divided by the total number of tetrads and diploid cells (based 
on hemocytometer counting) to determine the percent sporulation for each strain.  More than 500 
cells or tetrads were counted per strain, for 3 independent wild-type replicates and 4 independent 
ecm5/ replicates.
For tetrad dissections, tetrads were collected by centrifugation, resuspended in 0.05 mg/mL 
zymolyase 10T (US Biological) in 1M sorbitol, and incubated at 30oC for 20 minutes with 
nutating to digest the ascospore.  Digested tetrads were diluted 1:25 and placed on ice.  10 L of 
digested tetrads were dripped down the middle of a YPD plate, and an Axioscope 40 microscope 
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fi tted with an Axioscope Tetrad Manipulation System (Zeiss) was used to dissect individual 
tetrads onto clean sections of the plate.  Plates were incubated at 30oC and imaged after 2 days.  
Plates were then replica-plated onto YPD-G418 and YPD-Hygromycin plates to select for 
individual ecm5 knockout alleles.  Selection plates were grown overnight at 30oC and imaged the 
next day.
Determination of doubling times
YPD or SD CSM cultures were inoculated with each strain, and allowed to grow at least 5 hours 
to mid-log phase.  Samples of each culture were taken each hour for at least 8 hours and analyzed 
using the Beckman Coulter DU800 Spectrophotometer to determine optical densities at 600 nm 
(OD600s).  For each culture, optical densities were plotted as a function of time in Excel, and 
an exponential trendline (y=aebx) was fi tted to the curve, where y is OD600 and x is time.  The 
doubling time was then determined by taking ln(2)/b, based on the following derivation:  
The formula for exponential growth is C2 = C1*2
(x /D), where C1 is the initial concentration of 
cells, C2, is the fi nal concentration of cells, x is the time in culture, and D is the doubling time.
If eln 2 is substituted for 2, the equation becomes: C2 = C1*e 
(x*ln 2/D), which is in the same form as 
the exponential trendline.  From this, b=ln 2/D, and therefore, D=ln 2/b.
Doubling times were determined for 3 independent cultures and then averaged.
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H2O2 survival assays
Wild-type, ecm5, snt2, or rpd3 yeast strains were inoculated into YPD and grown to mid-
log phase.  An aliquot of each culture was taken, and the cell concentrations were determined by 
taking OD600 spectrophotometer readings and comparing to a previously determined standard 
curve relating OD600 readings and cells/mL measured on a hemocytometer.  Aliquots were 
diluted in YPD to 1667 cells/mL, and 6 x 100 L of each aliquot were plated on YPD (167 cells 
per plate, 1000 cells total).  H2O2 was then added to each culture to a fi nal concentration of 0.4 
mM, and cultures were put back in the 30oC shaking incubator.  4 hours after H2O2 addition, 
another aliquot was taken, diluted, and plated as described above.  After 2 days, the number of 
viable colonies on each plate was counted, and for each culture, the number of viable cells at the 
4 hour timepoint was divided by the number of viable cells before H2O2 addition, to determine 
percent survival.  Three independent replicates were performed for each strain, and the percent 
survival values were averaged across replicates.
Chromatin immunoprecipitation
For the H2O2 ChIP-sequencing experiments, cells for sequencing, Ecm5-Myc, Snt2-Myc, and an 
untagged control strain (BY4741) were inoculated into 1.5L YPD cultures, and grown to mid-
log phase (~2x107 cells/mL).  From each culture, 400 mL were separated and fi xed by adding 
formaldehyde to a fi nal concentration of 1%, shaking at room temperature for 20 minutes, and 
adding glycine to a fi nal concentration of 125 mM to quench.  Cells were then centrifuged, 
washed 4 times in cold PBS, and fl ash frozen in liquid nitrogen.  H2O2 was added to the 
remaining culture to a fi nal concentration of 0.4 mM, and 0.5 and 4 hours after H2O2 addition, 
cells were fi xed and harvested as described above.
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ChIP was performed essentially as described (Aparicio et al., 2005)B, with the following 
modifi cations.  Cells were resuspended in lysis buffer (50 mM HEPES pH 7.5, 1 mM EDTA, 140 
mM NaCl, 1% Triton X-100, 0.1% sodium deoxycholate, 1 mM PMSF, 5.8 M pepstatin, and 
0.5 g/mL leupeptin) to a fi nal concentration of 4x109 cells/mL and lysed by bead beating with 
zirconia-silica beads (Biospec Products), alternating between 3 minutes in the bead beater and 
1 minute on ice, for 10 cycles.  Lysates were then sonicated in 1 mL aliquots using a Bioruptor 
Sonicator, set on high, cycling between 30 seconds on and 30 seconds off for 100 minutes total 
time.  After sonication, DNA was purifi ed from an aliquot of each sample and run on an agarose 
gel to ensure DNA was sheared to between 150 and 400 bp.  
Chromatin from identical samples was pooled, and 16 g monoclonal Myc 9E10 antibody 
(#05-419, Millipore) were added to each sample.  Samples were incubated 16 hours at 4oC with 
rotation.  The next day, 160 L of Magna ChIP Protein G magnetic beads (Millipore) were 
used to IP each sample.  After washing, crosslinks were reversed, and input and IP DNA were 
purifi ed over Qiagen PCR purifi cation columns and eluted in 25 L Tris pH 8.0.  Purifi ed DNA 
was incubated with 30 g RNase A for 3 hours at 37oC (Fisher Scientifi c), purifi ed over a second 
Qiagen column with 25 L elution, and 5 L of the elution was saved for qPCR analysis.  The 
remaining 20 L of each sample were used to build sequencing libraries.  Small-scale ChIPs 
were performed similarly except that 1x109 cells, 2 g anti-Myc antibody, and 20 L Protein G 
beads were used per ChIP.  
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For ChIP-seq of rapamycin treated samples, Ecm5-Myc, Snt2-Myc, and an untagged control 
strain (BY4741) were inoculated into 2L SD CSM cultures, and grown to mid-log phase (~2x107 
cells/mL).  For the 0 hour timepoint, 450 mL of each culture were taken and fi xed as described.  
Cultures were split into two fl asks, one that received DMSO, and one that received rapamycin 
(fi nal concentration 100 nM).  After 0.5 hours, 450 mL of each culture were taken and fi xed, 
and 4 hours after rapamycin addition, 250 mL of each culture were taken and fi xed.  ChIPs were 
performed as described above.
Preparation of samples for sequencing and sequencing
ChIP sequencing libraries were prepared using a TruSeq DNA sample prep (Illumina), following 
manufacturer’s instructions, except that lower concentrations of TruSeq adapters were used: 8% 
of the recommended adapter concentration was used with the H2O2 ChIP samples, because the 
amount of DNA in these samples was expected to be much lower than the recommended started 
amount, since the kit is designed for making libraries out of genomic DNA.  For the rapamycin 
ChIP samples, 3.2% of the recommended adapter concentration was used, because the 8% used 
for the H2O2 library preparations still created dimers that were detectable after the amplifi cation 
step.  For the fi nal amplifi cation step, 20 cycles of PCR were used for the H2O2 -treated samples 
and 21 cycles for the rapamycin-treated samples.  Samples of each library were analyzed by 
agarose gel to assess library size distribution and quality.
RNA sequencing libraries were prepared from 4 g total RNA using a TruSeq RNA sample prep 
(Illumina) per manufacturer’s instructions.   For the fi nal amplifi cation step, 15 cycles of PCR 
were used.
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All libraries were validated using the nanodrop spectrophotometer, to check concentration 
and for a clean peak, and using an Agilent Bioanalyzer to more accurately determine size and 
quantity of DNA in libraries.  As a fi nal verifi cation, qPCR was purifi ed on an aliquot from 
the fi nal libraries, using primers to the CYC3 promoter, which is a previously reported Snt2 
ChIP target (Harbison et al., 2004), to ensure that DNA from this region is enriched in ChIP 
libraries relative to input libraries.  Libraries were sequenced on an Illumina HiSeq 2000 at the 
Rockefeller University Genomics Resource Center.
Alignment and analysis of sequencing data
Reads from ChIP-seq experiments were aligned to the S. cerevisiae genome (SacCer2) using 
the Bowtie alignment software (Langmead et al., 2009).  Unique reads that mapped to a single 
location with no more than two mismatches were kept and used to generate genome-wide 
distributions of  Ecm5 or Snt2 binding and for peak identifi cation.  
The Galaxy server (https://main.g2.bx.psu.edu/) was used for a much of the sequencing data 
analysis.  The software MACS, which was run off the Galaxy server, was used to identify peaks 
in the Ecm5 and Snt2 ChIP and input datasets using the time-matched ChIP from the untagged 
strain as a control (Zhang et al., 2008).  Peaks identifi ed in the ChIP samples that were also 
identifi ed in the inputs were discarded.  Peaks that were shared between Ecm5 and Snt2 were 
determined by asking the Intersect program on the Galaxy server to return genomic intervals 
where the intervals defi ning Ecm5 and Snt2 peaks overlapped by at least 200 bp.  In cases where 
the number of peaks differed depending on whether Ecm5 or Snt2 was the fi rst dataset (e.g. 
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places where 1 Ecm5 peak encompasses a region of the genome that contains two Snt2 peaks), 
the intersected list with the lower number of peaks was used.  A list of yeast genes was obtained 
from the UCSC Genome Browser (http://genome.ucsc.edu/).  Yeast promoter regions were 
defi ned by asking the Get Flanks program on Galaxy to return the 500 bp upstream of the start 
codon of each yeast gene.  The Intersect program was then asked to return the names of genes 
whose promoter regions overlapped with shared Ecm5/Snt2 peaks by at least 200 bp.  These 
genes were then used for functional gene ontology analysis using the FuncAssociate program 
(Berriz et al., 2009).  For the transcription start site (TSS) analysis, the TSS’s of all genes were 
taken from the UCSC Genome Browser.  TSS profi les were generated using a custom script that 
divides each gene into 50 bp windows surrounding the TSS, and counts the average number of 
reads at all genes within those windows per million mapped reads.  This analysis was repeated 
with the top 100 most highly expressed yeast genes, taken from a separate study (Miller et al., 
2011).
Reads from RNA-seq experiments were aligned to the S. cerevisiae genome using the software 
TopHat (Trapnell et al., 2009).  The Cuffl inks and Cuffdiff software were then used to generate 
expression values for each gene in each sample and ratios of expression for genes between 
samples (Trapnell et al., 2010).  These programs were all executed from the Galaxy server.  The 
heatmap was generated using a custom clustering script.
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Competitive Fitness Assays
Wild-type, ecm5, and snt2 strains were patched onto YPD and grown overnight at 30oC.  
These cells were then used to inoculate precultures in SD CSM media, which were grown 
overnight at 30oC.  The next morning, OD600 spectrophotometer readings of dilutions of the 
precultures were used to determine cell concentrations.  Equal numbers of wild-type and ecm5 
or snt2 cells were inoculated into SD CSM media, such that each culture started out with 2x105 
cells/mL total.  After inoculating, aliquots of each culture were taken, diluted and plated on 
YPD or YPD G418, aiming for approximately 120 cells per plate with 6 YPD plates and 6 YPD 
G418 plates per culture.  After 12 hours, aliquots of each culture were taken, diluted, and plated 
as described above.  After 24 hours in culture and each subsequent day, OD600 readings were 
used to determine the cell concentration in each culture, cultures were diluted to 2x105 cells/mL 
in fresh SD CSM media, and aliquots were taken, diluted, and plated as described above.  The 
dilution of cultures with fresh media each day ensured that the experiment tested competitive 
fi tness and not just which strain had longer chronological lifespan.  For each set of plates, 2 days 
after plating, colonies were counted, and for each culture, the number of colonies on the YPD 
G418 plates (which was proportional to the number of knockout cells in culture) was divided by 
the number of colonies on the YPD plates (which was proportional to the total number of cells 
in culture).  Three wild-type vs. ecm5 competitions and three wild-type vs snt2 competitions 
were performed, and results from replicates we re averaged.
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APPENDIX: SUMMARY OF SEQUENCING DATA
Table A.1 Summary of H2O2 ChIP Sequencing Experiment
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Table A.2 Summary of H2O2 RNA Sequencing Experiment
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Table A.3 Summary of Rapamycin ChIP Sequencing Data
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